Monoclonal antibodies to Herpes Simplex Virus type 2 by MacLean - Pieper, C.S.
CENTRM.E LANDBOUWCATALOGUS 
Promotor: dr. A. van Kauunen 
hoogleraar in de moleculaire biologie 
Co-promotor: dr. A.C. Minson 
hoogleraar in de virologie aan de University of 
Cambridge, Cambridge, Engeland 
C.S. McLean -P ieper 
MONOCLONAL ANTIBODIES TO 
HERPES SIMPLEX VIRUS TYPE 2 
Proefschrift 
ter verkrijging van de graad van 
doctor in de landbouwwetenschappen, 
op gezag van de rector magnificus, 
dr. C.C. Oosterlee, 
hoogleraar in de veeteeltwetenschap 
in het openbaar te verdedigen 
op vrijdag 3 September 1982 
des namiddags te vier uur in de aula 
van de landbouwhogeschool te Wageningen. 
'Ut.i&fW'Oi 
A C K N O W L E D G E M E N T S . 
I would l ike to thank the following people for t he i r help during 
the various stages of the work described in t h i s t h e s i s . Without 
them i t would never have been wr i t ten . 
F i r s t of a l l , Tony Minson, whose support and encouragement as my 
supervisor have been invaluable. He was always ava i lab le to give 
advice and p r a c t i c a l he lp when p rob lems .a rose . I have learned 
much form his c r i t i c a l superv i s ion , both in the p r a c t i c a l work 
and in the writing of t h i s t h e s i s . 
Ab van Kammen, especia l ly for h i s help and comments during the 
wri t ing . 
Tony Nash, for his invaluable help with the animal experiments, 
and for his discussion and comments on many aspects of the work. 
David Hancock, for his excellent technical assistance during the 
later stages of the project. 
Anne Buckmaster, who provided the data involving the antibodies 
AP7 and AP12, and was always available for friendly discussion. 
Professor P. Wildy, who made it possible for me to work in the 
department of pathology. 
Dr S. Buchan, who provided some of the data on antibody LP1. 
And all the members of the division of virology, for providing 
such a pleasant atmosphere to work in. 
I also want to thank my husband, Robert, whose help with the 
processing of this thesis. His continuous support has been 
invaluable. 
As a Ph.D is also the completion of a scientific education, I 
would like to thank my parents for giving me the opportunity to 
go to university, and for providing such a good home background. 
,STEIXINGEN 
fijtuoiio)) ^02 
I. The observation by Stevens and Cook, that anti-Herpes IgG is 
important for maintaining latent infections is invalidated in 
the light of Sekizawa et al's findings that in the absence of 
herpes specific antibodies, virus latency was still maintained. 
Sekizawa, T., Openshaw, H., Wohlenberg, C. and Notkins, A.L. (1980). 
Science 210: 1026-1028. 
Stevens, Y.G. and Cook, M.L. (1974). J. Immunol. 113: 1685-1693. 
II. Congenital human cytomegalovirus infections are a major cause 
of abnormalities in the newborn, but in view of the possible 
oncogenic potential of the virus, the vaccination of young women 
with live attenuated virus is unjustified. 
Elek, S.P. and Stern, H. (1974). Lancet 1: 15. 
Osborne, J.E. (1981). J. Inf. Dis. 143: 618-630. 
III. RNA tumor viruses are not important agents of human cancer, but 
the study of these viruses has led to the identification of genes 
and proteins involved in the induction of a wide range of neoplastic 
diseases. 
Parada, L.F., Tabin, C.Y., Shih, C. and Weinberg, R.A. (1982. 
Nature 297: 474-478. 
Kaplan, H.S. in "Molecular Biology of RNA-Tumor Viruses", Ed. J.R. 
Stephenson. Acad. Press, New York (1980). 
IV. The development of single-cell protoplasts for the study of plant 
virus replication in the early 1970's heralded a new era in plant 
virology. However, the outcome has been disappointing in that 
the progress made in plant virus replication in the past ten years 
does not compare with the success in -the study of animal virus 
replication following the introduction of animal tissue culture. 
Tabeke, I., Otsuka, Y. and Aoki, S. (1968). Plant and Cell Physiol. 
9: 115-124. 
V. The recent proposal by Prusiner et al. for a "prion" as the 
infectious scrapie agent is highly unorthodox. As Kimberlin 
points out, a much simpler working hypothesis, involving infectious 
nucleic acid, which fits all the established facts can be found. 
Kimberlin, R.H. (1982). Nature 297: 107-108. 
Prusiner, S.B. (1982). Science 216.- 136. 
VI. The widespread use of live attenuated poliovirus vaccines has 
led to the virtual elimination of poliomyelitis, but offers no 
i prospects of eliminating the virus. Countries using the live 
attenuated vaccine should adopt the policy already used in Sweden 
and the Netherlands and begin using killed vaccines in order to 
achieve elimination of the virus. 
Horstmann, D.M., Niederman, J.C. and Paul, J.R. (1959).J. Amer. 
Med. Ass. 170: 1-8. 
Salk, J. and Salk, D. (1977). Science 195: 834-847. 
VII. The use of PMSF as a protease inhibitor during the isolation of 
plant proteins is of little value. 
Borsers et al. (1982). Virology 116: 236-249. 
7111. The study of temperature-sensitive mutants of animal viruses can 
yield useful information, but the occurrence of silent, double and 
suppressor mutations make interpretation of results from the study 
of single viral mutants hazardous. 
Ahmed, R., Chakraborty, P.R., Graham, A.F., Raraig, R.F. and 
Fields, B.N. (1980). J. Virol. 34: 383-389. 
Cox, N.J., Kendal, A.P., Maassab, H.F., Scholtissek, C. and 
Spring, S.B. (1981). In "The replication of Negative Strand 
Viruses". D.H.L. Bishop and R.W. Compans, eds. p.405. Elsevier, 
North Holland. 
IX. The English system of competitive University entrance examination 
is preferable to the Dutch system of a lottery. 
Proefschrift van Cornelia S. McLean-Pieper 3 September 1982 
TABLE OF CONTENTS. 
Scope of the Investigations 1 
Chapter 1: Introduction 3 
Significance of monoclonal antibodies in viral research 4 
Herpes Simplex Virus proteins 5 
Control of viral protein synthesis 6 
Polypeptides of the virion 7 
Glycoproteins : structure and function 7 
Glycoproteins as targets of the immune system 9 
Glycoproteins as targets of neutralising antibodies 10 
Role of glycoproteins in ADCC and AbC' 11 
Glycoproteins as targets of cytotoxic T-cells 11 
Cross-reactive antigens in the Herpes Viruses 12 
Clinical applications of monoclonal antibodies to Herpes 
Simplex Virus 13 
Chapter 2; Fusion experiments 15 
Introduction 15 




Reverse Passive Haemagglutination 16 
Coupling of antibody to plastic surfaces 16 
Labelling of proteins using 125I 17 
Radioimmunoassay 17 
Immunisation schedule 17 
Fusion 18 
Cloning 18 
Labelling of secreted imunoglobulins 18 
Ouchterlony test 19 
Results 
A. Preliminary Experiments 19 
Immunisation schedule 19 
Assay systems 19 
Discussion 21 
Immunisation 21 
Assay methods 22 
B. Fusion experiments 22 
Raising of serum or asitic fluid 26 
Immunoglobulins secreted by the hybridoma's 26 
Discussion 27 
Chapter 3; Antibodies LP1 and LP4. 29 
Introduction 29 
Materials and methods 29 
Cells and virus 29 
Radioimmunoassay 29 
Fluorescence 29 




Table of antibodies 66 
References 67 
Abbreviations 79 
Identification of target antigens 30 
Neutralisation 31 
Results 31 
Identification of target antigens 31 
LP1 31 
LP4 32 
Cross-reactivity with other Herpes Simplex Virus strains 32 
Immunofluorescence 32 
Discussion 35 
Chapter 4; Antibodies to glycosylated proteins 37 
Introduction 37 
Materials and methods 37 






Coupling of IgG to sepharose beads 39 
Purification of IgG 39 
Results 39 
I. Antibodies directed against gD 39 
Immunoprecipitations 40 
Neutralisation 40 
Cross-reactivity with HSV-1 41 
Competition binding 43 
Fluorescence 44 
Rosetting 44 
Identification of gD-precursor 47 
II. Antibodies directed against gC and gE 47 
Immunoprecipitations 47 
Cross-reactivity of LP5 and LP6 with HSV-1 48 
Neutralisation 48 
Fluorescence 48 
III. Antibodies LP7, LP8 and LP9 48 
Discussion 50 
Antibodies to gD 50 
Antibody LP5 50 
Antibody LP6 
Antibodies LP7, LP8 and LP9 52 
Chapter 5; Antiviral role of LP2 and LP3 in vivo 53 
Introduction 53 
Materials and methods 54 
Virus, cells 54 
Mice 54 
Inoculation of mice 54 
Infectivity assays 54 
Sera and ascitic fluids 54 
Results 54 
Effect of LP2 and LP3 on infection with HSV-1 55 
Effect of LP2 and LP4 on infection with HSV-2 55 
Effect of LP2 and LP3 on the establishment of latency 58 
Discussion 59 
Discussion 61 
S C O P E OF T H E I N V E S T I G A T I O N S . 
In 1975, a method was developed by Kolher and Milstein for the 
production of large quan t i t i e s of monospecific an t ibod ies .They 
isola ted a HAT-sensitive mouse myeloma c e l l l i n e which, a f t e r 
fusion with sp leen c e l l s from an immunised mouse, produced 
hybrid c e l l s of p red i f ined s p e c i f i c i t y . Large q u a n t i t i e s of 
monoclonal antibodies against any given an t igen can be obta ined 
in t h i s way. The technique has been used succes s fu l l y for the 
p roduc t ion of monoclonal a n t i b o d i e s a g a i n s t many d i f f e r e n t 
a n t i g e n s , such as tumor a n t i g e n s , lymphocyte markers , human 
leucocyte interferon and many v i r a l a n t i g e n s . (Koprowski e t a l , 
1978; McMichael a t a l ,1979; Secher and Burke,1980; Wiktor and 
Koprowski,1978; Gerhard e t al ,1977.) 
These a n t i b o d i e s have proved u s e f u l t o o l s t o p robe and 
c h a r a c t e r i s e many b i o l o g i c a l sys tems . The i r a p p l i c a t i o n t o 
c l i n i c a l diagnosis and therapy and to l a r g e s c a l e p u r i f i c a t i o n 
of ce r t a in antigens wil l lead to a fur ther unders tanding of the 
antigenic determinants of the v i rus , the mechanism by which they 
infect c e l l s , the importance of neu t r a l i s i ng a n t i b o d i e s and the 
in te r re la t ionsh ips of different v i r a l p ro t e ins . They wi l l provide 
a source of specif ic reagents tha t can be used to c lea r ly define 
antigenic var ia t ionss in a given virus type. 
In r e c e n t y e a r s , t h e r e have b e e n many r e p o r t s on 
i d e n t i f i c a t i o n and c h a r a c t e r i s a t i o n of Herpes Simplex Virus 
p r o t e i n s , ( for a review: see Spear and Ro i zman , 1 980 ) . The 
r e s e a r c h in t h i s f i e l d has been g r e a t l y hampered by t h e 
complexi ty of the v i r u s , the g r e a t number of v i r u s - s p e c i f i c 
p r o t e i n s and t h e l a c k of k n o w l e d g e r e g a r d i n g t h e i r 
i n t e r r e l a t i onsh ip s . Monoclonal ant ibodies w i l l be useful t o o l s 
in provid ing more information about the unique i d e n t i t y and 
re la t ionsh ips between the proteins coded for by t h i s v i r u s . They 
wi l l a lso be of great value as c l i n i c a l reagents for se ro typ ing 
HSV s t r a i n s . 
The aim of the work presented in t h i s thes i s was to produce 
monoclonal antibodies against Herpes Simplex Virus Type 2 (HSV-
2 ) . At the time of t h e s t a r t of t h e s e i n v e s t i g a t i o n s , no 
monoclonal antibodies to Herpes Simplex Virus had been reported. 
We decided not to se lec t for specif ic v i r a l ant igens , but to t ry 
and obtain monoclonal antibodies against a v a r i e t y of d i f f e r e n t 
v i r a l p ro t e in s . 
In t h e f i r s t c h a p t e r a s h o r t r ev iew i s g i v e n on t h e 
s i g n i f i c a n c e of monoclonal a n t i b o d i e s in v i r u s r e s e a r c h . In 
a d d i t i o n t h i s c h a p t e r c o n t a i n s a r ev iew on t h e r e l e v a n t 
p r o p e r t i e s of Herpes Simplex V i r u s Type 2 , f o c u s s i n g in 
pa r t i cu l a r on the glycoproteins of the v i r u s . 
The second chapter describes the production of monoclonal 
antibodies against HSV-2. In t o t a l , nine s t a b l e hybridoma l i n e s 
were obtained, each secret ing antibodies of the immunoglobulin G 
c l a s s . Several immunisation schedules were compared for t h e i r 
effectiveness in ra is ing an antibody response a g a i n s t HSV-2 in 
Balb/c mice. A v a r i e t y of assays for the d e t e c t i o n of mouse 
ant i -HSV-2-ant ibodies were t e s t e d , and the two most s u i t a b l e 
systems were used in the subsequent screening of hybridoma's. 
In chapters 3 and 4 the fu r t he r c h a r a c t e r i s a t i o n of these 
monoclonal antibodies i s desc r ibed . They were t e s t e d for t h e i r 
a b i l i t y to n e u t r a l i s e i n f e c t i o u s v i r u s and t h e i r t y p e -
s p e c i f i c i t y . If poss ib le , t h e i r t a r g e t - a n t i g e n was i d e n t i f i e d . 
They were also t e s t e d in immunofluorescence and r ed -b loodce l l 
r o s e t t i n g a s s a y s . In c h a p t e r 3 , t h e c h a r a c t e r i s a t i o n of 
hybridoma's LP1 and LP4, which s e c r e t e a n t i b o d i e s d i r e c t e d 
against the proteins VP16 and ICSP11/12 ( the major DNA-binding 
protein) i s presented. Their possible use in the i n v e s t i g a t i o n 
of t h e s e p r o t e i n s and t h e i r use in c l i n i c a l d i a g n o s i s i s 
discussed. 
In chapter 4, four monoclonal a n t i b o d i e s d i r e c t e d a g a i n s t 
d i f ferent antigenic s i t e s on glycoprotein D are presented . These 
antibodies give further i n s i g h t in the a n t i g e n i c s t r u c t u r e of 
t h i s p r o t e i n , which i s an important c o n s t i t u e n t of the v i r a l 
membrane. In the same chapter, two an t ibodies d i r e c t e d a g a i n s t 
the glycoproteins gC and gE are also described. 
In the f i f th chapter the protect ive effect of several of the 
monoclonal a n t i b o d i e s on Herpes Simplex Virus i n f e c t i o n of 
Balb/c mice i s invest igated. I t was found that antibody LP2 had 
a s igni f icant effect in reducing both i n f e c t i o u s v i ru s t i t r e s 
and ea r swel l ing in H S V - l - i n f e c t e d m i c e . N o n - n e u t r a l i s i n g 
a n t i b o d i e s did not have any e f f e c t , wi th t he e x c e p t i o n of 
ant ibody LP3, which gave a s l i g h t l y enhanced in f lammatory 
r e a c t i o n . The e f f ec t of LP2 on the e s t ab l i shmen t of l a t e n t 
infection i s also discussed. 
In chapter 6, conclusions are drawn and a short d e s c r i p t i o n 
of the u t i l i s a t i o n of some of the monoclonal a n t i b o d i e s in 
future invest igat ions is given. 
C H A P T E R 1 : I N T R O D U C T I O N . 
Herpes Simplex Virus Type 2 (HSV-2) i s a l a rge DNA v i ru s 
belonging to the Herpesvirus fami ly . Together with four o t h e r 
Herpesviruses, Herpes Simplex Virus Type 1 (HSV-1), V a r i c e l l a -
Zoster Virus, Cytomegalovirus, and Epstein-Barr v i r u s , i t i s a 
natural pathogen of man. The d i f f e ren t i a l cha rac t e r i s t i c s of the 
Herpesvirus family are a l i nea r , double-stranded DNA-genome, with 
a molecular weight ranging from 80 x 106 to 150 x 106 ; an 
i c o s a h e d r a l c a p s i d c o n s i s t i n g of 162 capsomers (Wildy e t 
a l ,1960) ; an i l l -def ined s t ruc tu ra l component cal led the tegument (Roizman and Furlong, 1974) , and a t r i l a m i n a r membrane, t h e 
envelope , which i s acquired by budding th rough the n u c l e a r 
membrane (for a review see Spear and Roizman,1980). The envelope 
con t a in s both h o s t - and v i r u s - d e r i v e d m a t e r i a l (Wildy e t 
a l ,1960) . 
HSV-1 and HSV-2 have ve ry s i m i l a r s t r u c t u r a l and 
b i o l o g i c a l p r o p e r t i e s and s h a r e c e r t a i n common a n t i g e n i c 
d e t e r m i n a n t s . Although HSV-1 i s g e n e r a l l y a s s o c i a t e d wi th 
infect ions of the o r a l mucosa and cornea , while HSV-2 causes 
infect ions of the geni ta l regions, the symptoms produced by these 
two viruses are ind i s t ingu ishab le i f inocu la ted i n to the same 
s i t e (Rawls,1973). 
The r ecen t i n t e r e s t in Herpes Simplex Vi rus can be 
a t t r i b u t e d to v a r i o u s f a c t o r s . 1. HSV c a u s e s r e c u r r e n t 
e p i t h e l i a l l e s i o n s . The v i r u s remains l a t e n t in the sensory 
c e l l s of the t r i gemina l nerve gang l ion ; under cond i t i ons of 
s t r e s s , fever or exposure to sunlight the virus becomes activated (Stevens,1973; Wildy e t a l ,1982) . The resu l t ing l e s ions u s u a l l y 
occur on the mucocutaneous junction of the l i p and tend to recur 
a t the same s i t e time af te r time. Although th i s condi t ion i s by 
no means serious or l i f e - th rea ten ing , i t i s very widespread and 
causes discomfort and embarrassment to the pa t ien t s concerned. 2. 
A number of H e r p e s v i r u s e s t h a t i n f e c t humans have b e e n 
associated with cancer. In p a r t i c u l a r , i n t e r e s t has focussed on 
t h e o n c o g e n i c p o t e n t i a l of HSV-2 i n c e r v i c a l t i s s u e s (review:Rawls ,1973; Spear and Roizman, 1980) . 3 . In fec t ion of 
newborn or immunocompromised i n d i v i d u a l s with Herpes Simplex 
Viruses can be l i fe - threa ten ing (Nahmias and Roizman, 1973) . 4. 
HSV-1 i s the major cause of a d u l t e n c e p h a l i t i s (Olson e t 
a l ,1967; Miller and Ross,1968). 5. HSV-2 has become the major 
cause of venereal infec t ions . 
In the l a s t f i f teen years or so , much has become known 
about the molecular biology of HSV-1 and HSV-2 (see Spear and 
Roizman, 1980) . In t h i s chapter a short review w i l l be given of 
the prote ins of HSV-2, and some emphasis w i l l be placed on the 
glycoproteins as these are l ike ly to be of pa r t i cu l a r importance 
in immuni ty . F i r s t , a s h o r t r e v e i w i s g i v e n a b o u t t h e 
s i g n i f i c a n c e of monoclonal a n t i b o d i e s in v i r a l r e s e a r c h in 
general . 
Significance of monoclonal antibodies in v i r a l research. 
Soon a f te r the introduction of hybrid myeloma's s e c r e t i n g 
monoclonal antibodies of predefined spec i f i c i t y , the po ten t ia l of 
t h i s technique in producing antibodies to viruses was r e a l i s e d . 
Antibodies produced by t h i s method have very de f in i t e p r a c t i c a l 
advantages over the conventional sera produced by an immunised 
a n i m a l . The m i x t u r e of a n t i b o d y s p e c i e s a s w e l l a s t h e 
v a r i a b i l i t y between se ra obta ined from d i f f e r e n t animals have 
presented a major drawback for the use of convent ional s e ra as 
standard biochemical reagents . Monoclonal antibodies are defined 
molecular spec ies , directed against one antigenic s i t e , and a r e 
cheap and easy to produce. In addit ion, t he r e i s no v a r i a b i l i t y 
from animal to animal as with convent ional s e r a . The f ac t t h a t 
only one antigenic s i t e i s being recognised al lows problems of 
a n t i g e n i c r e l a t i o n s h i p s between p r o t e i n s , and q u e s t i o n s 
regarding t h e i r p recu r so r -p roduc t r e l a t i o n s h i p , to be solved 
unambiguously. Monoclonal a n t i b o d i e s are t h e r e f o r e l i k e l y to 
r e p l a c e many convent iona l s e ra in c l i n i c a l a s w e l l a s non-
c l i n i c a l l abora to r i es . 
The f i r s t monoclonal a n t i b o d i e s d i r e c t e d a g a i n s t a v i r u s 
were d e s c r i b e d by Koprowski e t a l ( 1 9 7 7 ) , who p r o d u c e d 
monoclonal a n t i b o d i e s a g a i n s t i n f l u e n z a v i r u s . Monoclonal 
a n t i b o d i e s a g a i n s t r a b i e s v i r u s fo l lowed soon (Wiktor and 
Koprowski , 1978) and s i n c e t hen a s n o w b a l l - e f f e c t i n t h e 
p roduc t ion of monoclonal a n t i b o d i e s a g a i n s t many d i f f e r e n t 
viruses has been observed. Monoclonal a n t i b o d i e s have now been 
ob ta ined a g a i n s t such widely d i f f e r i n g v i r u s e s as meas l e s (Giraudon and Wild,1981); murine leukemia v i r u s e s (Costron e t 
al,1979 Harlow e t a l , 1 9 8 1 ; Nowinski e t a l , 1 9 7 9 ) ; SV-40 tumour 
antigens (Deppert et a l ,1981); pol iovirus (Ferguson e t al,1980) 
Herpes Simplex Virus (Zweig e t a l , 1 9 7 9 ; Pe re i r a e t a l ,1980 
K i l l i n g t o n e t a l , 1 9 8 1 ) ; r e o v i r u s e s (Lee e t a l , 1 9 8 1 ) 
r e t r o v i r u s e s (Orosz l an and N o w i n s k i , 1 9 8 0 ) ; S i n d b i s Vi rus (Roet r ig e t a l , 1 9 8 1 ) ; Adenovi rus ( R u s s e l l e t a l , 1 9 8 1 ) and 
h e p a t i t i s (Wai-kuo Shih e t a l ,1980) . 
An example of the po ten t ia l of monoclonal a n t i b o d i e s for 
c l i n i c a l as well as n o n - c l i n i c a l a p p l i c a t i o n i s the r e sea rch 
car r ied out with monoclonal antibodies a g a i n s t inf luenza v i r u s . 
Not only were monoclonal a n t i b o d i e s used s u c c e s s f u l l y t o 
d i s t i n g u i s h a n t i g e n i c v a r i a n t s of t h e v i r u s (Gerhard and 
Webster,1978; Kendall e t a l , 1 9 8 1 ) , bu t the complete a n t i g e n i c 
topology of the virus haemagglutinin was determined (Wiley e t 
a l , 1 9 8 1 ) . V a r i a t i o n in t h e a n t i g e n i c s t r u c t u r e of t h e 
haemagglutinin i s associated with the recur rence of in f luenza 
vi rus in man. When the three-dimensional s t r u c t u r e and primary 
sequence of the 1968 Hong Kong h a e m a g g l u t i n i n became known (Wilson e t al,1981) , a panel of monoclonal ant ibodies d i r e c t e d 
a g a i n s t t h e h a e m a g g l u t i n i n m o l e c u l e was used t o o b t a i n 
information about the r e l a t i o n s h i p between observed mutat ions 
induced by t h e p r e s e n c e of t h e s e a n t i b o d i e s and c h a n g e d 
a n t i g e n i c p r o p e r t i e s of t he h a e m a g g l u t i n i n . The obse rved 
mutations clustered into four major areas of the haemagglutinin 
molecule , r e p r e s e n t i n g four a n t i g e n i c s i t e s . Gerhard e t a l (1981) also used t h i s technique of obtaining mutants by growing 
vi rus in the presence of monoclonal ant ibodies . They obta ined 34 
PR-8 mutants, using anti-haemagglutinin ant ibodies , and with the 
aid of 58 an t i -haemagg lu t in i monoclonal a n t i b o d i e s they a l so 
observed four d i s t i n c t antigenic s i t e s on t h i s molecule . These 
experiments provided i n s i g h t in t h e mechanism of a n t i g e n i c 
"shi f t" and "dr i f t " and the importance of ce r ta in antigenic s i t e s 
in these processes. 
Another example of the use of monoclonal a n t i b o d i e s in 
diagnosis and in the invest igat ion of the antigenic r e l a t e d n e s s 
of v i r u s s t r a i n s i s t h e work c a r r i e d o u t wi th monoclonal 
a n t i b o d i e s a g a i n s t r a b i e s v i r u s . U n t i l t h e d i s c o v e r y of 
monoclonal a n t i b o d i e s , the knowledge of the serology of t h i s 
virus was poor. The only method to d is t inguish rabies virus from 
the r a b i e s - r e l a t e d v i r u s e s was t h e use of c r o s s - a b s o r b e d 
a n t i s e r a , and t h i s was not ve ry s a t i s f a c t o r y . Monoclonal 
antibodies defined the rab ies-group unambiguously by provid ing 
r eagen t s which e i t h e r r e a c t with both the r a b i e s and r a b i e s -
re la ted v i ruses , or with rabies virus only. Yet a th i rd group of 
a n t i b o d i e s shows s p e c i f i c i t y for l im i t ed numbers of s t r e e t 
v i ruses , so further sub-dividing the rabies virus group.A panel 
of monoclonal antibodies was used to study a number of v a r i a n t s 
of the v i rus , laboratory-induced ones as well as s t r e e t - v a r i a n t s . 
These antibodies showed for the f i r s t time the g r e a t a n t i g e n i c 
va t ia t ion between virus s t r a i n s , and demonstrated t h a t r a b i e s 
virus has a s imilar po ten t ia l to influenza to undergo a n t i g e n i c 
va r i a t ion . In vivo experiments showed t h a t t h e r e was no c r o s s -
protect ion between va r i an t s . The frequency of var iants of s t r e e t -
s t r a i n s of r ab ies , isolated from fa ta l human c a s e s , seems to be 
high (Wiktor e t a l ,1980 Wiktor and Koprowski , 1980 ) . These 
f ind ings immediately r a i s e d the ques t ion of the adequacy of 
e x i s t i n g r a b i e s v a c c i n e s , and a modi f ica t ion of the vaccine 
potency t e s t by including the r eg iona l s t r e e t v i ru s v a r i a n t in 
the challenge was proposed. 
A more deta i led invest igat ion of the antigenic d i f f e r ences 
between the nucleocapsid p r o t e i n s of the r a b i e s v a r i a n t s has 
also been carr ied out , resu l t ing in an estimate of the number of 
antigenic s i t e s on the molecule. (Flamand e t a l , 1980a). S imi la r 
s tudies were done for the glycoprotein (Flamand e t a l , 1980b). 
This kind of s tudies wi l l provide ins ight in the role of ce r ta in 
antigenic determinants in neu t ra l i sa t ion and antigenic v a r i a t i o n 
of v i ruses . 
Herpes Simplex Virus Prote ins . 
Estimates concerning the number of p r o t e i n s coded for by 
HSV-1 and HSV-2 have s t e a d i l y increased in r ecen t y e a r s . The 
approximate number of d i s t i n c t p o l y p e p t i d e s which can be 
reso lved by s i n g l e dimension e l e c t r o p h o r e s i s i s now usua l ly 
quoted as around f i f t y (Balachandran e t a l , 1 9 8 1 ; Powell and 
Courtney, 1975), but in a recent paper, using two-dimensional gel 
e l e c t r o p h o r e s i s , as many as 230 s e p a r a t e v i r u s - s p e c i f i c 
polypeptides could be de tec ted in in fec ted c e l l s . (Haarr and 
Marsden,1981). One of the d i f f i c u l t i e s in i n t e r p r e t i n g these 
kind of r e s u l t s i s the lack of knowledge regard ing p r e c u r s o r -
product re la t ionships between the di f ferent polypeptides. Many of 
the polypeptide species detected by Haarr and Marsden were shown 
to be p r e c u r s o r s , b u t t h e r e can be l i t t l e doubt t h a t t h e 
estimate of f i f ty polypeptides i s an under-estimate of the t o t a l 
number specified by Herpes Simplex Viruses. 
Whatever t h e t o t a l number, t h e c o m p l e x i t y of t h e 
po lypep t ide p a t t e r n observed f o l l o w i n g e l e c t r o p h o r e s i s of 
i n fec t ed c e l l p r o t e i n s has led to cons ide rab le p rob lems of 
nomenclature. Different groups of workers have used d i f f e r e n t 
polypeptide nomenclatures , and i t i s f r equen t ly d i f f i c u l t to 
r e l a t e d i f ferent nomenclatures. Roizman and coworkers have used a 
system of numbering po lypep t ides according to t h e i r o rde r of 
migration in s ingle dimension polyacrylamide g e l s , the l a r g e s t 
po lypep t ide being given the number 1. Polypept ides from the 
p u r i f i e d v i r i o n ( the s t r u c t u r a l po lypep t ides ) a re given VP-
numbers (Vir ion P o l y p e p t i d e , e . g . VP5 i s t h e major c a p s i d 
antigen) while polypeptides in the infected c e l l a r e given ICP 
numbers (Infected Cell Polypeptide, e .g . ICP8 i s the major DNA-
binding p ro t e in ) , and each VP has an equ iva len t ICP (Spear and 
Roizman,1972; Honess and Roizman,1973) . This nomenclature has 
the d isadvantage t h a t i t i s i n f l e x i b l e and canno t e a s i l y 
accommodate the discovery of new p o l y p e p t i d e s . Furthermore the 
o rde r of p o l y p e p t i d e m i g r a t i o n may be i n f l u e n c e d by t h e 
e lec t rophore t ic ge l system used. Marsden e t a l (1976) used a 
nomenclature which r e l i e s s o l e l y on the molecular weight of a 
p o l y p e p t i d e , each p o l y p e p t i d e b e i n g g i v e n a number which 
r e f l e c t s i t s molecular weight in thousands . The i r sys tem i s 
f l ex ib le but has the disadvantage t h a t d i f f e r e n t l a b o r a t o r i e s 
wi l l obtain dif ferent molecular weights for the same polypeptide 
and wi l l therefore give i t a d i f f e r e n t d e s i g n a t i o n . Powell and 
Courtney (1975), follpwing the example of Roizman 's g r o u p , 
numbered the po lypep t ides of HSV according to t h e i r migra t ion 
order . Each polypeptide was given an ICSP number ( Infected Cel l 
S p e c i f i c P o l y p e p t i d e ) . The c o n f u s i o n r e s u l t i n g from t h e s e 
d i f fe ren t systems of nomenclature i s compounded by the fact that 
d i f ferent workers have used dif ferent s t r a in s of HSV-1 and HSV-2 
and di f ferent c e l l types . The po lypept ide p a t t e r n presen ted in 
t he l i t e r a t u r e by d i f f e r e n t groups o f ten show o n l y l i m i t e d 
s i m i l a r i t y . In t h i s t h e s i s I s h a l l use where p o s s i b l e t h e 
nomenclature of Powell and Courtney (for HSV-2) since these seem 
to be the most widely used in the l i t e r a t u r e . 
A r e l a t i v e l y small number of HSV-specific p r o t e i n s have 
been p u r i f i e d and t h e i r p r o p e r t i e s i n v e s t i g a t e d , b u t t h e 
cha rac t e r i s t i c s of the majori ty of the po lypep t ides a re known 
only in very genera l terms - migra t ion in g e l s , k i n e t i c s of 
s y n t h e s i s during i n f e c t i o n , whether they a re g lycosy la ted or 
phosphorylated and whether they are present in the mature v i r ion . 
Many of the polypeptides specified by HSV therefore remain poorly 
defined. Indeed one of the major c o n t r i b u t i o n s of monoclonal 
a n t i b o d i e s t o h e r p e s v i r u s r e s e a r c h w i l l be t h a t t h e s e 
ant ibodies , since they are specif ic for s i n g l e a n t i g e n i c s i t e s , 
w i l l d i s s e c t t h i s complex mixture of po lypep t ide s and a l l o w 
unambiguous designation of unidentified polypeptides. 
Control of viral protein synthes is . 
The synthesis of v iral prote ins i s temporally ordered in a 
cascade fashion. Thus, three groups groups of proteins can be 
distinguished , namely « - , $- and jf-proteins. The e<-proteins are 
synthesized immediately a f t e r i n f e c t i o n of the c e l l . To d a t e , 
s i x a -po lypep t ide s have been i d e n t i f i e d . S y n t h e s i s of Q-
polypeptides depends on the presence of func t iona l « - p r o t e i n s (Honess and Roizman,1974 ;1975). Examples of ^ -po lypep t ides a re 
the thymidine k inase and v i r a l DNA-polymerase (Honess and 
Roizman, 1974 ;1975; Powell and P u r i f o y , 1 9 7 7 ; G a r f i n k l e and 
McAuslan,1974). The y - p r o t e i n s can only be syn thes ized when 
functional polypeptides belonging to both the « - and (J-group a re 
present . Structural proteins form the major components of the y -
group. This des igna t ion in oi-, fl- and J^-proteins n e c e s s a r i l y 
remains approximate, and i t may be that p r o t e i n s w i l l be found 
which do not f a l l into any of these groups. 
Polypeptides of the virion. 
Estimates of the number of prote ins contained in HSV-1 and 
HSV-2 vir ions vary between 15 and 33 (Heine e t a l ,1974) . Several 
of these p r o t e i n s a re g l y c o s y l a t e d . Three groups of v i r i o n 
polypeptides can be ident i f ied : 1. The p r o t e i n s p re sen t in the 
nucleocapsid pr ior to envelopement. 2. Glycosylated polypeptides, 
which are present in the v i r a l membrane. 3. The remainder of the 
v i r i o n - p o l y p e p t i d e s , which are probably c o n s t i t u e n t s of t h e 
tegument (Spear and Roizman,1980). 
Glycoproteins: s t ruc ture and function. 
A great deal of i n t e r e s t has been focussed on the second 
group of p ro te ins , the v i rus-spec i f ic antigens contained on the 
su r face of the envelope and the in fec ted c e l l . Convalescent 
antibody i s directed against these surface p r o t e i n s , and i t i s 
responsible for the n e u t r a l i s a t i o n of the v i r u s (Plummer,1964; 
Nahmias and Dowdle,1968). The components of the immune system 
tha t react with the vir ion have been shown to r e a c t with v i r a l 
an t igens on the sur face of the i n f e c t e d c e l l ( G l o r i o s o e t 
a l ,1978; Norrild e t al,1979 and 1980). C l e a r l y , these p r o t e i n s 
play a major role in the induction of the immune response to the 
virus in the infected host . 
Most of the work concerning HSV-glycoproteins has been done 
with HSV-1, but each of the main g lycoprote ins in type -1 v i r u s 
seems to have i t s counterpar t , be i t sometimes with a s l i g h t l y 
d i f ferent molecular weight, in HSV-2 (Cassai e t a l , 1975 ) . Unt i l 
recen t ly , four major a n t i g e n i c a l l y and f u n c t i o n a l l y d i s t i n c t 
species of glycoproteins were ident i f ied , namely gB, gC, gD and 
gE, A f i f th glycoprotein, gA, i s probably a modified form of gB (Eber l e and C o u r t n e y , 1 9 8 0 ; Haffey and S p e a r , 1 9 8 0 ) . A new 
g l y c o p r o t e i n , gF , was r e c e n t l y d e s c r i b e d i n HSV-2' by 
B a l a c h a n d r a n e t a l , ( 1 9 8 1 ) . T h e r e a r e p r o b a b l y more 
g l y c o p r o t e i n s than the ones descr ibed above, and monoclonal 
a n t i b o d i e s may provide the t o o l s for i d e n t i f y i n g them i n t o 
ant igenica l ly d i s t i n c t c l a s se s . 
Much of the research into the s t ruc ture and function of the 
g l y c o p r o t e i n s of HSV has made use of a n t i s e r a r a i s e d a g a i n s t 
these p ro te ins . Many of these sera were monospecif ic , i . e . the 
prote in was isolated from an SDS-polyacrylamid gel and ant iserum 
raised against the so purif ied polypept ide. Some a n t i s e r a were 
ra ised against p rec ip i t i n bands (monoprecipitin s e r a ) , and s e r a 
a g a i n s t gC were sometimes p r e p a r e d u s i n g a b s o r p t i o n of 
hyper immune serum w i t h a m u t a n t t h a t l a c k s gC ( s e e 
Norrild,1980) 4 These an t i s e ra have g r e a t l y con t r i bu t ed to our 
knowledge of the glycoproteins, both for t h e i r ident i f ica t ion and 
t h e i r processing and function. They have, however, some obvious 
d i sadvan tages : t h e r e a lways r emains some doubt as t o t he 
spec i f i c i ty of the antiserum, because of the p o s s i b l e impuri ty 
of the an t igen to which i t was r a i s e d . Furthermore, the SDS 
p r e s e n t in polyacryamide ge l s dena tures the p r o t e i n and may 
modify or des t roy c e r t a i n a n t i g e n i c s i t e s . These p o i n t s a re 
i l l u s t r a t e d in the fact t h a t the a n t i s e r a r a i s e d by d i f f e r e n t 
groups of workers against gC, for i n s t a n c e , seem to have very 
d i f f e r e n t p r o p e r t i e s (Eberle and Courtney,1980a; Spear ,1976; 
Powell e t a l , 1 9 7 4 ; Courtney and Powell 1975; Vestergaard and 
Norri ld, 1979; Cohen e t a l , 1980a). I t i s obvious that monoclonal 
antibodies directed against the dif ferent glycoproteins w i l l be 
ve ry u s e f u l t o o l s i n t h e i r f u r t h e r i d e n t i f i c a t i o n and 
charac te r i sa t ion : the disadvantages mentioned above do not apply 
to them. 
L i t t l e i s known about the funct ions of the g lycopro te ins 
specified by HSV. Some (or a l l of them) p lay a r o l e in v i r i o n 
i n f e c t i v i t y , such as attachment to or penetrat ion of c e l l s . 
A temperature-sensit ive mutant of HSV-1, tsB5 ( i s o l a t e d by 
A.Buchan, Birmingham), which f a i l s to synthesize gB, i s unable to 
penet ra te c e l l s , even though absopt ion does take p lace a t the 
non-permissive temperature (Sarmiento e t a l , 1 9 7 9 ) . Manservigi (1977) , using a d i f f e r e n t m u t a n t , found t h a t gB was a l s o 
important in c e l l fusion. A r ecen t r e p o r t by Haffney and Spear (1980) confirmed the ro le of gB in v i r u s i n f e c t i v i t y and c e l l 
fusion. 
The major, ful ly glycosylated form of gB of HSV-1 has a 
molecular weight of 126.000D, and a p a r t i a l l y g l y c o s y l a t e d 
p r ecu r so r of 113.000D (pgB) can be found in p u l s e - l a b e l i n g 
experiments (Spear ,1976) . gA might be a p recur so r of gB, as 
suggested by Eberle and Courtney (1980). 
gC has a molecular weight of 130,000 D. I t s p a r t l y 
g lycosy l a t ed p r ecu r so r has an a p p a r e n t m o l e c u l a r we igh t of 
110,000 D (Cohen,1980). Using tunicamycin, an unglycosyla ted 
form of the protein could be detected, with a molecular weight 
of 85,000 D (Pizer e t a l ,1980) . The function of gC i s not known, 
but many syncyt ia l mutants lack gC, and i t may be that gC and gB 
work antagonis t ica l ly (Manservigi,1977). 
Nothing i s known about the function of g lycopro te in D, but 
some d e t a i l e d work has been done on the p r o c e s s i n g of t h i s 
molecule (Pizer e t a l , 1980). The fully glycosylated form of gD 
in HSV-1 has a molecular weight of approximately 59,000 D. Using 
tunicamycin, an unglycosyla ted p recu r so r of the p r o t e i n was 
discovered with a molecular weight of 50,000D. This p r ecu r so r i s 
no t no rma l ly found in i n f e c t e d c e l l s , a s one o r more 
o l i g o s a c c h a r i d e chains are immediately a t t ached to i t , thus 
forming a p recu r so r to gD (pgD) with a molecular we igh t of 
52.000D (Cohen e t a l ,1980) . Analysis on two-dimensional g e l s has 
shown tha t the processing of pgD to gD involve 11 d i sc ree t steps (Haa r r and M a r s d e n , 1 9 8 1 ) . T h i s work was done u s i n g a 
monoprec ip i t in ant iserum a g a i n s t gD which , b e c a u s e of i t s 
possible impurity, l e f t some doubt as to the r e l a t e d n e s s of the 
polypeptides ident i f ied as intermediates between pgD and gD. The 
use of monoclonal antibodies directed against gD has now proved 
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unambiguously that a l l the 12 polypeptides are re lated and have 
been derived from one common precursor (Harsden et a l , 1 9 8 1 ) . 
This work was carried out using an HSV-1 s t r a i n . The processing 
of gD for HSV-2 has not been worked out in such d e t a i l . gD in 
HSV-2 has a s l i g h t l y lower molecular weight than in HSV-1, 
namely 56.000D, with a partly glycosylated precursor of 51.000D (Eisenberg et a l , 1980). 
The only other protein that has been associated with a 
particular function i s gE. The appearance of gE on the surface of 
the infected c e l l coincides with the appearance of Fc-binding 
ac t iv i ty . The detergent-solubil ised form of gE has an a f f i n i t y 
for the Fc-region of immunoglobulin-molecules, and in fact gE 
can be isolated from virions using a f f i n i t y chromatography on 
sepharose beads to which antigen-antibody complexes have been 
coupled (Baucke and Spear, 1979). The molecular weight of gE of 
HSV-1 i s approximately 80,000 D, with a precursor of about 
65,000 D. gE of HSV-2 has a s l i g h t l y higher molecular weight, 
about 90,000 D, with a precursor of 67,000 D. There i s a cer ta in 
variabi l i ly in these molecular weights depending on the virus 
strain used (Para et a l , 1982a and b ) . 
gE i s present on the surface of in tac t v i r i o n s , which 
exh ib i t Fc-binding a c t i v i t y . The r o l e of t h e s e Fc-binding 
receptors in virus replication and biology remains unclear. It 
has been suggested that the binding of immunoglobulin to the Fc-
receptors can in some way in ter f ere with c y t o t o x i c immune 
reac t ions , which would prevent the infected c e l l from be ing 
lysed and perhaps even favour the e s t a b l i s h m e n t of l a t e n c y (Westmoreland and Watkins,1974 Lehner et a l , 1 9 7 5 ) . It has been 
demonstrated that aggregated IgG can protect infected c e l l s to 
some extent from immune c y t o l y s i s (Adler e t a l , 1 9 7 8 ) , but the 
use of native immunoglobulin did not prevent neutra l i sa t ion of 
the virus by an ant i -gE serum. The f a c t that the v i r i o n -
membrane, including the Fc-recptors, fuses with the cell-membrane 
when the virus enters the c e l l , suggests that the protein might 
be required for some purpose on the surface of the i n f e c t e d 
c e l l , or i t may be important in mediating the attachment of 
virions to c e l l s (Para et al,1982a and b ) . 
Glycoproteins as targets of the immune system. 
The presence of the glycoproteins on the surface of the v ir ion 
and of the infected c e l l s indicates that these molecules are the 
prime targets for the immune system of the infected host. Indeed 
i t has been shown that the viral glycoproteins are the targets 
of neutra l i s ing antibodies (Powell e t a l ,1974 e t a l , 1 9 7 3 ) , 
antibody-dependent c e l l u l a r c y t o l y s i s (Norrild e t a l , 1 9 7 9 ) , 
complement-mediated cytolys is (Glorioso et al ,1978), and T - c e l l -
mediated c y t o t o x i c i t y (Lawman e t a l , 1 9 8 0 ) . The d i f f e r e n t 
glycoproteins each carry a unique set of antigenic determinants. 
Some glycoproteins are mainly type-common, while at l e a s t one 
glycoprotein, gC, seems to have only type-specific determinants. 
The properties of the HSV-glycoproteins as targets of the immune 
system and their antigenic spec i f i c i ty , wil l be discussed below. 
This review w i l l o n l y i n c l u d e r e s u l t s o b t a i n e d u s i n g 
conventional ant i sera; recent d i scover ie s in t h i s f i e l d using 
monoclonal antibodies wi l l be discussed later in this thes i s . 
Glycop ro t e in s as t a r g e t s of n e u t r a l i s i n g a n t i b o d i e s . 
The f i r s t a n t i g e n i c component of HSV recogn ised to be t h e t a r g e t 
of n e u t r a l i s i n g a n t i b o d i e s was t h e b a n d - I I a n t i g e n (Watson and 
W i l d y , 1 9 6 9 ) . A n t i s e r u m r a i s e d t o t h i s a n t i g e n was c a p a b l e of 
n e u t r a l i s i n g bo th HSV-1 and HSV-2 (Sim and Watson,1973) . I t h a s 
b e e n shown t h a t t h i s a n t i g e n c o r r e s p o n d s t o g l y c o p r o t e i n D. 
S e v e r a l a n t i s e r a t o gD have s i n c e been p r e p a r e d , u s i n g p u r i f i e d 
p r o t e i n b a n d s f rom g e l s , c h r o m a t o g r a p h i c p r o d e d u r e s o r 
i m m u n o p r e c i p i t a t e s from c r o s s e d i m m u n o e l e c t r o p h o r e t i c g e l s 
( P o w e l l e t a l , 1 9 7 4 ; Powel l and Wa t son ,1975 V e s t e r g a a r d and 
N o r r i l d , 1 9 7 9 ; Cohen e t a l , 1 9 7 8 ) . A l l t h e s e a n t i s e r a showed 
n e u t r a l i s i n g a c t i v i t y f o r HSV-1, w h i l e a l l b u t one showed t h e 
same a b i l i t y t o n e u t r a l i s e HSV-2. The f a i l u r e of t h e a n t i - g D 
serum produced by Powell e t a l (1974) t o n e u t r a l i s e HSV-2 was 
p r o b a b l y due t o t h e d e n a t u r a t i o n o f gD by s o d i u m d o d e c y l 
s u l p h a t e , a s t h i s a n t i s e r u m was p r o d u c e d a g a i n s t gD p u r i f i e d 
from SDS-polyacrylamide g e l s . 
I t i s appa ren t from t h e r e s u l t s de sc r i bed above t h a t gD i s an 
i m p o r t a n t t a r g e t f o r t h e p r o d u c t i o n o f c r o s s - r e a c t i v e 
n e u t r a l i s i n g a n t i b o d i e s , a l though by c r o s s - a b s o r p t i o n r e a c t i v i t y 
a g a i n s t the he t e ro logous a n t i g e n can be absorbed o u t , l e a v i n g a 
low-potency serum which i s t y p e - s p e c i f i c . 
Another a n t i g e n which seems t o p l a y a major r o l e i n v i r u s 
n e u t r a l i s a t i o n i s gB. A n t i s e r a r a i s e d a g a i n s t the gA/gB complex 
have been r e p o r t e d by Ves te rgaard and N o r r i l d (1979) and E b e r l e 
and C o u r t n e y ( 1 9 8 0 a ) . T h e s e a n t i s e r a h a v e t h e a b i l i t y t o 
n e u t r a l i s e homologous a s w e l l a s h e t e r o l o g o u s v i r u s . C r o s s -
a b s o r p t i o e x p e r i m e n t s , however , showed t h e e x i s t e n c e of some 
t y p e - s p e c i f i c r e a c t i v i t y a g a i n s t t h i s p r o t e i n as w e l l . I t has not 
been p o s s i b l e t o r a i s e a n t i s e r a a g a i n s t e i t h e r gA o r gB, which 
i s not s u r p r i s i n g in t h e l i g h t of t h e f i n d i n g s by E b e r l e e t a l 
(1980) , who sugges t t h a t gA i s a p r e c u r s o r of gB . The r e l a t i v e 
i m p o r t a n c e of gB a s a t a r g e t f o r n e u t r a l i s i n g a n t i b o d i e s 
co r r e sponds t o i t s p o s s i b l e r o l e i n v i r u s i n f e c t i v i t y , mentioned 
e a r l i e r i n t h i s r ev iew. 
A t h i r d a n t i g e n which a c t s a s a t a r g e t f o r n e u t r a l i s i n g 
a n t i b o d i e s t o HSV i s gC. A n t i s e r a t o t h i s p r o t e i n have been 
r a i s e d by s e v e r a l d i f f e r e n t m e t h o d s , and t h e y have d i f e r e n t 
n e u t r a l i s i n g a b i l i t i e s . Some a r e n o n - n e u t r a l i s i n g (Cohen e t 
a l , 1 9 8 0 b ) , some o n l y n e u t r a l i s e i n t h e p r e s e n c e of complement 
(Courtney and Powell , 1975) , and some do n o t r e q u i r e complement 
f o r n e u t r a l i s a t i o n ( V e s t e r g a a r d and N o r r i l d , 1 9 7 9 ) . A l l t h e 
a n t i s e r a , however, a r e t y p e - s p e c i f i c . I t i s i n t e r e s t i n g i n t h i s 
c o n t e x t t o no te t h a t the g e n e t i c map p o s i t i o n for gC on HSV-land 
HSV-2 i s comple te ly d i f f e r e n t . 
N e u t r a l i s i n g a n t i b o d i e s a g a i n s t gE have a l s o b e e n found 
(Baucke and S p e a r , 1 9 7 9 ) , b u t t h e i r n e u t r a l i s i n g a b i l i t y i s 
dependent on t h e p resence of complement. The serum n e u t r a l i s e s 
HSV-1 b e t t e r than HSV-2, i n d i c a t i n g t h a t t h e r e a r e t y p e - s p e c i f i c 
as we l l as type-common s i t e s on the gE-molecule . 
In c o n c l u s i o n , i t can be s a i d t h a t the two main t a r g e t s of 
n e u t r a l i s i n g a n t i b o d i e s seem to be t h e g l y c o p r o t e i n s gB and gD, 
b u t t h e r e i s a r o l e for gC and gE as w e l l . 
C o n f i r m a t i o n of t h e i m p o r t a n c e of t h e g l y c o p r o t e i n s a s 
t a r g e t s fo r a n t i b o d i e s , n e u t r a l i s i n g and n o n - n e u t r a l i s i n g , i n 
humans i n f e c t e d wi th HSV, came from a r e c e n t s tudy by Eber le and 
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Courtney (1981) who showed t h e p re sence of a n t i b o d i e s d i r e c t e d 
a g a i n s t gB,gC and gD in a number of human s e r a from i n d i v i d u a l s 
i n f e c t e d wi th HSV-1, HSV-2 o r b o t h . 
Role o f g l y c o p r o t e i n s i n a n t i b o d y - d e p e n d e n t c e l l - m e d i a t e d 
c y t o t o x i c i t y (ADCC) and complement-mediated c y t o t o x i c i t y ( A b C ) . 
R e s u l t s ob t a ined by s e v e r a l l a b o r a t o r i e s have shown t h a t 
s e r a o b t a i n e d a g a i n s t i n d i v i d u a l g l y c o p r o t e i n s c a u s e c y t o l y s i s 
of i n f e c t e d c e l l s i n b o t h ADCC and AbC' t e s t s ( N o r r i l d e t 
a l , 1 9 7 9 ; Glor ioso e t a l , 1 9 7 8 ) . C e l l s i n f e c t e d wi th HSV-1 c a n b e 
lysed as e a r l y as t h r e e hours a f t e r i n f e c t i o n in t h e p resence of 
a n t i b o d y and complement (Cromeans and S h o r e , 1 9 8 1 ) . A n t i s e r a 
a g a i n s t gB, gC and gD a r e a l l capab le of l y s i n g HSV-1 i n f e c t e d 
c e l l s in t h i s t e s t (Nor r i ld e t a l , 1 9 7 9 ; Glor ioso e t a l , 1 9 7 8 ) . In 
a d d i t i o n , t h e s e c e l l s were a l s o l y s e d by a n t i - g B , a n t i - g C and 
a n t i - g D s e r a i n A D C C - t e s t s . These f i n d i n g imply t h a t e ach of 
t h e s e g l y c o p r o t e i n s i n d i v i d u a l l y s e r v e s a s a t a r g e t f o r immune 
c y t o l y s i s . In a d d i t i o n , i t was shown t h a t an t l -gC s e r a o n l y l y s e 
c e l l s i n f e c t e d w i t h t h e homologous v i r u s , w h i l e a n t i - g B and 
a n t i - g D were c a p a b l e of l y s i n g b o t h HSV-1 and HSV-2 i n f e c t e d 
c e l l s . Fur thermore , an t i -gC s e r a do not l y s e c e l l s i n f e c t e d wth 
HSV-l(MP), a s t r a i n which does no t p r o d u c e gC. These r e s u l t s 
s u p p o r t the c o n c l u s i o n t h a t gA/gB and gD have type-common a s 
w e l l a s t y p e - s p e c i f i c s i t e s , w h e r e a s gC seems t o be t o t a l l y 
t y p e - s p e c i f i c . 
G lycop ro t e in s as t a r g e t s of c y t o t o x i c T - c e l l s . 
V i r u s - s p e c i f i c c y t o t o x i c T - l y m p h o c y t e s r e c o g n i s e v i r a l 
a n t i g e n s on v i r u s i n f e c t e d c e l l s o n l y i n a s s o c i a t i o n w i t h 
c e r t a i n a n t i g e n s coded f o r by t h e major h i s t o c o m p a t i b i l i t y 
complex (Zinkernage l and Welsh ,1976) . S t u d i e s i n most i n v i t r o 
systems have r e v e a l e d t h a t t h e g l y c o p r o t e i n s a r e t h e a n t i g e n s 
r e c o g n i s e d by c y t o t o x i c T - l y m p h o c y t e s ( C T L ) . Two g r o u p s o f 
w o r k e r s have shown t h a t t h e g l y c o p r o t e i n s a r e t h e a n t i g e n s 
r ecogn i sed by HSV-1 s p e c i f i c CTL: Both Lawman e t a l (1980) and 
C a r t e r e t a l (1981) used an HSV-mutant, t s A l , which i s d e f e c t i v e 
in g l y c o p r o t e i n s y n t h e s i s a t t h e non-permiss ive t e m p e r a t u r e . They 
a l s o made use of tun icamycin and 2 - d e o x y - D - g l u c o s e t o i n h i b i t 
g l y c o p r o t e i n s y n t h e s i s i n t h e t a r g e t c e l l s . The t a r g e t c e l l s 
i n f e c t e d wi th the mutant o r t r e a t e d wi th the i n h i b i t o r s showed a 
very marked r e d u c t i o n in t h e i r a b i l i t y t o be l y s e d by CTL. The 
c o n c l u s i o n t h a t can be drawn from t h e s e e x p e r i m e n t s i s t h a t t h e 
e x p r e s s i o n of g l y c o p r o t e i n s on the s u r f a c e of t h e i n f e c t e d c e l l 
i s n e c e s s a r y f o r t h e T - c e l l m e d i a t e d l y s i s of H S V - i n f e c t e d 
c e l l s . In a r e c e n t r e p o r t (1981) E b e r l e and h i s c o w o r k e r s 
s u g g e s t t h a t two s u b p o p u l a t i o n s of c y t o t o x i c T - c e l l s ' e x i s t : 
t hose which r e c o g n i s e t y p e - s p e c i f i c and t h o s e r e c o g n i s i n g t y p e -
common a n t i g e n i c d e t e r m i n a n t s . E f f e c t o r c e l l s g e n e r a t e d b y 
pr iming and r e s t i m u l a t i n g w i t h t h e same v i r u s r e c o g n i s e d b o t h 
type-common and t y p e - s p e c i f i c a n t i g e n i c s i t e s on t h e t a r g e t 
c e l l s , b u t e f f e c t o r c e l l s p r imed w i t h HSV-1 and r e s t i m u l a t e d 
wi th HSV-2 recogn ised on ly type-common d e t e r m i n a n t s . In a d d i t i o n , 
i t was shown t h a t gC i s one of t h e t y p e - s p e c i f i c d e t e r m i n a n t s 
r e c o g n i s e d , by us ing t h e mutant MP. I t was proved , however, t h a t 
t h e r e i s a t l e a s t one o t h e r t y p e - s p e c i f i c s u r f a c e a n t i g e n 
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r ecogn i sed by anti-HSV CTL, a p a r t from gC. Th i s i s not s u r p r i s i n g 
i n view of t h e f a c t t h a t gA/gB, gD and gE a l l c a r r y t y p e -
s p e c i f i c a s we l l as type-common a n t i g e n i c d e t e r m i n a n t s . 
C r o s s - r e a c t i v e a n t i g e n s in t h e H e r p e s v i r u s e s . 
The H e r p e s v i r u s g r o u p c o m p r i s e s o v e r s e v e n t y members , 
i n f e c t i n g a g r e a t v a r i e t y of d i f f e r e n t h o s t s . Very l i t t l e i s 
known about the r e l a t i o n s h i p s between t h e v a r i o u s members of the 
g roup . The s e r o l o g i c a l d a t a on t h e group do as y e t no t g i v e any 
conv inc ing s y s t e m a t i c b a s i s fo r subgrouping of the h e r p e s v i r u s e s 
(Honess and Watson,1977; K i l l i n g t o n e t a l , 1 9 7 7 ) . 
One of t h e c r i t e r i a f o r t h e a n t i g e n i c s u b g r o u p i n g of t h e 
h e r p e s v i r u s e s has been n e u t r a l i s a t i o n . I t h a s b e e n shown, f o r 
i n s t a n c e , t h a t HSV-1, HSV-2 and Bovine Mammal i t i s V i r u s (BMV) 
c r o s s - n e u t r a l i s e each o t h e r , whi le Equine A b o r t i o n V i r u s (EAV) 
and Pseudorab ies Virus (PRV) were on ly n e u t r a l i s e d by homologous 
a n t i s e r a ( K i l l i n g t o n e t a l , 1 9 7 7 ) . Many o t h e r s e r o l o g i c a l methods, 
s u c h a s i m m u n o d i f f u s i o n , i m m u n o f l u o r e s c e n c e o r immune 
a g g l u t i n a t i o n of v i r u s p a r t i c l e s , have b e e n used t o i d e n t i f y 
s e r o l o g i c a l r e l a t i o n s h i p s between h e r p e s v i r u s e s . A l t h o u g h t h e s e 
t e s t s gave an i n d i c a t i o n of t h e range of a n t i g e n i c d i f f e r e n c e s 
between t h e s e v i r u s e s , very l i t t l e work has b e e n done t o r e l a t e 
t h e s e d a t a t o any s t r u c t u r a l b a s i s . 
One of t h e d i f f i c u l t i e s i n t h i s t y p e of s t u d y l i e s i n t h e 
complexi ty of t h e v i r u s e s invo lved . Even t h e compar ison b e t w e e n 
s u c h c l o s e l y r e l a t e d v i r u s e s a s HSV-1 and HSV-2 i s made 
d i f f i c u l t by t h e f a c t t h a t t h e comparable p r o t e i n s i n t h e s e two 
v i r u s e s h a v e d i f f e r e n t m o l e c u l a r w e i g h t s a n d m i g r a t i o n 
c h a r a c t e r i s t i c s . These p r o b l e m s o n l y g e t worse when moving t o 
l e s s c l o s e l y r e l a t e d v i r u s e s . The r o l e of a n t i s e r a a g a i n s t t h e 
v i r u s e s t o be s t u d i e d i s t h e r e f o r e very i m p o r t a n t . The r e s u l t s 
p u b l i s h e d so f a r have r e l i e d on c o n v e n t i o n a l s e r a , i n m o s t 
i n s t a n c e s r a i s e d a g a i n s t t h e whole v i r u s . In one o r two c a s e s , 
a n t i s e r a r a i s e d a g a i n s t one p a r t i c u l a r p r o t e i n were u s e d . A 
s h o r t d e s c r i p t i o n of t h e d i f f e r e n t a n t i g e n s which seem t o be 
impor tan t i n c r o s s - r e a c t i o n b e t w e e n t h e h e r p e s v i r u s e s i s g i v e n 
be low. 
A few e a r l y expe r imen t s s u g g e s t e d t h a t t h e major c a p s i d 
p r o t e i n might be a c r o s s - r e a c t i v e a n t i g e n b e t w e e n a number of 
h e r p e s v i r u s e s (Ross e t a l , 1 9 7 2 Kirkwood e t a l , 1 9 7 2 ; Honess e t 
a l , 1 9 7 4 ; K i l l i n g t o n e t a l , 1 9 7 7 ) . In a r e c e n t r e p o r t (Yeo e t 
a l , 1 9 8 1 ) , t h e p r o t e i n s and g l y c o p r o t e i n s o f f i v e d i f f e r e n t 
h e r p e s v i r u s e s , namely HSV-1, HSV-2, BMV, EAV and PRV have b e e n 
compared and t h e i r a n t i g e n i c r e l a t i o n s h i p i n v e s t i g a t e d . From 
i m m u n o p r e c i p i t a t i o n d a t a u s i n g a n t i s e r a r a i s e d a g a i n s t t h e s e 
f i v e v i r u s e s i t seems c l e a r t h a t one a n t i g e n which i s s t r o n g l y 
c r o s s - r e a c t i v e b e t w e e n a l l t h e s e v i r u s e s i s t h e m a j o r DNA-
b i n d i n g p r o t e i n (ICSP 1 1 / 1 2 ) . Th i s r e s u l t was c o n f i r m e d u s i n g a n 
an t i se rum r a i s e d s p e c i f i c a l l y a g a i n s t t h i s p r o t e i n . The major 
c a p s i d p r o t e i n i s a l s o c r o s s - r e a c t i v e , b u t t o a much l e s s e r 
e x t e n t . 
The g l y c o p r o t e i n s , which a r e t h e o t h e r major g r o u p of 
p r o t e i n s i m p l i c a t e d i n c r o s s - r e a c t i o n t h r o u g h n e u t r a l i s a t i o n 
s t u d i e s and immunoprec ip i t a t i on d a t a , do n o t have such a wide 
range of c r o s s - r e a c t i v i t y as the major DNA-binding p r o t e i n . The i r 
12 
c r o s s - r e a c t i v i t y seems to be l i m i t e d t o t h e s u b g r o u p t o which 
t h e y b e l o n g . For i n s t a n c e , t h e r e i s s t r o n g c r o s s - r e a c t i v i t y 
between the g l y c o p r o t e i n s of HSV-1 and HSV-2, and some c r o s s -
r e a c t i v i t y b e t w e e n t h e s e two v i r u s e s and BMV, a s t h e h i g h -
molecu la r weight g l y c o p r o t e i n s of BMV a r e p r e c i p i t a t e d by a n t i -
HSV-1 and anti-HSV-2 s e r a . This i s in agreement wi th the r e s u l t s 
by N o r r i l d e t a l (1978) . No c r o s s - r e a c t i v i t y c o u l d be d e t e c t e d 
between the g l y c o p r o t e i n s of EAV and PRV. 
The d a t a on t h e c r o s s - r e a c t i v i t y of t h e g l y c o p r o t e i n s 
through immunoprec ip i ta t ion s t u d i e s thus agree wi th t h e f i n d i n g s 
in n e u t r a l i s a t i o n s t u d i e s , where HSV-1, HSV-2 and BMV form a s o -
c a l l e d n e u t r o - s e r o n , w h i l e EAV and PRV a r e two s e p a r a t e 
n e u t r o s e r o n s , a l though they a r e more r e l a t e d to each o t h e r t h a n 
t o HSV-1, HSV-2 o r BMV (Honess and Watson,1977) . 
Some c r o s s - r e a c t i v i t y was a l s o o b s e r v e d b e t w e e n s e v e r a l 
minor components of the f i v e v i r u s e s s t u d i e d i n t h e r e p o r t by 
Yeo e t a l (1981) . The p r o t e i n s involved in t h e s e r e a c t i o n s have 
not y e t been i d e n t i f i e d . 
U n t i l more members of t h e H e r p e s v i r u s f a m i l y have b e e n 
examined for t h e p resence of t h e major DNA-binding p r o t e i n , i t 
i s i m p o s s i b l e t o s a y w h e t h e r t h i s p r o t e i n c a n b e u s e d a s a 
marker fo r the whole h e r p e s v i r u s g roup . In t h e p a p e r by Yeo e t 
a l , i t i s s u g g e s t e d t h a t t h i s p r o t e i n m i g h t b e u s e f u l f o r t h e 
c l a s s i f i c a t i o n of t h e Herpesv i rus g roup , w h i l e t h e major c a p s i d 
p r o t e i n may he lp to i d e n t i f y some c r o s s - r e l a t i o n s h i p s b e t w e e n 
members of t h e g roup , and t h a t t h e g l y c o p r o t e i n s w i l l de f ine t h e 
subgroups of t h e f ami ly . If t h e s e p r o t e i n s a r e going t o b e used 
a s "markers" i n t h i s way, i t w i l l b e n e c e s s a r y t o have a more 
d e t a i l e d knowledge of t h e i r a n t i g e n i c p r o p e r t i e s . Monoc lona l 
a n t i b o d i e s a g a i n s t t h e s e p r o t e i n s w i l l be v e r y h e l p f u l i n t h i s 
kind of r e s e a r c h . 
C l i n i c a l a p p l i c a t i o n s of monoclonal ant ibod ie s t o Herpes Simplex 
V i r u s . 
The c l i n i c a l d i a g n o s i s of an i n f e c t i o n w i t h HSV i s a t 
p r e s e n t r e l a t i v e l y s t r a i g h t forward. The v i r u s i s e a s y t o grow 
i n many t i s s u e c u l t u r e s y s t e m s and c a n be r e a d i l y d i a g n o s e d 
u s i n g f l u o r e s c e n c e m e t h o d s . High q u a l i t y r a b b i t a n t i s e r a a r e 
a v a i l a b l e for t h i s p u r p o s e . However, t he d i f f e r e n t i a l d i a g n o s i s 
b e t w e e n HSV-1 and HSV-2 i s no t so s t r a i g h t f o r w a r d . As t h e 
t r e a t m e n t for HSV-1 and HSV-2 i s t h e same a t t h e moment, t h e 
demand f o r t h i s type of d i a g n o s i s i n c l i n i c a l l a b o r a t o r i e s i s 
not very h igh . I t i s p o s s i b l e , however , t h a t w i t h t h e p r e s e n t 
r a p i d developement of d r u g - t h e r a p y , d r u g s w i l l be found which 
a r e e f f e c t i v e a g a i n s t HSV-1 o r HSV-2 o n l y . Two such d r u g s have 
a l r e a d y been r e p o r t e d , namely b romoviny l -deoxyur id ine (BVDU) and 
Iodov iny l -deoxyu r id ine (IVDU). Both a r e a c t i v e a g a i n s t HSV-1 b u t 
n o t a g a i n s t HSV-2 (De C l e r c q e t a l , 1 9 8 0 ) . At p r e s e n t , t h e 
d i f f e r e n t i a l d i a g n o s i s b e t w e e n HSV-1 and HSV-2 r e l i e s on 
c o n v e n t i o n a l a n t i s e r a which have been c r o s s - a b s o r b e d i n o r d e r t o 
make them t y p e - s p e c i f i c . These s e r a a r e g e n e r a l l y of low potency 
and have a r e s i d u a l a c t i v i t y a g a i n s t t h e h e t e r o l o g o u s v i r u s . 
Monoclonal a n t i b o d i e s could be of g r e a t v a l u e i n f a c i l i t a t i n g 
t h e r a p i d d i a g n o s i s of HSV-1 o r HSV-2. Because of t h e h i g h 
s p e c i f i c i t y of monoclonal a n t i b o d i e s , i t may be neces sa ry to use 
m i x t u r e s of t y p e - s p e c i f i c a n t i b o d i e s , i n o r d e r t o a v o i d t h e 
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recognition of certain subgoups only, instead of the whole range 
of HSV-1 or HSV-2 isolates. 
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CHAPTER 2: FUSION EXPERIMENTS. 
As d e s c r i b e d in t h e f i r s t c h a p t e r , HSV-2 i s a complex v i r u s 
which codes fo r a t l e a s t f i f t y v i r u s - s p e c i f i c p r o t e i n s . Although 
some p r o g r e s s has been made i n t h e c h a r a c t e r i s a t i o n of some o f 
t h e s e p r o t e i n s us ing conven t i ona l a n t i s e r a , i t i s o b v i o u s t h a t 
monoclonal a n t i b o d i e s a g a i n s t any of t h e v i r a l p r o t e i n s w i l l b e 
v e r y u s e f u l t o o l s i n t h e i r f u r t h e r i d e n t i f i c a t i o n a n d 
c h a r a c t e r i s a t i o n . At t h e t i m e of t h e s t a r t of t h e e x p e r i m e n t s 
d e s c r i b e d i n t h i s c h a p t e r , no monoclonal a n t i b o d i e s a g a i n s t HSV-
1 o r HSV-2 had b e e n r e p o r t e d . In o u r e f f o r t s t o p r o d u c e 
monoclonal a n t i b o d i e s t o HSV-2, we had t h e c h o i c e of looking a t a 
l i m i t e d number of a n t i g e n s ( i . e . p u r i f i e d v i r u s , p u r i f i e d 
membrane a n t i g e n s , n u c l e i of i n f e c t e d c e l l s , e t c . ) o r u s i n g a 
" sho t -gun" approach and no t s e l e c t i n g f o r any p a r t i c u l a r g r o u p 
of a n t i g e n s . As a t t h i s t ime m o n o c l o n a l a n t i b o d i e s a g a i n s t any 
of t h e v i r a l a n t i g e n s would have been u s e f u l , we d e c i d e d on t h e 
l a t t e r a p p r o a c h and used HSV-2 i n f e c t e d c e l l s o n i c a t e s t o 
immunise mice b e f o r e t h e f u s i o n . T h i s would s t i l l i n v o l v e a 
c e r t a i n s e l e c t i o n , a s t h e d i f f e r e n t a n t i g e n s may v a r y i n 
inununogenici ty. Also , i n t h e i n f e c t e d c e l l c e r t a i n a n t i g e n s a r e 
produced in much l a r g e r q u a n t i t i e s than o t h e r s . 
In t h e f i r s t p a r t of t h i s c h a p t e r I d e s c r i b e a number o f 
p r e l i m i n a r y exper iments which e s t a b l i s h e d t h e most s a t i s f a c t o r y 
i m m u n i s a t i o n r o u t i n e . In t h i s s e c t i o n t h e d e v e l o p m e n t o f a 
s u i t a b l e a ssay-sys tem for t h e d e t e c t i o n of a n t i b o d i e s a g a i n s t 
HSV-2 i s a l s o d e s c r i b e d . I t was i m p o r t a n t t o have a f a s t and 
r e l i a b l e a s say - sys t em, as i t was n e c e s s a r y t o b e a b l e t o d e c i d e 
q u i c k l y which hybr idoma c u l t u r e s were s e c r e t i n g a n t i - H S V - 2 
a n t i b o d i e s and were t h e r e f o r e worth keep ing . In e a r l i e r r e p o r t e d 
f u s i o n e x p e r i m e n t s i n v o l v i n g v i r u s e s such a s i n f l u e n z a and 
r a b i e s , haemagg lu t ina t ion a s s a y s and f l u o r e s c e n c e were u s e d . We 
developed a number of d i f f e r e n t r a d i o i m u n o a s s a y s , and p r e s e n t 
r e s u l t s which e n a b l e d us t o d e c i d e which a s s a y was t h e most 
r e l i a b l e and s e n s i t i v e . 
The s econd p a r t of t h i s c h a p t e r d e a l s w i t h t h e f u s i o n 
e x p e r i m e n t s and t h e s e l e c t i o n of s t a b l e , a n t i b o d y - s e c r e t i n g 
c l o n e s from t h e s e f u s i o n s . 
MATERIALS AND METHODS. 
V i r u s . 
The v i r u s s t r a i n used was type 2 s t r a i n 25766 (ob ta ined from 
p r o f e s s o r K.R.Dumbell, Wright Fleming I n s t i t u t e , London) . V i r u s 
s t o c k s were prepared by i n f e c t i n g BHK-21 c e l l s wi th 0 . 1 pfu p e r 
c e l l f o r 48 h o u r s a t 33°C. I n f e c t e d c e l l s w e r e h a r v e s t e d , 
s o n i c a t e d and t h e number of p laque forming u n i t s measured u s i n g 
BHK-21 c e l l s as de sc r i bed by Russe l l (1962) . Virus s t o c k s t o be 
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used for immunisation of mice for fusion-experiments were grown 
in 3T3-cells , using the same p r o t o c o l . All v i r u s s tocks were 
kept frozen a t - 7 0 ^ . 
Ce l l s . 
BHK-21 c e l l s were grown in Glasgows modified Eagles medium (GMM), supplemented with 10 % newborn calf serum and 10% tryptose 
phosphate b r o t h (ETC). 3T3-ce l l s were passed in D u l b e c c o ' s 
modified Eagles medium (DMM) with 10% f o e t a l ca l f serum (FCS). 
The myeloma c e l l l i n e P 3 . N S l / l A g . 3 . 4 . 1 . ( k i n d g i f t of 
Dr.C.Milstein, M.R.C. Cambridge) was passed in GMM supplemented 
with 5% FCS (GMM-5%FCS). After a fus ion , hybridoma c e l l s were 
kept in GMM-20%FCS, and l a t e r in HAT-medium (GMM-20%FCS, 
supplemented with 0.1M hypoxanthine, ImM aminopterine and 40 mM 
t h y m i d i n e ) o r HT-medium ( a s HAT-medium, b u t w i t h o u t 
aminopterine). Cells were frozen in l iqu id n i t rogen in 60% FCS-
30% GMM-10% glycerol , a t a concentration of 2.106 c e l l s per ml. 
Mice. 
Female Balb/c mice aged 5-6 weeks were obtained from Bantin 
and Kingman Ltd. (Aldbrough,Hull) and used when 6-9 weeks o l d . 
In some cases male Balb/c mice, over 20 weeks old , were used for 
t he produc t ion of a s c i t e s f l u i d following an i n j e c t i o n with 
hybridoma c e l l s . 
Reverse Passive Haemagglutination. 
Trypsinised Sheep red blood c e l l s (Tr.Shrbc) were obtained 
from professor R.R.A.Coombs (Division of Immunology, Department 
of Pathology, Cambridge). Ce l l s were e x t e n s i v e l y washed in 
sa l ine before use, and made to a 80% suspension in s a l i n e . The 
CrCl? stock solut ion used for the coupling react ion was prepared 
as described by Bradburne e t a l (1979) and was a kind g i f t of 
professor R.R.A.Coombs. The solution was stored a t 4°C. 
In order to couple antibodies to the c e l l s , IgG ( p u r i f i e d by 
DEAE-cellulose chromatography) was ex tens ive ly d ia lysed a g a i n s t 
sa l ine and di luted to a concentration of 2 mg/ml; 50 u l of t h i s 
preparat ion was mixed with 50 ul Shrbc-suspension, and 100 u l of 
a 1/50 d i l u t e d CrCl 3 - s tock s o l u t i o n added with s imultaneous 
mixing. The mixture was l e f t a t room temperature for 1 hour, 
washed 4 times in Hepes-buffered GMM and made to 4 ml with Hepes-
bufferd GMM, to give a 1% suspens ion . At t h i s s t age the c e l l s 
could be stored for up to a week a t 4°C. 
The r eve r se pas s ive haemagglut inat ion (RPH) t e s t was 
car r ied out in Nunclon 96-well round bottom t r a y s . A two-fold 
d i lu t ion s e r i e s of the antigen (HSV-2) was made in 25 u l s a l i n e 
per well . A 1/3 d i lu t ion of the coupled Shrbc in Hepes-bufferd 
GMM (supplemented with 5% FCS), was prepared. One drop of t h i s 
solut ion (25 u l ) was added to each well , and the r e su l t s observed 
a f t e r two hours. 
Coupling of ant ibody to p l a s t i c su r faces us ing c a r b o d i i m i d e (CDI). 
This was e s s e n t i a l l y c a r r i e d o u t as d e s c r i b e d by Nash (1976). P las t ic of t i s sue-cu l tu re grade was used in a l l c a s e s . 
In a 0.2 ml wel l , 25 pi of a 2 mg/ml solut ion of purified Rabbit 
anti-HSV-2-IgG in s a l i n e was mixed with 25 jil of a 1 mg/ml 
solut ion of carbodiimide in s a l i ne . The mixture was l e f t for one 
hour a t room temperature and subseqeunt ly washed with j e t s of 
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sal ine . The wells could be f i l l e d with sal ine at this stage and 
stored at 4°C. 
Labelling of protein with 1 2 5 I . 
The protein to be l a b e l l e d was d i s s o l v e d in PBS to a 
concentration of 1 rag/ml. 25 pi of this solution was mixed with 
10 ul '" I (lmCi, carrier-free , Amersham Corp.) and 30 ul lOmH 
Chloramine T. After 3 min. incubation at room temperature the 
mixture was put on ice and 25 pi 10mm sodium metabisulphite and 
10 pi KI added to stop the react ion . The labe l l ed protein was 
separated from the unbound 12S I by chromatography on a Sephadex 
G25 column. The specif ic a c t i v i t y of the labe l l ed protein was 
between 5-10 pCi/pg. 
Radioimmunoassay. 
RIA-l:Target = infected BHK-21 cell monolayers. 
Confluent BHK-21 c e l l monolayers in 0.28cm wel ls (Linbro 
48-well flat-bottom trays, Flow laboratories) were infected with 
10 pfu per c e l l and incubated for 8 hours a t 37°C. The 
m o n o l a y e r s were then washed in PBS, f i x e d wi th 0.2% 
glutaraldehyde for five minutes at room temperature, and washed 
ex tens ive ly in PBS. They were dried at room temperature and 
stored at -20°C. To prevent non-specific binding, each wel l was 
treated with one drop of heat-inactivated FCS (IPCS) before the 
assay was carried out . The we l l s were reacted with 50 pi of 
antibody-solution for 1 hour at room temperature. After washing 
in PBS, bound antibody was detected using '" I - labe l l ed a n t i -
mouse-Fab (kind g i f t of Dr D.Secher, M.R.C., Laboratory of 
Molecular Biology, Cambridge). Individual wells were cut out and 
the isotope was measured in a Philips gamma-counter. Normal mouse 
serum was used as a negative control. 
RIA-2: Target = Infected c e l l antigens coupled to p las t i c . 
This assay was carried out in exactly the same way as RIA-1, 
with the difference that instead of BHK-cell monolayers HSV-2 
antigens were coupled to the wells: 25 p i of an HSV-2 infected 
BHK-cell sonicate (2 .10 7 pfu/ml),which had been ex tens ive ly 
dia lysed against s a l i n e , was mixed with 25 p i of a 1 mg/ml 
solution of carbodiimide. After one hour at room temperature the 
plates were washed, and used for the assay. 
RIA-3: Target = HSV-2 specif ic antigens selected with hyperimmune 
antibody. 
Purified Rabbit anti-HSV-2-IgG was coupled to 0.4 ml 
LinbrowelIs using CDI. The wells were subsequently treated with 
a solution of HSV-2 infected BHK-cell sonicate in PBS at 10* pfu 
per well for 30 min. at room temperature. Unbound protein was 
washed off using PBS.These targets were then used as described 
for RIA-1. 
Immunisation Schedule. 
Female Balb/c mice were infected with 104 pfu 3T3-grown 
virus into the ear pinna. Four weeks later a second injection of 
5xl04 pfu was given i . p . , and two weeks later another i n j e c t i o n 
of 10s pfu via the same route. The f ina l in jec t ion of 10spfu 
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( i n a c t i v a t e d v i r u s u s i n g 0.02% formaldehyde) was g i v e n 
intravenously three days before the fusion. 
Fusion. 
The fusion was e s s e n t i a l l y c a r r i e d out as d e s c r i b e d by 
Galfre e t al (1977). Immunised mice were s a c r i f i c e d t h r ee days 
a f t e r t h e f i n a l i . v . i n j e c t i o n . The s p l e e n was removed 
a sep t i ca l ly , and gently homogenised to obtain a c e l l suspension. 
The spleen c e l l s were washed s e v e r a l t imes in cold GMM-2%FCS. 
The myeloma c e l l s (NS1) were harvested whilst in the log-phase 
of growth and washed in GMM-2%FCS. 2xl08 spleen c e l l s were 
mixed with 2xl07 myeloma c e l l s and cen t r i f uged . The p e l l e t , 
a f te r having been broken up gent ly, was placed a t 37°C and 1 ml 
50% PEG-1500 was added under cons tan t s t i r r i n g over 1 minute . 
Increasing amounts of GMM were added over the next ten minutes to 
a t o t a l of 20 ml. The c e l l s were subsequent ly c e n t r i f u g e d , 
resuspended in 100 ml GMM-20% FCS and divided among 48 wel ls (Linbro 24-well t r a y s , 2 ml/well. Flow l a b o r a t o r i e s ) . The next 
day, 1 ml of the medium in each well was rep laced wi th HAT-
medium. This procedure was repeated every 48 hours u n t i l the 
medium was b e g i n n i n g t o t u r n y e l l o w . At t h i s s t a g e t h e 
s u p e r n a t a n t s were a s sayed fo r t h e p r e s e n c e of an t i -HSV-2 
a n t i b o d i e s and t h e c e l l s from t h o s e w e l l s wi th p o s i t i v e 
supernatants were passaged for one more week in HAT-medium and 2-
3 weeks in HT-medium. After t h i s p e r i o d s u p e r n a t a n t s were 
reassayed and c e l l s from those c u l t u r e s which c o n t i n u e d to 
secre te antibody were cloned in soft agar. Posit ive c lones were 
stored in l iqu id n i t rogen and a l so in j ec t ed i n to Balb/c mice, 
e i t he r subcutaneously or intravenously, to produce ant iserum or 
a s c i t e s f lu id . 
Cloning. 
Hybridoma c e l l s were cloned when in t h e l o g - p h a s e of 
growth. Soft agar p la tes were prepared using Difco-Bacto aga r . 
Each p l a t e conta ined 10 ml 0.5% agar in GMM-20%FCS, and was 
allowed to s e t on the bench for one hour . In t h e meant ime, 
d i lu t ions of the c e l l s to be cloned were prepared in GMM-20%FCS 
and a solut ion of 0.5% agar in GMM-20%FCS was kept ready a t 40°C; 
1 ml of the c e l l suspension, containing 103 o r 104 c e l l s , was 
mixed with 1 ml of the 0.5% agar so lu t ion and poured on top of 
the 0.5% agar p l a t e . The p l a t e s were t r a n s f e r r e d to a gassed 
incubator a t 37°C and colonies which appeared af te r 3 or 4 days 
were picked using a microscope. Colonies were transferred to 2 ml 
Linbro-wells in GMM-20%FCS and cul ture supe rna tan t s assayed as 
before. Posit ive clones were gradually transferred to GMM-5%FCS 
and stored in l iquid ni trogen. 
Labeling of secreted immunoglobulins. 
In a 2 ml Linbro-well 10 s hybr idoma-cel l s were incubated 
for 5 hours in l y s i n e - f r e e minimum e s s e n t i a l medium i n t h e 
presence of 5 uCi 1 4 C-lys ine . At the end of t h i s p e r i o d , the 
supernatant was taken and 20 u l analysed by e l e c t r o p h o r e s i s in 
SDS-polyacrylamide g e l s . The procedure for preparing and running 
the gels i s describ'ed in chapter 3. Gels were dried down and the 
isotope detected by autoradiography for 3-4 weeks. 
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Ouchter lony t e s t fo r t h e d e t e c t i o n of t h e immunoglobulin c l a s s of 
t h e a n t i b o d i e s . 
In o r d e r t o d e t e r m i n e t h e immunoglob.ul in s u b c l a s s of t h e 
a n t i b o d i e s s e c r e t e d by t h e hybridoma c e l l s , c u l t u r e s u p e r n a t a n t s 
were c o n c e n t r a t e d u s i n g a v a c u u m - f i l t e r and t e s t e d i n an 
O u c h t e r l o n y a s s a y p l a t e (1% a g a r , 8 u l p e r w e l l ) . A n t i s e r a 
s p e c i f i c fo r I g G l , IgG2a, IgG2b and IgG3 were a k i n d g i f t of 
Dr .R .M.I .Parkhouse , Mi l l H i l l , London. 
RESULTS. 
A. Preliminary Experiments. 
Immunisation schedule. 
The v i r u s used fo r t h e immunisation of mice t o be used for a 
fus ion was grown in 3 T 3 - c e l l s . Th i s was done b e c a u s e 3 T 3 - c e l l s 
a r e a B a l b / c d e r i v e d s t r a i n . I t was hoped t h a t t h e a n t i b o d y 
r e s p o n s e i n t h e mouse would o n l y be d i r e c t e d a g a i n s t v i r a l 
a n t i g e n s , t h u s p r e v e n t i n g t h e s e l e c t i o n of hybr idoma 's d i r e c t e d 
a g a i n s t c e l l u l a r a n t i g e n s . 
The f i r s t s t e p i n a n y i m m u n i s a t i o n s c h e d u l e was t h e 
e s t a b l i s h i n g o f l a t e n t i n f e c t i o n . T h i s was d o n e u s i n g 
i n t r a d e r m a l i n o c u l a t i o n of t h e v i r u s i n t o t h e e a r p inna ( H i l l e t 
a l , 1 9 7 5 ) . Primary i n f e c t i o u s d o s e s of 1 0 3 and 10 4 pfu HSV-2 
w e r e g i v e n t o d i f f e r e n t g r o u p s o f m i c e , a n d s e c o n d a r y 
i m m u n i s a t i o n s w e r e g i v e n e i t h e r i n t r a p e r i t o n e a 1 l y o r 
i n t r a v e n o u s l y . No F r e u n d s a d j u v a n t was used i n any of t h e s e 
i n s t a n c e s . At v a r y i n g t i m e s d u r i n g t h e i m m u n i s a t i o n s c h e d u l e 
mice were b l e d and t h e serum a n t i b o d y t i t r e m e a s u r e d u s i n g 
n e u t r a l i s a t i o n , r e v e r s e p a s s i v e heamagg lu t ina t ion o r R I A - 1 . The 
r e s u l t s i n t a b l e 1 show t h a t i n j e c t i o n w i t h h i g h e r d o s e s of 
v i r u s l e a d s t o a l a r g e r a n t i b o d y - r e s p o n s e and t h a t s e c o n d a r y 
i n t r a p e r i t o n e a l i m m u n i s a t i o n g i v e s a s l i g h t l y l ower a n t i b o d y 
response as measured by RIA-1 than i n t r avenous immunisat ion. 
Assay sy s t ems . 
The major c r i t e r i a f o r e ach a s s a y s y s t e m w e r e s p e e d , 
r e l i a b i l i t y and s e n s i t i v i t y . T h r e e d i f f e r e n t r a d i o i m m u n o a s s a y 
systems were compared. In a l l e a r l i e r e x p e r i m e n t s , a n t i - m o u s e -
Fab was used as t h e r a d i o l a b e l l e d a g e n t . In l a t e r e x p e r i m e n t s , 
t h i s was r e p l a c e d b y p r o t e i n A. In t h e f i r s t t y p e o f 
radioimmunoassay, 
RIA-1, (see f i g . l a ) BHK-cell monolayers i n smal l w e l l s were 
i n f e c t e d w i t h HSV-2 and f i x e d i n g l u t a r a l d e h y d e . W e l l s w e r e 
r e a c t e d w i t h s e r i a l t e n - f o l d d i l u t i o n s of a hyperimmune mouse 
s e r u m , washed and 1 2 5 1 - a n t i - m o u s e - F a b used t o d e t e c t b o u n d 
an t ibody (50 ,000 c p m / w e l l ) . Each s o l u t i o n was a l s o t e s t e d on 
u n i n f e c t e d B H K - c e l l s , and normal mouse s e r u m was u s e d a s a 
n e g a t i v e c o n t r o l . The r e s u l t s of t h e e x p e r i m e n t a r e l i s t e d i n 
t a b l e 2 : t h e b a c k g r o u n d i n a l l c a s e s i s l e s s t h a n 1% of t h e 
t o t a l i n p u t 1 2 5 I , and b i n d i n g r a t i o ' s of 6 o r 7 a r e r e a c h e d a t 
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serum d i l u t i o n s of 1/100 and 1/1000. Even a t a d i l u t i o n of 
1/10,000 a binding r a t i o of 1.9 i s obtained. On uninfected BHK-
c e l l s , immune mouse serum and normal mouse serum bind to the 
same extent , so the react ion with immune serum i s s p e c i f i c for 
HSV-2 infected c e l l s . 
RIA-1 RIA-2 RIA-3 
1 
Fig 1. I l l u s t r a t i o n of three d i f fe ren t radioimmunoassays to 
measure antibody. 0 = v i r a l antigen, If =anti-HSV-2-IgG, Y = a n t i b ° d y 
























































Table 1. Comparison of di f ferent immunisation schedules, 
i .v .=intravenous; i . p . i n t r a p e r i t o n e a l . 
RIA-2. (see f ig . l b ) . I t i s possible tha t some an t igens are 
not r e s i s t a n t to g lu ta ra ldehyde f i x a t i o n . I t was t h e r e f o r e 
thought d e s i r a b l e to have an a l t e r n a t i v e assay which would 
present v i r a l antigens in a native form. To th i s end, d i f f e r e n t 
d i lu t ions of an HSV-2-infected BHK-cell sonicate were coupled to 
0.4 ml Linbro-wells using carbodiimide. After washing the wel l s 
were blocked with IFCS, and a radioimmunoassay carr ied out using 
hyperimmune mouse serum and 1 2 5I-ant i -mouse-Fab a t the same 
concentrations as for RIA-1. As can be seen from t a b l e 2, t h i s 
method also detected v i r a l an t igens s p e c i f i c a l l y , but b inding 
r a t i o ' s were not as high as were obtained using infected BHK-cell 
monolayers, except a t low serum d i l u t i o n s , where the r e su l t s are 
unre l i ab le . Increasing the amount of v i r a l antigen per well did 
not r a i se the number of bound cpm ( resu l t s not shown). 
A third type of radioimmunoassay was tested, 
RIA-3. (see f ig . l c ) . In t h i s method the v i r a l an t igens were 
selected by a hyperimmune anti-HSV-2 r abb i t serum. To t h i s end, 
pur i f ied anti-HSV-2-IgG was coupled to 0.4 ml Linbro-wel ls as 
described in "materials and methods", and subsequent ly reac ted 
with a d i lu t ion of a sonicate of HSV-2-infected BHK-cells. This 
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t a rge t (unlike the ta rge t in RIA-1 and 2) i s composed of v i r u s -
speci f ic antigen and should, in theory, give low backgrounds. I t s 
disadvantage i s t h a t i t con ta in s only the an t igens for which 
a n t i b o d i e s a r e p r e s e n t in t h e serum.A r a d i o i m m u n o a s s a y 
comparable to the ones performed using RIA-1 and 2 was c a r r i e d 
ou t . The r e su l t s are shown in table 2. A d i lu t ion of hyperimmune 
serum of 1/100 gives the h ighes t b inding r a t i o , bu t even a t a 
d i lu t ion of 1/10,000 antibody can s t i l l be detected. The va lues 
obtained for normal mouse serum are very low, as expected. The 
t e s t was repeated using uninfec ted BHK-cell a n t i g e n s as a 
t a r g e t , and no detectable binding of hyperimmune anti-HSV-2 serum 






































































Table 2 . Comparison of t h r e e radioimmunoassay systems fo r t h e 
d e t e c t i o n of anti-HSV-2 an t ibody in immune o r normal 
mouse serum. R e s u l t s a r e expressed in bound cpm/wel l , 
(mean of 2 ) . Binding r a t i o ' s a r e expressed as 
i mmu ne/no rma1. 
DISCUSSION. 
Immunisat ion. 
A l t h o u g h i n t r a p e r i t o n e a l i n o c u l a t i o n of v i r u s e s o r v i r a l 
a n t i g e n s has been s u c c e s f u l l in hybridoma p r o d u c t i o n (Koprowski 
e t a l , 1 9 7 7 ; Wik to r e t K o p r o w s k i , 1 9 7 8 ; Nowinski e t a l , 1 9 7 9 ) , I 
d e c i d e d t o e s t a b l i s h l a t e n t i n f e c t i o n i n B a l b / c m i c e b y 
i n j e c t i o n of l i v e v i r u s i n t o t h e e a r p i n n a . T h i s r o u t e was 
chosen because of t h e f a c t t h a t t h e so p r o d u c e d i n f e c t i o n h a s 
been we l l c h a r a c t e r i s e d in our l a b o r a t o r y , and i t was known t h a t 
a n e u t r a l i s i n g a n t i b o d y r e s p o n s e t o a t i t r e o f 1 /40 wou ld 
d e v e l o p f o l l o w i n g i n f e c t i o n w i t h 10 4 pfu of v i r u s (Nash e t 
a l , 1 9 8 0 a ) . The d i f f e r e n c e between i n t r a v e n o u s and i n t r a p e r i t o n e a l 
secondary i m m u n i s a t i o n s was s m a l l , b u t i . v . seemed t o g i v e a 
s l i g h t l y h i g h e r a n t i b o d y r e s p o n s e a s m e a s u r e d b y RPHI and 
n e u t r a l i s a t i o n . The serum a n t i b o d y t i t r e was most a f f e c t e d by 
t h e dose of v i r u s a d m i n i s t e r e d : a h i g h e r d o s e g i v e s r i s e t o a 
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higher ant ibody response . The immunisation schedule t h a t was 
adopted a f t e r c o n s i d e r a t i o n of t h e s e d a t a i s o u t l i n e d in 
"Materials and Methods" of t h i s c h a p t e r . After i n f e c t i o n with 
104 pfu in the ear pinna, two inc reas ing doses of l i v e v i r u s 
are given in t r ape r i tonea l ly , followed by the f i n a l in t ravenous 
inject ion three days before the fusion. Secondary immunisations 
u s i n g t h e i n t r a p e r i t o n e a l r o u t e were chosen i n s t e a d of 
in t ravenous i n j e c t i o n s b e c a u s e of t h e f a c t t h a t t h e mice 
f r equen t ly died of a n a p h y l a c t i c shock f o l l o w i n g r e p e a t e d 
intravenous challenge with l ive v i ru s . The antibody t i t r e in mice 
thus immunised was u s u a l l y between 1/1000 or 1 /10 ,000 , as 
measured by RIA-1. Although a primary immunisation u s i n g a 
h igher dose of i n f e c t i o u s v i ru s would give r i s e to a higher 
antibody t i t r e (see table 1) , a dose of 105 pfu or more was not 
p rac t i ca l as a great percentage of the mice thus immunised died 
following the infect ion. 
In a recent repor t , i t was suggested that in fec t ious v i ru s 
i s infer ior to inact ivated virus as an immunogen (Ki l l ing ton e t 
a l ,1981) . This observation was made on the bas is of a comparison 
between the yield of pos i t ive hybrids following a fusion with the 
spleen of mice t h a t were e i t h e r immunised with l i v e v i r u s or 
with i n a c t i v a t e d v i r u s p lus Freund 's Adjuvant. A much higher 
number of p o s i t i v e hybr ids was obta ined in the l a t t e r c a s e . 
However, in our s t u d i e s we have found no evidence for a poor 
immune response to l ive v i r u s , if adminis tered i n t r a d e r m a l l y . 
Also, the yield of pos i t ive hybr ids was h igher in our fus ions 
than in the ones described in the above paper. The d i f f e rence i s 
t h e r e f o r e probably not so much due to the i n f e c t i v i t y of the 
virus as to the route of infect ion: i . p . or i . v . i n j e c t i o n with 
l ive virus i s infer ior to intradermal in ject ion. 
Assay methods. 
Of the three assay systems compared, RIA-3 was found to be 
the most s ens i t i ve , mainly because of the very low background 
values . RIA-1 was also s a t i s f a c t o r y as f a r as s e n s i t i v i t y and 
s p e c i f i c i t y were concerned. Both the p l a t e s and r a d i o l a b e l d 
reagents could be s to red for reasonable l engh t s of t ime.Both 
assays were l i m i t e d , however, in t h e p r e s e n t a t i o n of v i r a l 
antigens : RIA-1 uses glutaraldehyde to f ix the in fec ted c e l l s , 
and i t i s not known to what ex ten t t h i s modif ies t h e v i r a l 
an t igens and to what e x t e n t c y t o p l a s m i c and i n t r a n u c l e a r 
antigens are exposed to an t ibody . RIA-3 i s r e s t r i c t e d by the 
f a c t t h a t Rabbit anti-HSV-2 immunoglobulin i s used to s e l e c t 
t a rge t ant igens, thus s e l e c t i n g for the an t igens which give a 
dominant immune response in the r abb i t . Furthermore, the assay 
involves the use of large amounts of hyperimmune mouse serum. 
The differences in presentat ion of the ta rge t antigen in the two 
assays, (RIA-1 and 3) , are ref lected in the f ac t t h a t they seem 
to detect di f ferent monoclonal antibodies (see section B). 
B: Fusion Experiments. 
Three f u s i o n e x p e r i m e n t s were c a r r i e d o u t u s i n g t h e 
immunisation routine outined in "materials and methods", which 
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i s based on the r e s u l t s descr ibed in s e c t i o n A. A f t e r each 
fus ion , the c e l l s were d i s t r i b u t e d over 48 w e l l s , and c e l l 
growth was observed in each well . 
The r e s u l t of the f i r s t fus ion can be found in f i g . 2 ; 
supe rna t an t s from 48 wel l s were assayed by RIA-1 and RIA-3, 
using 125I-anti-mouse-Fab. Posit ive wells were defined as having 
a binding r a t i o of 2 or more. The c o n t r o l in both assays was 
supe rna tan t from NS1 c e l l c u l t u r e s . Of the 48 w e l l s , 36 were 
found to be p o s i t i v e by t h e a s s a y on i n f e c t e d BHK-ce l l 
monolayers (RIA-1) and 31 by the assay using a n t i b o d y - s e l e c t e d 
v i r a l antigens (RIA-3). However, many of the we l l s p o s i t i v e in 
both assays had a much h igher b inding r a t i o in RIA-1 than in 
RIA-3 or v ice v e r s a . This proves t h a t the two a s s a y sys tems 
present v i r a l antigens in different amounts and in a d i f f e r e n t 
way. 
Ten wel l s with a b inding r a t i o of 4 o r h igher in a t 
l e a s t one of the assay systems were passed for four weeks in 
HAT-medium and HT-medium. The reason for t h i s was the repor ted 
i n s t a b i l i t y of many hybridoma's. I t was hoped t h a t passage of 
the c e l l s for a c e r t a i n time would s e l e c t for the hybridoma's 
s tab le in the secret ion of antibody. At the end of t h i s p e r i o d , 
the supernatants were t e s t e d again in the two assay sys tems. 
Although each of the supe rna t an t s was s t i l l p o s i t i v e , t h e 
binding r a t i o s of s ix of them had dropped more than 50% compared 
with four weeks e a r l i e r in RIA-1. In RIA-3, a l l b ind ing r a t i o s 
were a t l e a s t halved compared to the f i r s t a s say . Thus, four 
hybridoma mixtures were s t i l l h igh ly p o s i t i v e in RIA-1 on ly . 
These mixtures were cloned in so f t agar and p o s i t i v e c lones 
could only be isolated from one of the m i x t u r e s . These c lones 
were grown up and r e c l o n e d in s o f t a g a r . The f r equency of 
pos i t ive subclones was 100%. The hybridoma was named LP1. 
The second fusion was c a r r i e d out in the same way as the 
f i r s t one, with the exception t h a t only RIA-1 was used in the 
assay of the 48 w e l l s . A t o t a l of 30 o u t of 48 w e l l s was 
p o s i t i v e (see f i g . 3 ) . The ten most p o s i t i v e w e l l s , wi th a 
binding r a t i o of s ix or more, were passed for three weeks and the 
supernatants assayed by RIA-1 and RIA-3. Six wells s t i l l had the 
same or a higher b inding r a t i o as before in RIA-1, and these 
were a l so p o s i t i v e in RIA-3. These hybridoma m i x t u r e s were 
cloned, and pos i t ive clones could be i s o l a t e d from four of the 
mixtures. These were grown and subcloned as for fusion 1. The 
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Fig.2. Selection of positive hybridoma's from fusion 1. 
RIA-1 and RIA-3 as described in chapter 2A. 
Positive wells were defined as having a binding 
ratio >2. The binding ratio was defined as: cpm 
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Fig .3 . Selection of pos i t ive hybridoma's from fusion 2. 
RIA-1, RIA-3 and def in i t ion of pos i t ive wells and 
binding r a t i o s as for f i g . 2 . 
The assay system for the t h i r d fusion d i f f e r ed from t h a t 
for the f i r s t two in t h a t 1 2 5 I - p r o t e i n A was used ins t ead of 125I-anti-mouse Fab. This excluded the use of RIA-3, as p r o t e i n 
A would bind to rabbit-IgG coupled to the p l a s t i c . There fore , 
a l l assays were carr ied out using in fec ted BHK-cell monolayers 
as t a r g e t s . Out of 48 wel ls , 17 had a binding r a t i o of 2 or more. 
The c e l l s from the twelve most p o s i t i v e wel l s were passed for 
three weeks and reassayed: seven supe rna t an t s had an equal or 
higher binding r a t i o as before. The c e l l s from these wel l s were 
cloned and in soft agar. Posit ive clones were isola ted from four 
of the seven hybridoma mix tu re s . These were recloned and the 
frequency of pos i t ive subclones was 100%. The hybridoma's were 
named LP2, LP4, LP5 and LP6. 
The p o s i t i v e supe rna t an t s of the hybridoma mixtures of 
each of the three fusions, t h a t were passed for s eve ra l weeks 
a f te r the f i r s t assay, were tested for t he i r a b i l i t y to bind to 
un infec ted BHK-cells. This was done in a rad io immunoassay 
s imilar to RIA-1, but using uninfec ted c e l l s as a t a r g e t . No 
detectable binding could be found for any of the hybr idoma 's . 
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This experiment was repeated with supernatants of the selected 
positive clones, and the same result was obtained. 
FUSION 3 
Supernatant test 10 
days after fusion:.. 
Nr. of wells selected, 
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Fig.4 . Selection of pos i t ive hybridoraa's from fusion 3. 
RIA-1 and def in i t ion of pos i t ive wells and 
binding r a t i o s as in Fig.2 . 
Raising of serum or a s c i t i c f lu id . 
The hybridoma c e l l s of each l i n e were i n j ec t ed i n to Balb/c 
mice subcutanously o r i n t r a p e r i t o n e a l l y in o r d e r t o r a i s e 
antiserum or a s c i t i c f lu id . The antibody t i t r e s of these sera or 
a s c i t i c f lu ids varied from 1/104 to 1/106 , as measured by RIA-
1. The v a r i a t i o n , however, was between c l o n e s : the same clone 
would give a s i m i l a r t i t r e every t ime , varying p e r h a p s by a 
factor of 2 or 3. 
Immunoglobulins secreted by the hybridoma's. 
The immunoglobulins secre ted by the s t a b l e hybridoma l i n e s 
isolated from the three fusion experiments described above were 
c h a r a c t e r i s e d . The hybridoma c e l l s were i n c u b a t e d in t h e 
presence of 1 4C-lysine, and the supe rna t an t s analysed on SDS-
polyacrylamide g e l s . The r e s u l t with a few of the supe rna tan t s 
i s shown in f ig . 5. All l ines produce immunoglobulin of the IgG 
c l a s s . Di f fe ren t c lones from the same o r i g i n a l well s e c r e t e 
heavy and l i gh t chains of the same electrophoret ic mobil i ty. 
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The immunoglobulin-G s u b c l a s s of each of t h e h y b r i d o m a ' s was 
de termined u s i n g a n t i s e r a s p e c i f i c f o r e a c h of t h e s u b c l a s s e s . 
?™ r ? ? U w t ? W e r e a S f o l l o w S ! a n t i b o d i e s LP2,LP3, LP4, LP5 and 
LP6 a l l be long t o t h e IgG2a s u b c l a s s , w h i l e I ,P1, LP7, LP8, and 
LP9 a r e of t h e IgGl s u b c l a s s . These r e s u l t s c a n be s e e n i n t h e 
t a b l e a t t h e end of t h i s t h e s i s . 
A E 
« * * * 
l iSLiS . Immunog lobu l in s s e c r e t e d b y some of t h e h y b r i d o m a ' s , 
l a b e l l e d wi th C- ly s ine and r u n on an 10% S D S - p o l y a c r y l a m i d e 
? S ; . u P - ; B : L F 2 ' - C=LP4; D=LP6; E = LP5; F=LP3. H ,L : heavy and 
l i g h t cha in of immunoglobulin G. 
DISCUSSION. 
The number of p o s i t i v e s u p e r n a t a n t s d e r i v e d from e a c h o f 
t h e t h r e e f u s i o n s d e s c r i b e d a b o v e ( 7 7 % , 63% a n d 35% 
r e s p e c t i v e l y ) compares favourab ly wi th o t h e r r e p o r t s c o n c e r n i n g 
ant i -HSV-1 o r anti-HSV-2 monoc lona l a n t i b o d i e s ( K i l l i n g t o n e t 
a l , 1 9 8 1 ; Zweig e t a l , 1 9 7 9 ) . In t h e c a s e of t h e t h i r d f u s i o n a 
lower number of p o s i t i v e w e l l s was o b t a i n e d t h a n i n t h e f i r s t 
two f u s i o n s . T h i s c a n p r o b a b l y be e x p l a i n e d by t h e f a c t t h a t 
p r o t e i n A was used t o d e t e c t t h e s e c r e t e d i m m u n o g l o b u l i n s , and 
t h i s method w i l l n o t d e t e c t a l l i m m u n o g l o b u l i n c l a s s e s o r 
s u b c l a s s e s . I t i s p robab le t h a t many s e c r e t i n g h y b r i d o m a ' s were 
no t d e t e c t e d in fus ion 3 . 
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The procedure of pass ing p o s i t i v e hybridoma c u l t u r e s for 
s e v e r a l weeks before c loning in o rder to s e l e c t fo r s t a b l e 
hybridoma's worked sa t i s f ac to ry . Admittedly, a l a rge p ropor t ion 
of p o s i t i v e hybridoma's i s l o s t in t h i s way:presumably some 
cul tures contain non-producing c e l l s which overgrow producing 
c e l l s , wh i l e some p r o d u c i n g c e l l s t h e m s e l v e s may be ve ry 
unstable . The advantage of t h i s per iod of passage i s t h a t i t 
allows s table hybridoma's to be i d e n t i f i e d , and i t i nc reases 
the homogeneity of the c u l t u r e s by s e l e c t i n g fo r t h e " f a s t 
growers". This reduces the effor t involved in c lon ing : in most 
i n s t ances p o s i t i v e c lones were r e a d i l y obta ined from a small 
number of picked colonies , and in several instances a l l colonies 
were pos i t i ve . One can thus be f a i r ly c e r t a i n of the s t a b i l i t y 
of the clones. The nine hybridoma's descr ibed in t h i s chap te r 
have a l l been passed for s e v e r a l months without any l o s s of 
t h e i r a b i l i t y to secrete antibody. 
None of the p o s i t i v e s u p e r n a t a n t s gave any d e t e c t a b l e 
binding to uninfected BHK-cells. In consequence, the ant ibody 
secreted by these hybridoma's i s in a l l cases d i r e c t e d a g a i n s t 
v i r a l ant igens. 
The f ac t t h a t d i f f e r e n t c l o n e s d e r i v e d from t h e same 
o r ig ina l hybridoma cul ture always secre te immunoglobulins with 
heavy and l i g h t cha ins of the same e l e c t r o p h o r e t i c mobi l i ty 
suggests tha t these c lones are der ived from the same p a r e n t . 
This observation was confirmed in l a t e r exper iments , when the 
c lones were c h a r a c t e r i s e d in more d e t a i l . A p p a r e n t l y , t h e 
hybridoma cul tures are often overgrown very rapidly by one or a 
few fas t growing hybrids. This i s in agreement with the findings 
of Gerhardt e t a l (1977) in the p r o d u c t i o n of h y b r i d o m a ' s 
secret ing antibodies against influenza v i rus . 
In conclusion, t h i s chap te r d e s c r i b e s the gene ra t ion of 
n i n e h y b r i d o m a ' s s e c r e t i n g a n t i b o d y a g a i n s t HSV-2. A l l 
antibodies are of the IgG c l a s s . A fur ther c h a r a c t e r i s a t i o n of 
the antibodies i s given in the following chapters . 
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CHAPTER 3: A N T I B O D I E S LP1 AND L P 4 . 
INTRODUCTION. 
I n t h i s c h a p t e r we d e s c r i b e t h e f u r t h e r c h a r a c t e r i s a t i o n o f 
two m o n o c l o n a l a n t i b o d i e s , LP1 a n d L P 4 . T h e i r p r o d u c t i o n h a s 
a l r e a d y b e e n d e s c r i b e d i n c h a p t e r 1 . B o t h a n t i b o d i e s a r e o f t h e 
I g G - c l a s s . T h e i r t a r g e t a n t i g e n s w e r e i d e n t i f i e d b y 
i m m u n o p r e c i p i t a t i o n and p o l y a c r y l a m i d e g e l e l e c t r o p h o r e s i s . T h e i r 
r e a c t i v i t y w i t h s e v e r a l s t r a i n s o f H S V - 1 a n d H S V - 2 w a s 
e s t a b l i s h e d , and t h e i r a b i l i t y t o n e u t r a l i s e i n f e c t i o u s v i r u s 
m e a s u r e d . 
MATERIALS AND METHODS. 
C e l l s and v i r u s . 
Hybr idoma c e l l s w e r e p a s s e d i n GMM s u p p l e m e n t e d w i t h 5% FCS. 
BHK-21 c e l l s w e r e p a s s e d i n ETC a s d e s c r i b e d i n c h a p t e r 2 . 
S t r a i n s o f H e r p e s S i m p l e x V i r u s u s e d w e r e a s f o l l o w s : T y p e 1 
s t r a i n s : s t r a i n C l ( 1 0 1 ) , Dubbs and K i t ( 1 9 6 4 ) ; s t r a i n HFEM, w a t s o n 
e t a l ( 1 9 6 6 ) ; s t r a i n F , E j e r c i t o e t a l . ( 1 9 6 8 ) ; s t r a i n S C 1 6 , H i l l 
e t a l . ( 1 9 7 5 ) . Type 2 s t r a i n s : s t r a i n B r y , T h o u l e s s a n d S k i n n e r 
( 1 9 7 1 ) s t r a i n 2 5 7 6 6 ( i s o l a t e d b y K . R . D u m b e l l , W r i g h t F k e m i n g 
I n s t i t u t e , L o n d o n ) ; s t r a i n 3 3 3 , ( i s o l a t e d b y R a w l s , M c M a s t e r 
U n i v e r s i t y , O n t a r i o ) . V i r u s e s w e r e p r o p a g a t e d i n BHK-21 c e l l s . 
R a d i o i m m u n o a s s a y . 
The r a d i o i m m u n o a s s a y u s e d w a s R I A - 1 d e s c r i b e d i n c h a p t e r 2 , 
w i t h t h e d i f f e r e n c e t h a t 1 " I - l a b e l l e d S t a p h A p r o t e i n w a s u s e d 
f o r t h e d e t e c t i o n o f a n t i b o d i e s i n s t e a d o f 125I-anti-mouse Fab. 
Fluorescence. 
Sub-confluent BHK-cell monolayers were grown on glass 
microscope slides and infected with HSV-2 at an approximate 
multiplicity of 3 pfu per cell . Eight hours after infection the 
cells were fixed in methanol at -20°C overnight. Fixed cel ls 
were reacted with antibody for 1 hour at room temperature, washed 
in PBS and then reacted with FITC-labelled, affinity-purified 
sheep anti-mouse Fab (gift from Dr.A.Muro) for 1 hour at room 
temperature. 
Preparation of isotope-labelled antigen. 
Monolayers of BHK-21 cells were infected with HSV-1 or HSV-2 
at a multiplicity of 10 pfu per cell and labelled from 3 to 8 
hours after infection in. methionine-free medium containing 200 
uCi/ml 35S-methionine (sp. act.>600 Ci/mmole, Amersham Corp.). 
32P-labelled antigens were prepared by incubating cel ls from 3 
to 8 hours post infection in phosphate-free medium containing 22 
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uCi/ml ( 32P)-orthophosphate ( ca r r i e r - f r ee , Amersham Corp.) . Cells 
l a b e l l e d with e i t h e r i so tope were h a r v e s t e d in PBS a t 107 
ce l l s /ml . Cell suspensions were lysed by the a d d i t i o n of 0.1 
volume of l y s i s buffer (0.9 M NaCl, 0.01M tr is-Cl" pH 7.4, 7.5 mM 
L-methionine, 10% Triton and 10% deoxycholate), and incubated 15 
minutes a t 0°C. Insoluble material was removed by c e n t r i f u g a t i o n 
a t 10,000g for 10 min. The supernatants were made to 0.02mM with 
respect to phenyl methylsulphonylfluoride (PMSF) and s to red a t -
70°C. 
Immunoprecipitation. 
20 u l of i s o t o p e - l a b e l l e d a n t i g e n was mixed wi th 5 u l 
antibody (asc i tes f luid or serum) and incubated for 30 min. a t 
room tempera tu re . 25 u l of a 50% s u s p e n s i o n of p r o t e i n - A 
sepharose Cl-4B-beads (Pharmacia Ltd) was added toge the r with 
150 u l 0.15M NaCl, 0.01M tr is -Cl" pH 7.4, 75 mM L-methionine, 1% 
Triton and 1% sodium deoxycholate. This mixture was kept a t room 
temperature for 2 hours with continuous ag i ta t ion s u f f i c i e n t t o 
keep the beads in suspens ion . The beads were c o l l e c t e d by 
centr i fugat ion, washed three times in 0.5M LiCl, 0.1M tr i l -Cl" pH 
7.4, 1% 2-mercaptoethanol, and the immune complexes d i sso lved by 
addit ion of 50 u l 0.025M t r i s -C l " pH 7 .0 , 2% SDS, 20% g l y c e r o l , 
1.5% d i t h i o t h r e i t o l , 0.02% bromophenol b lue . Samples were heated 
to 100°C for two minutes and electrophoresed for about 4 hours a t 
12V/cm in 10% or 12.5% acrylamide gels c r o s s - l i n k e d with 0.15% 
bisacrylamide. The buffer system used for e lec t rophores is was as 
described by Laemmli (1970). After e lectrophoresis the gels were 
s t a i n e d in 0.1% Coomassie Blue in me thano l : ace t i c ac id :wa te r (50:10:40), destained in the same solvent , dried on f i l t e r paper 
and exposed to X-ray film for 2 to 10 days. 
Ident i f ica t ion of ta rge t antigens by treatment of acrylamide gels 
with antibody. 
As an a l t e r n a t i v e t o i m m u n o p r e c i p i t a t i o n f o l l o w e d by 
electrophoresis in some experiments unlabelled ex t rac t s of virus 
i n f e c t e d c e l l s were s u b j e c t e d t o S D S - p o l y a c r y l a m i d e 
e lect rophoresis and the ta rge t antigen i d e n t i f i e d by t rea tment 
of the gel with an t ibody . 12% polyacrylamide g e l s were c r o s s -
l inked with NN1 d i a l - t a r t a r d i a m i d e (Heine e t a l , 1 9 7 4 ) and 
antigens were disrupted pr ior to e l e c t r o p h o r e s i s by incubat ing 
for 10 min. at 45°C in 2% SDS, 5% 2-mercaptoethanol, 3% sucrose 
in 0.05 M tris-Cl"pH 7.0. After e l ec t rophores i s ge l s were fixed 
in methanol:acetic acid:water (46:8:46) At -20°C for a t l eas t 12 
hours and were washed for 24 hours in th ree samples of PBS. The 
g e l s were then shaken for 5 hours in a s e a l e d p l a s t i c bag 
containing suf f ic ient antibody solution to keep the ge l su r face 
moist (about 5ml for a 5x11 cm g e l s l i c e ) . A s c i t e s f l u i d s 
containing monoclonal an t ibodies were d i l u t e d 100-fold in PBS 
containing 200 ug/ml ovalbumin. After react ion with ant ibody the 
g e l s were washed for 36 hours in PBS and i n c u b a t e d in PBS 
containing 200 ug/ml ovalbumin and 2 uCi 12S I - label led protein A (specif ic a c t i v i t y 10 u C i / u g ) . Gels were again washed for 36 
hours to remove unreacted p r o t e i n A and were s t a i n e d wi th 
Coomassie Blue, des ta ined and dr ied onto f i l t e r paper before 
autoradiography. 
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Fig. Electrophoresis of LP1-precipitates. Samples were prepared as 
described in "Materials and Methods", and electrophoresed on a 
12.5% acrylamide gel. Artotal 32P-labelled extract; B:immune 
precipitate with LP1; D:total 3sS-methionine labelled extract; 
C:immune precipitate with LP1. 
Fig. Detection of LPl-target antigen in unlabelled extracts.Target 
antigen was identified by reacting the gel with antibody and 
125I-protein A (see methods). l:uninfected cell extract; 2:HSV-1 
infected cell extract; 3:HSV-2 infected cell extract; 4:purified 
HSV-2 particles; 5: 3SS-methionine labelled HSV-1 infected cell 
extract. Gel A was reacted with LP1 and gel B with normal rabbit 
serum. 
Fig.3. Electrophoresis of LP4 immunoprecipitates. A: 3%-methionine 
labelled cell extracts. 1 :LP4 with HSV-2 infected cell extract; 
2: LP4 with uninfected cell extract; 3:normal mouse serum with 
HSV-2 infected cell extract. 5: total HSV-2 infected cell extract. 
i*^^i i * » * 
MDBP is arrowed. 
B: purified major DNA-
binding protein. Gel was 
stained with Coomassie Blue. 
1: MDBP; 2: MDBP precipitated 
with LP4; 3: as track 2, but 
precipitated with LP3; 4: LP4 
alone. H and L mark positions 




N e u t r a l i s a t i o n . 
The n e u t r a l i s i n g a c t i v i t y of monoclonal a n t i b o d i e s was t e s t e d 
by adding 10 p i serum t o 104 pfu HSV-2 o r HSV-1, i n 100 u l o f a 
mix tu re of 50% GMM-40% PBS-10%FCS. Af te r i ncuba t i on o v e r n i g h t a t 
4°C t h e number of r e m a i n i n g pfu was measured i n a s u s p e n s i o n 
a s s a y , as d e s c r i b e d in c h a p t e r 2 . 
RESULTS. 
Identification of target antigens. 
LP1. 
In o r d e r t o i d e n t i f y t h e t a r g e t a n t i g e n of an t ibody LP1, HSV-2 
i n f e c t e d BHK-21 c e l l s were l a b e l l e d wi th 3 5 S - m e t h i o n i n e , l y s e d , 
and a l i g u o t s of t h e l y s a t e r e a c t e d wi th an t i se rum o b t a i n e d from 
d i f f e r e n t c l o n e s of LP1 . The immune p r e c i p i t a t e s o b t a i n e d i n 
t h i s way were a n a l y s e d on p o l y a c r y l a m i d e g e l s . As shown i n 
f i g . l a , monoclonal a n t i b o d y LP1 p r e c i p i t a t e s a p r o t e i n w i t h a 
molecu la r we igh t of 65 ,000 D. Each c l o n e r e a c t s w i t h t h e same 
p o l y p e p t i d e (not shown). 
In o r d e r t o d e t e r m i n e t h e n a t u r e of t h e 6 5 K - p r o t e i n , LP1 
a n t i b o d i e s were r e a c t e d wi th a " P - l a b e l l e d HSV-2 i n f e c t e d c e l l 
l y s a t e . Fig lb shows t h a t t h e 65K p r o t e i n p r e c i p i t a t e d by LP1 i s 
p h o s p h o r y l a t e d . I d e n t i c a l r e s u l t s were o b t a i n e d w i t h HSV-1 
i n f e c t e d c e l l e x t r a c t s . S e v e r a l g r o u p s h a v e r e p o r t e d t h e 
p r e s e n c e of phosphory la ted p o l y p e p t i d e s of a p p r o x i m a t e l y 6 5 , 0 0 0 
molecu la r we igh t i n HSV-infec ted c e l l s . A p r o m i n e n t s t r u c t u r a l 
p o l y p e p t i d e of t h i s molecu la r weight has been de s igna t ed VP16 i n 
HSV-1 and HSV-2 ( S p e a r and R o i z m a n , 1 9 7 2 ; C a s s a i e t a l , 1 9 7 5 ; 
Honess and R o i z m a n , 1 9 7 3 ) , and i s p h o s p h o r y l a t e d (Gibson and 
R o i z m a n , 1 9 7 4 ) . T h i s p r o b a b l y c o r r e s p o n d s t o t h e p o l y p e p t i d e 
d e s i g n a t e d M65 and P65 ' i n HSV-1 i n f e c t e d c e l l s by Marsden e t a l 
(1978) and t o ICSP 31 i n HSV-2 i n f e c t e d c e l l s ( P o w e l l and 
C o u r t n e y , 1975) . Knopf and Kaemer ( 1 9 8 0 ) i d e n t i f i e d a 65K 
phosphopro te in a s s o c i a t e d w i t h t h e c h r o m a t i n i n HSV-1 i n f e c t e d 
c e l l s and RC-37 c e l l s , b u t could not d e t e c t t h i s p o l y p e p t i d e i n 
p u r i f i e d v i r i o n s . To e s t a b l i s h whether t h e t a r g e t a n t i g e n of LP1 
i s a v i r i o n p o l y p e p t i d e , p u r i f i e d HSV-1 p a r t i c l e s were d i s r u p t e d 
and s u b j e c t e d t o e l e c t r o p h o r e s i s i n p a r a l l e l w i t h e x t r a c t s of 
u n i n f e c t e d c e l l s , HSV-1 i n f e c t e d c e l l s and HSV-2 i n f e c t e d c e l l s . 
The g e l was t h e n r e a c t e d w i t h a n t i b o d y LP1 f o l l o w e d by , 2 5 I -
l a b e l l e d p r o t e i n A as d e s c r i b e d in " M a t e r i a l s and M e t h o d s " . The 
r e s u l t i n g a u t o r a d i o g r a p h ( f i g . 2 ) shows the t a r g e t a n t i g e n t o b e 
p r e s e n t i n i n f e c t e d c e l l s and in p u r i f i e d p a r t i c l e s and t o be of 
s i m i l a r m o l e c u l a r w e i g h t i n t y p e 1 and t y p e 2 i n f e c t e d c e l l s . 
The p r o p e r t i e s o f t h e LP1 t a r g e t a n t i g e n s u g g e s t t h a t i t 
co r re sponds t o p o l y p e p t i d e VP16 in HSV-1 and ICSP 31 i n HSV-2. 
However, t h i s conc lu s ion should be t r e a t e d wi th c a u t i o n i n v iew 
of t h e c o m p l e x i t i e s of t h e pub l i shed HSV p o l y p e p t i d e p a t t e r n s i n 
t h i s r e g i o n of SDS acry lamide g e l s and t h e c u r r e n t c o n f u s i o n i n 
HSV p o l y p e p t i d e nomenc l a tu r e . In any e v e n t a n t i b o d y LP1 s h o u l d 
prove u s e f u l i n h e l p i n g t o a c h i e v e a c o n s i s t e n t n o m e n c l a t u r e 
among d i f f e r e n t groups of workers us ing d i f f e r e n t v i r u s i s o l a t e s 
and d i f f e r e n t g e l e l c e c t r o p h o r e s i s sy s t ems . 
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LP4 
Electrophoresis of immunoprecipi tates prepared from 3 5S-
methionine l a b e l l e d c e l l e x t r a c t s of HSV-2 i n f e c t e d c e l l s (f ig.3a) showed tha t the ta rge t antigen of LP4 was a polypeptide 
of approximately 130,00 M.W. The e l e c t r o p h o r e t i c behaviour of 
t h i s polypeptide suggested tha t i t might correspond t o t he HSV-2 
major DNA-binding prote in , designated ICSP 11/12 by Purifoy and 
Powell (1976). This was confirmed by showing t h a t LP4 could 
r e a c t with the p u r i f i e d major DNA-binding p r o t e i n (Powell e t 
a l ,1981) . This was achieved in two ways. F i r s t l y , p u r i f i e d ICSP 
11/12 (a g i f t from Dr.K.Powell) was prec ip i ta ted by LP4 and not 
by a dif ferent monoclonal antibody of the same subclass (fig 3b). 
Secondly, purif ied ICSP 11/12 blocked the binding of LP4 to HSV-2 
infected ta rge t c e l l s in a radioimmunoassay, whereas i t did not 
block the binding of a different monoclonal antibody of the same 
subclass ( f i g . 4 ) . LP4 i s t he re fo re d i r e c t e d a g a i n s t the major 
DNA-binding protein of HSV-2. 
Cross-react iv i ty with other Herpes Simplex Virus s t r a i n s . 
The type-speci f ic i ty of antibodies LP1 and LP4 was t e s t e d by 
radioimmunoassay. BHK-cell monolayers were in fec ted with t h r ee 
di f ferent type 2 s t r a i n s (25766, Bry and 333) and four dif ferent 
type 1 s t r a in s (CI(101), HFEM, F and SC16) a t a m u l t i p l i c i t y of 
10 pfu per c e l l . The c e l l s were f ixed in g lu ta ra ldehyde and a 
1/1000 d i lu t ion of each of the monoclonal an t i sera was tested on 
the p l a t e s . Controls were normal mouse serum and hyperimmune 
rabbi t serum a g a i n s t HSV-2. Bound ant ibody was de t ec t ed using 1 2 5I-protein A. The r e s u l t s in t a b l e 1 show t h a t ant ibody LPl 
reac ts strongly with a l l the v i r u s s t r a i n s t e s t e d . Monoclonal 
antibody LP4, on the contrary binds very e f f i c i e n t l y to type 2 
infected c e l l s but shows no r e a c t i v i t y with the type 1 s t r a i n s 
F, Cl(101) and HFEM, and a very fa in t r e a c t i v i t y with SC16. LPl 
and LP4 ant isera were also t e s t e d on uninfec ted BHK c e l l s and 
gave no detectable binding. 
Immunofluorescence. 
I n d i r e c t immunofluorescence wi th b o t h t h e a n t i b o d i e s 
r e s u l t e d in a predominantly nuc lear f luo rescence in HSV-2 
in fec t ed c e l l s , c o n s i s t a n t with t h e t a r g e t a n t i g e n of t h e 
ant ibodies . Antibody LPl gave a homogeneous nuclear fluorescence 
while t h e d i s t r i b u t i o n of a n t i b o d y LP4 was h e t e r o g e n e o u s ( f i g . 5 ) . 
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Fig.4. Blocking experiment using RIA-1 and purified MDBP. Wells were treated 
with increasing amounts of MDBP before reaction with antibody (diluta 
1/1000) and 125I-protein A. Controls were antibodies LP2, LP5 and 
buffer. 
Fig.5. Immunofluorescent staining with LP1 and LP4. Uninfected BHK-cells 
(c and d) or HSV-2 infected BHK-cells (a and b) were fixed in methanol 
8 hours after infection and treated with LP1 (a,c) or LP4 (b,d). 

































































































Table 1. R e a c t i v i t y of LP1 and LP4 wi th d i f f e r e n t v i r u s 
s t r a i n s , (serum d i l u t i o n s 1/1000) us ing RIA-1. 
imm=hyperimmune a n t i HSV-2 serum 
nms=normal mouse serum. 
b i n d i n g r a t i o i s def ined as no. of cpm bound/ 
no . of cpm bound fo r nms. 
DISCUSSION. 
In t h i s c h a p t e r we d e s c r i b e d t h e c h a r a c t e r i s a t i o n of two 
monoclonal a n t i b o d i e s , LP1 and LP4. Both a n t i b o d i e s were s e l e c t e d 
a g a i n s t type 2 s t r a i n 25766, b u t show r e a c t i v i t y a g a i n s t two 
o t h e r type 2 s t r a i n s , 333 and B r y . In a d d i t i o n , LP1 b i n d s t o 
four d i f f e r e n t t y p e 1 s t r a i n s t e s t e d , b u t LP4 d o e s no t r e a c t 
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with any of these s t r a i n s . Both a n t i b o d i e s do not n e u t r a l i s e 
infect ious virus ( r e su l t s not shown). 
The true monoclonal nature of each of the hybridoma's has 
been es tab l i shed : c lones and subclones of LP1 p r e c i p i t a t e the 
same protein and secrete antibodies with heavy and l i g h t cha ins 
of the same electrophoret ic mobi l i ty (see chap te r 2B). This i s 
also t rue for LP4. 
The antibody secreted by hybridoma LP1 i s d i r e c t e d a g a i n s t 
the vi r ion polypeptide designated ICSP 31 in HSV-2 and VP16 in 
HSV-1. This i s the f i r s t r epo r t of an ant ibody aga ins t t h i s 
polypeptide and LP1 should prove useful in the c h a r a c t e r i s a t i o n 
of the s t ruc ture and function of VP16. Antibody LP4 reacts type-
spec i f ica l ly with the major DNA-binding p r o t e i n ICSP 11/12 of 
HSV-2. This antigen i s highly conserved among the members of the 
herpesvirus group (Killington e t al ,1977; Yeo e t a l ,1981; L i t t l e r 
e t al,1981) and has recently been purif ied (Powell e t a l , 1 9 8 1 ) . 
Ant ibodies to the major DNA-binding p r o t e i n a r e a p p a r e n t l y 
elevated in pa t i en t s with cervical carcinoma (Anzai e t a l ,1975 
Melnick e t a l , 1 9 7 6 ) and t h e p r o t e i n has been d e t e c t e d by 
serological techniques in HSV-2 transformed c e l l s (Flannery e t 
a l ,1977) and in c e r v i c a l carcinoma b i o p s i e s (Dreesman e t a l , 
1980). This evidence has been interpreted to implicate HSV-2 in 
cervical carcinoma, but , as Powell e t al (1981) point out , given 
the cons ide rab le c r o s s - r e a c t i v i t y of t h e major DNA-binding 
prote in of di f ferent herpesviruses, the use of po lyc lona l s e ra 
to detect t h i s antigen does not define i t s o r ig in . Since LP4 i s 
type-speci f ic , t h i s antibody should prove a more p r e c i s e probe 
for d e t e c t i n g ICSP 11/12 in c e r v i c a l ca rc inoma b i o p s i e s . 
Showalter e t a l (1981) have r e c e n t l y descr ibed a monoclonal 
ant ibody whose t e n t i t a t i v e t a r g e t i s the major DNA-binding 
prote in of HSV-1. I t i s notable t h a t , d e s p i t e the s t r u c t u r a l 
conse rva t ion of t h i s an t igen among d i f f e r e n t h e r p e s v i r u s e s ( L i t t l e r e t a l ,1981) and the broad c r o s s - r e a c t i v i t y of t he 
po lyc lona l se ra r a i s e d a g a i n s t i t (Powell e t a l , 1 9 8 1 ) , bo th 
monoclonal antibodies to t h i s antigen are type-speci f ic . 
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CHAPTER 4 : A N T I B O D I E S A G A I N S T G L Y C O S Y L A T E D 
P R O T E I N S . 
INTRODUCTION 
I n t h e p r e v i o u s c h a p t e r d a t a w e r e p r e s e n t e d w h i c h 
c h a r a c t e r i s e d two m o n o c l o n a l a n t i b o d i e s a g a i n s t n o n - g l y c o s y l a t e d 
p r o t e i n s o f H S V - 2 . I n t h i s c h a p t e r , s i x a n t i b o d i e s w i l l b e 
d e s c r i b e d w h i c h a r e d i r e c t e d a g a i n s t s e v e r a l d i f f e r e n t 
g l y c o p r o t e i n s o f t h e v i r u s . The g l y c o p r o t e i n s o f H e r p e s S i m p l e x 
V i r u s a r e i m p o r t a n t c o n s t i t u e n t s o f t h e v i r a l m e m b r a n e . A 
d e s c r i p t i o n o f t h e p r o p e r t i e s a n d f u n c t i o n o f t h e d i f f e r e n t 
g l y c o p r o t e i n s was g i v e n i n t h e i n t r o d u c t i o n t o t h i s t h e s i s . I t 
was shown t h a t e a c h o f t h e g l y c o p r o t e i n s c a n a c t a s a t a r g e t f o r 
n e u t r a l i s i n g a n t i b o d i e s , c y t o t o x i c T - c e l l s , c o m p l e m e n t - m e d i a t e d 
c y t o l y s i s and a n t i b o d y - m e d i a t e d immune c y t o l y s i s . T h e a n t i g e n i c 
p r o p e r t i e s o f t h e g l y c o p r o t e i n s g B , g C , gD a n d gE w e r e a l s o 
d i s c u s s e d , and i t was shown t h a t g B , gD and gE h a v e t y p e - c o m m o n 
a s w e l l a s t y p e - s p e c i f i c s i t e s , w h i l e gC i s c o m p l e t e l y t y p e -
s p e c i f i c . 
I p r e s e n t i n t h i s c h a p t e r t h e c h a r a c t e r i s a t i o n o f o n e 
a n t i b o d y a g a i n s t a p r o t e i n t e n t a t i v e l y d e s i g n a t e d a s g C , o n e 
a n t i b o d y d i r e c t e d a g a i n s t a p r o t e i n t e n t a t i v e l y d e s i g n a t e d a s 
g E , and f o u r a g a i n s t gD. Two o f t h e a n t i - g D a n t i b o d i e s (AP7 a n d 
AP12) w e r e i s o l a t e d b y Ms. A . B u c k m a s t e r ( d e p a r t m e n t o f P a t h o l o g y , 
U n i v e r s i t y o f C a m b r i d g e ) , b u t t h e s e a r e i n c l u d e d i n t h i s c h a p t e r 
a s t h e y a r e n e c e s s a r y t o c o n f i r m t h e e x i s t e n c e o f t h r e e d i s t i n c t 
t ype -common a n t i g e n i c s i t e s o n gD. 
A s h o r t d e s c r i p t i o n o f o u r a t t e m p t s t o i d e n t i f y t h e 
t a r g e t a n t i g e n o f a n t i b o d i e s LP7 , LP8 and LP9 i s a l s o g i v e n . No 
t a r g e t a n t i g e n c o u l d b e i d e n t i f i e d f o r t h e s e a n t i b o d i e s . 
MATERIALS AND METHODS. 
V i r u s s t r a i n s , c e l l s and medium. 
The v i r u s s t r a i n s u s e d w e r e t y p e 2 s t r a i n 25766 and t y p e 
1 s t r a i n SC16 , a s d e s c r i b e d i n c h a p t e r 3 . P r o p a g a t i o n o f t h e 
v i r u s was a s d e s c r i b e d i n c h a p t e r 2 . BHK-21 c e l l s , N S l - c e l l s and 
h y b r i d o m a c e l l s w e r e p a s s e d i n ETC o r GMM-5%FCS a s d e s c r i b e d i n 
c h a p t e r 2 . 
R . I . A . 
The a s s a y u s e d was R I A - 1 a s d e s c r i b e d i n c h a p t e r 2 , u s i n g 
1 2 5 I - p r o t e i n A t o d e t e c t bound a n t i b o d i e s . 
Neutralisation. 
In o r d e r t o m e a s u r e t h e n e u t r a l i s i n g a c t i v i t y o f 
a n t i b o d i e s s e c r e t e d b y h y b r i d o m a c e l l s i n t o t h e c e l l 
s u p e r n a t a n t , 100 u l of s u p e r n a t a n t was mixed wi th 104 pfu HSV-2 
o r HSV-1, and t h e m i x t u r e i n c u b a t e d o v e r n i g h t a t 4°C. A 1/10 
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d i l u t i o n was subsequent ly p l a t ed out on BHK-21 c e l l s and the 
number of plaques sco red a f t e r two d a y s . The c o n t r o l was 
supernatant from the c e l l l ine NS1. The neutra l is ing a c t i v i t y of 
monoclonal antiserum or a s c i t i c fluid was tested as described in 
chapter 3. 
Immunoprecipitations. 
Two methods were used in immunoprecipitations. The f i r s t 
one. A, was as described in chapter 3. The second one, B, was as 
described by Balachandran e t a l (1981). Briefly, conf luent BHK-
c e l l monolayers were infected with 10 pfu HSV-2 per c e l l . After 
two hours adsorp t ion the c e l l s were washed and incubated in 
methionine-free medium containing 100/iCi 3 5S-methionine per ml, 
and supplemented with 1% L-glutamine. For the label l ing with 14C-
glucosamine, the methionine-free medium was replaced by medium 
containing 20% glucose and 50iiCi 14C-glucosamine per ml. After 
20 hours incubation a t 37°C, the c e l l s were scraped off i n to 
PBS, washed three times in PBS and p e l l e t s stored a t -70°C. The 
c e l l p e l l e t s were lysed with RIPA-buffer (0.05M t r i s - C l " pH 7 . 2 ; 
0.15 M NaCl sodium deoxycholate; 0.1% sodium dodecyl s u l p h a t e ; 
1% T r i t o n X-100) c o n t a i n i n g 50jjg/ml DNAse and 0 . 1 mM 
phenylmethylsulfonyl f luoride (PMSF). The lysate was s o n i c a t e d , 
centrifugated a t 100,000xg for 1 hour, and the supernatant used 
for immunoprecipitations. To th i s end, 300ul of supe rna tan t was 
mixed with 15 ill ant ibody (serum or a s c i t i c f l u i d ) . After 30 
min. incubation a t room temperature, 100 >al of p ro te in A l inked 
to sepharose beads (Pharmacia Ltd, 15 mg in RIPA-buffer, p r e -
incubated with an HSV-2 infected Hep-2 c e l l l y s a t e for 1 hour 
and washed in RIPA) was added. In some c a s e s , IOJJI of Rabbit 
anti-mouse IgG was added to the mixture before the a d d i t i o n of 
protein-A sepharose, and incubated for a further 15 minutes. The 
react ion mixture containing protein-A sepharose was kept for two 
hours at °4 C under constant mixing, a f te r which time the beads 
were collected by centrifugation and washed three times in RIPA. 
The bound p ro t e in s were s o l u b i l i z e d in 30ul Laemmli's bu f fe r (see chapter 3) and analysed on 10 or 12.5% polyacrylamide g e l s 
as described in chapter 3. 
Fluorescence. 
The method used for fixed c e l l s was as descr ibed in 
chapter 3, with the difference t h a t in fec ted c e l l s were f ixed 
for 20 minu tes in co ld a c e t o n e on c a r d i c e i n s t e a d of in 
methanol. Fluorescence experiments with unfixed c e l l s were 
c a r r i e d out using f resh ly harves ted BHK-21 c e l l s . These were 
washed several times in GMM and p e l l e t e d (approx. 2xl07 c e l l s 
per p e l l e t ) . The p e l l e t was mixed with 20 pfu HSV-2 per c e l l in 
a t o t a l volume of 200^1. The c e l l s were incubated a t 37 °C for 1 
hour, under frequent mixing. The c e l l s were subsequently washed 
and incubated in a small pe t r i -d i sh a t 37°C in ETC. After 5 hours 
the c e l l s were removed from the dish using a p i p e t t e , washed in 
warm PBS and placed on i c e . 5xl05 BHK-cells p e r tube were 
reacted with a few drops of IFCS, washed and incubated with 50JJ1 
of a d i lu t ion of the antibody on ice for 30 min. The c e l l s were 
then washed by spinning them through a c u s s i o n of FCS, and 
reacted with 50ul of a preparation of FITC-label led anti-mouse 
Fab for a further 30 minutes on i ce . After a second wash through 
IFCS the c e l l s were suspended in mounting b u f f e r ( t r i s - C l " 
pH9.0:glycerol=l:9) and examined under a microscope. 
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R o s e t t i n g . 
T r y p s i n i z e d S h e e p r e d b l o o d c e l l s w e r e c o a t e d w i t h 
m o n o c l o n a l I g G - p r e p a r a t i o n s u s i n g C r C l 3 . T h e m e t h o d f o r t h e 
c o u p l i n g w a s t h e s a m e a s d e s c r i b e d i n c h a p t e r 2 . T h e I g G -
f r a c t i o n s w e r e i s o l a t e d f rom a s c i t i c f l u i d u s i n g 50% ammonium 
s u l p h a t e f o l l o w e d b y e x t e n s i v e d i a l y s i s a g a i n s t s a l i n e . 
BHK-21 c e l l s w e r e i n f e c t e d i n s u s p e n s i o n a s d e s c r i b e d 
f o r " s u r f a c e f l u o r e s c e n c e " . F i v e h o u r s a f t e r i n f e c t i o n t h e y w e r e 
w a s h e d i n P B S , p e l l e t e d a n d r e s u s p e n d e d i n PBS a t 2 x 1 0 s 
c e l l s / m l ; 3 5 u l o f t h i s s u s p e n s i o n w a s a d d e d t o 3 5 u l o f a 1% 
s u s p e n s i o n o f c o a t e d S h r b c , g e n t l y p e l l e t e d and l e f t o n i c e f o r 
1 h o u r . T h e p e l l e t w a s t h e n g e n t l y r e s u s p e n d e d a n d t h e c e l l s 
e x a m i n e d u n d e r t h e m i c r o s c o p e . R o s e t t e s w e r e s c o r e d a s B H K - c e l l s 
w i t h 4 o r more r e d - b l o o d c e l l s a t t a c h e d t o t h e m . 
C o u p l i n g o f IgG t o C N B r - a c t i v a t e d s e p h a r o s e b e a d s . 
The I g G - f r a c t i o n w a s p u r i f i e d f r o m a s c i t i c f l u i d o r 
s e r u m u s i n g 50% ammonium s u l p h a t e . A p p r o x i m a t e l y 10 mg . IgG w a s 
c o u p l e d t o 1 g r a m o f d r i e d g e l . T h e d r i e d g e l w a s w a s h e d i n 
0 . 0 0 1 M HC1, a n d s u b s e q u e n t l y m i x e d w i t h t h e IgG i n c o u p l i n g 
b u f f e r ( 0 . 1 M NaHCO , 0 . 5 M N a C l , pH9 ) . A f t e r t w o h o u r s 
i n c u b a t i o n a t room t e m p e r a t u r e u n d e r c o n s t a n t r o t a t i o n , u n b o u n d 
m a t e r i a l w a s w a s h e d a w a y u s i n g c o u p l i n g b u f f e r , a n d a n y 
r e m a i n i n g a c t i v e g r o u p s w e r e r e a c t e d w i t h 1 M e t h a n o l a m i n e a t pH 
8 . 0 f o r two h o u r s . A t t h e e n d o f t h i s p e r i o d , t h e b e a d s w e r e 
washed t h r e e t i m e s , e a c h w a s h i n g c y c l e c o n s i s t i n g o f a wash a t pH 
4 . 0 ( 0 . 1 M a c e t a t e b u f f e r ; 1 M NaCl) and o n e a t pH 8 . 0 ( c o u p l i n g 
b u f f e r ) . 
P u r i f i c a t i o n o f IgG u s i n g p r o t e i n A S e p h a r o s e . 
T h e IgG f r a c t i o n o f a s c i t i c f l u i d s o f m o n o c l o n a l 
a n t i b o d i e s w h i c h b o u n d w e l l t o p r o t e i n A w e r e p u r i f i e d u s i n g 
p r o t e i n - A - S e p h a r o s e c o l u m n s . The p r o t e i n - A was s w o l l e n i n 0 . 1 M 
p h o s p h a t e b u f f e r (pH 7 . 8 ) . The s e r u m t o b e p u r i f i e d w a s d i l u t e d 
1 /1 w i t h t h e same b u f f e r and r u n t h r o u g h t h e c o l u m n . A f t e r a l l 
b o u n d p r o t e i n was washed o f f ( c h e c k e d b y m e a s u r i n g t h e O . D . 2 8 0 
nm) t h e b o u n d IgG was e l u t e d o f f u s i n g 1 M a c e t i c a c i d . T h e IgG 
was i m m e d i a t e l y d i a l y s e d e x t e n s i v e l y a g a i n s t PBS and s t o r e d a t -
2 0 ° C . 
RESULTS. 
I . A n t i b o d i e s d i r e c t e d a g a i n s t gD. 
T h e a n t i b o d i e s L P 2 , L P 3 , AP12 a n d AP7 w e r e t h e 
r e s u l t o f t h r e e d i f f e r e n t f u s i o n e v e n t s . Two o f t h e s e f u s i o n s 
h a v e b e e n d e s c r i b e d i n d e t a i l i n c h a p t e r 2 . The t h i r d f u s i o n was 
p e r f o r m e d b y Ms A . B u c k m a s t e r , w i t h t h e a i m o f p r o d u c i n g 
n e u t r a l i s i n g m o n o c l o n a l a n t i b o d i e s a g a i n s t H S V - 2 . T h i s f u s i o n 
d i f f e r e d f r o m t h e o t h e r t w o i n t w o w a y s : 1 . T h e m i c e w e r e 
i n f e c t e d w i t h 1 0 4 p f u H S V - 2 i n t h e e a r , b u t n o s e c o n d a r y 
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immunisations were given, except for the final intravenous 
challenge three days before the fusion; 2. hybridoma supernatants 
were tested for neutralising activity against HSV-2 as well as by 
radioimmunoassay. The two monoclonal antibodies described in this 
chapter which resulted from this fusion are called AP7 and AP12. 
The antibodies LP2, LP3, AP7 and AP12 were characterised 
by neutralisation, immunoprecipitation and fluorescence. Their 
type-specificity was also determined. 
Immunoprecipitations. 
Immunoproecipitat ions with a n t i b o d i e s LP2 and LP3 
were carr ied out using the p ro toco l A descr ibed in "ma te r i a l s 
and me thods" . T h i s p r o c e d u r e had t o be modi f i ed fo r t h e 
p r e c i p i t a t i o n r e a c t i o n with LP3, as no p r e c i p i t a t e d p r o t e i n 
could be detected using t h i s antibody and pro te in-A Sepharose 
beads. The add i t ion of Rabbit anti-mouse IgG to the r e a c t i o n 
mixture solved th i s problem. Monoclonal ant ibody AP12 does not 
bind to p r o t e i n A a t a l l . In t h i s case the IgG-f rac t ion was 
purif ied from a s c i t i c f luids using ammonium s u l p h a t e , and t h i s 
IgG was coupled to CNBr-activated Sepharose beads . These beads 
were mixed with S-methionine l a b e l l e d HSV-2 in fec ted c e l l 
lysa te and the bound antigen washed and eluted in the same way 
as for protein-A Sepharose beads. 
The immunoprecipitates were analysed on SDS-polyacrylamide 
ge l s . F ig . l showes that each of the antibodies p r e c i p i t a t e s two 
polypeptides with M.W. of 52 K and 57 K. This corresponds to the 
molecular weights of gD and i t s p r e c u r s o r . In o rder to prove 
that these polypeptides were glycoproteins similar p rec ip i t a t ion 
react ions were done using C-glucosamine labelled ex t r ac t s , and 
the same polypeptides were detected on ge l s (see f i g . 2 ; r e s u l t s 
shown fo r LP2 and LP3 o n l y ) . The f i n a l proof t h a t t h e s e 
antibodies were d i r e c t e d a g a i n s t g lycopro te in D came from an 
experiment using anti-band I I antiserum (gif t of Prof.D. Watson, 
Leeds). The polypeptide bands prec ip i ta ted by th i s antiserum co-
ran exactly with the LP3-precipitated bands (fig 3) . 
Neutralisation. 
The neutra l is ing ac t i v i t y of a s c i t i c f l u i d s obta ined from 
hybr idoma ' s LP2, LP3, AP7and AP12 was measured . S e v e r a l 
d i lu t ions of each antiserum were mixed with 104 pfu HSV-2 and 
a f t e r incubat ion o v e r n i g h t a t 4°C, v i r u s i n f e c t i v i t y was 
measured as desc r ibed . The r e s u l t s a re shown in t a b l e 1. This 
experiment was repeated in the presence of 10pl gu inea p i g 
complement, giving a dif ferent r e su l t for antibody AP7. As shown, 
antibodies LP2 and AP12 neut ra l i se HSV-2 e f fec t ive ly , while LP3 
has no effect on virus i n f e c t i v i t y . Antibody AP7 only reduces 
virus in fec t iv i ty in the presence of complement. If no complement 
i s present , an increased number of plaques is observed compared 
to the control value with normal mouse serum. 
The neutra l is ing ac t i v i t y of the four antibodies for HSV-
1 was also measured: LP2 and AP12 reduce HSV-1 i n f e c t i v i t y to 
the same extent as HSV-2; LP3 i s n o n - n e u t r a l i s i n g for HSV-1, 
while AP7 does neut ra l i se HSV-1 in the presence of complement, 
but f a i l s to give s ign i f i can t enhancement of v i r u s plaques in 






































































Table 1. N e u t r a l i s a t i o n of HSV-2 (10 pfu 
p e r v i a l ) by a n t i b o d i e s LP2,LP3, 
AP7 and AP12. compl. = guinea p ig 
complement, lOul pe r v i a l . 
Experiments wi th AP7 and AP12 performed 
by Ms A.Buckmaster. 
C r o s s - r e a c t i v i t y wi th HSV-1. 
The c r o s s - r e a c t i v i t y of LP2, LP3, AP7 and AP12 wi th HSV-1 
was measured by r a d i o i m m u n o a s s a y ( R I A - 1 ) . S e v e r a l a n t i b o d y -
d i l u t i o n s were t e s t e d on HSV-1 i n f e c t e d BHK-cel l m o n o l a y e r s . 
Antibody AP12 could not be measured in t h i s a s say as i t does not 
b ind to p r o t e i n A. 
Table 2 shows t h a t LP2. LP3 and AP7 r e a c t w i t h HSV-1 a s 
we l l as wi th HSV-2 i n f e c t e d c e l l s . T h i s c o r r e s p o n d s w i t h t h e 
n e u t r a l i s a t i o n d a t a , as AP7 and LP2 n e u t r a l i s e HSV-1 and HSV-2 
t o the same e x t e n t (AP7 i n ' t h e p resence of complement o n l y ) . The 
combined r e s u l t s of n e u t r a l i s a t i o n and RIA t e s t s p rove t h a t t h e 
four a n t i b o d i e s a r e a l l c r o s s - r e a c t i v e wi th HSV-1. 
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^ ^ ' H ^ °f immunoprecipitates with ^S-methionine
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HSV-2 mfected cell extracts. A: AP7; B: AP12; C: LP3; D:LP2; E:normal 
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Fig .7 . Electrophoresis of immunoprecipitates using 35S-methionine 
label led HSV-2 infec ted c e l l e x t r a c t s . +tunicamycin: 
2jjg/ml tunicamycin. A,E: t o t a l i n f e c t e d c e l l e x t r a c t . C , F : 
p r ec ip i t a t e s with antibody LP3. D,G: p rec ip i t a t e s with ant ibody 
LP2. 
Fig .8 . Electrophoresis of immunoprecipitates using 35S-methlonine 
(A) or 14C-glucosamine (B) label led HSV-2 infected c e l l e x t r a c t s . 
A: l,3:monoclonal anti-gC. 4:monoclonal ant i -gAB. 5:LP5. 6:LP6. 
7:monoclonal ant i-gE. 8:monoclonal an t i -gF . 9:normal mouse serum. 
10 : to ta l infected c e l l ex t r ac t . 
B: a:LP5; b:monoclonal an t i - gC ; ctmonoclonal anti-gAB; d:LP6; 
e:monoclonal anti-gE; fimonoclonal ant i -gF; g : t o t a l infected c e l l 
e x t r a c t . 
Monoclonal anti-gAB, an t i gC, anti-gE and anti-gF were g i f t s from 



























Table 2. Cross-react iv i ty of LP2 and LP3 
with HSV-1 as measured by RIA-1. 
nms = normal mouse serum 
imm. = Hyperimmune anti-HSV-2 serum. 
Competition binding. 
The n e u t r a l i s a t i o n r e s u l t s suggest t h a t the four 
a n t i b o d i e s are d i r e c t e d a g a i n s t a t l e a s t t h r e e d i f f e r e n t 
a n t i g e n i c s i t e s on the gD molecule . In o rder to o b t a i n more 
information about the number of antigenic s i t e s to which these 
antibodies are d i r e c t e d , compet i t ion b inding experiments were 
carr ied out . The IgG fraction of asc i tes f l u i d s of LP2, LP3 and 
AP7 was p u r i f i e d u s i n g p r o t e i n A Sepharose columns ( s e e 
"materials and methods") . The p u r i f i e d IgG was l a b e l l e d with 
I . Six d i f f e r e n t d i l u t i o n s of each of t h e n o n - l a b e l l e d 
monoclonal antibodies were used to block HSV-2 infected BHK-cell 
monolayers, before I-IgG was added and the number of counts 
bound measured. As a c o n t r o l homologous ant ibody was used to 
block i t s e l f , and as a negative c o n t r o l a monoclonal ant ibody 
against gC was used, as well as PBS. The r e s u l t s are shown in 
f i g . 4 . Binding of label led LP2 to the infec ted c e l l s i s blocked 
ef fec t ive ly by unlabelled LP2 as well as by AP12. Neither LP3 nor 
AP7 prevent the b inding of LP2 to the p l a t e s . The binding of 
l a b e l l e d LP3 i s only prevented by L P 3 - a n t i s e r u m , t h e o t h e r 
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antibodies do not have any ef fec t . The same i s t rue for AP7. In 
a l l c a s e s , a s l i g h t r educ t ion of b inding i s obse rved a t low 
s e r u m - d i l u t i o n s , even for the con t ro l - an t i body API. T h i s i s 
presumably due to the very high concentra t ions of IgG in t he se 
m i x t u r e s . AP7 seems to block s l i g h t l y more t h a n t h e o t h e r 
antibodies a t a d i lu t ion of 1/30, but i t does t h i s for LP2 as 
well as for LP3, so t h i s can not be a specif ic e f fec t . 
The conclusions tha t can be drawn from t h i s experiment are 
t h a t LP2 and AP12 a r e d i r e c t e d a g a i n s t t h e same o r c l o s e 
neighbouring antigenic s i t e s on the gD molecule , while AP7 and 
LP3 are directed against d i f ferent antigenic s i t e s . 
Fluorescence. 
In order to determine the locat ion of the t a r g e t an t igen 
of the four monoclonal a n t i b o d i e s in the c e l l , f luorescence 
experiments were carr ied out on fixed and unfixed HSV-2 infected 
BHK-cel ls wi th a n t i b o d i e s LP2 and LP3. On f i x e d c e l l s , 
fluorescence i s observed mainly on the o u t s i d e of the in fec ted 
c e l l , as well as some in t h e c y t o p l a s m . On u n f i x e d c e l l s , 
membrane fluorescence could be de tec ted with both LP2 and LP3 (see fig 5 . ) . The controls in each case were uninfec ted c e l l s 
and c e l l t r e a t e d wi th normal mouse serum. In t h e s u r f a c e 
fluorescence experiment, an extra control was added in the form 
of antibody LP1, which i s not d i r e c t e d a g a i n s t a membrane 
pro te in . The controls were a l l negative as expected. 
Resetting. 
The presence of the target-ant igen of LP2, LP3 and AP7 on 
the sur face of in fec ted c e l l s was confirmed by r o s e t t i n g of 
infected c e l l s with Sheep red blood c e l l s to which ant ibody was 
coupled, (for method, s ee " m a t e r i a l s and m e t h o d s ) . HSV-2 
infected c e l l s were mixed with the coupled red blood c e l l s , and 
the number of r o s e t t e s counted. Controls were red blood c e l l s 
sens i t ized with antibody LP1 and uninfected BHK-cells. Red blood 
c e l l s s e n s i t i z e d with po lyc lona l anti-HSV-2 IgG a c t e d as a 
pos i t ive cont ro l . In f ig . 5, a table i s p resen ted which showes 
t h e p e r c e n t a g e of r o s e t t e s o b t a i n e d w i t h t h e d i f f e r e n t 
ant ibodies . LP2, LP3 and AP7 were a l l p o s i t i v e , bu t LP3 gave 
constantly lower values . The negative controls were a l l less then 
2%. 
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Fig.4. Competition binding experiments using I-labelled monoclonal IgG. 
A: Binding of I-labelled LP3 to fixed HSV-2 infected BHK cell 
monolayers (prepared as for RIA-1); wells pretreated with 
increasing amounts of blocking antibody. Assay conditions as for 
RIA-1. 
B: As for A, using I-labelled AP7. 
C: As for A, using I-labelled LP2. 
Fig.5. Immunofluorescent staining of fixed (a-e) or unfixed (f,g) HSV-2 
infected BHK-cells. Conditions as described in "methods", a: LP2; 























Fie Resetting of HSV-2 infected BHK-cells with Shrbc coated with monoclonal antibody or 
hyperimmune anti-HSV-2 IgG (imm). Control= 
uncoated Shrbc (none). 
a=rosett ing with LP2-coated c e l l s , b=LP3-
coated c e l l s , c=LPl-coated c e l l s . 
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Ident i f ica t ion of gD-precursor. 
The following experiment was designed to d e t e c t if the 
antibodies LP2 and LP3 were directed against the polypept ide o r 
the carbohydrate-part of the gD-molecule. To t h i s end, BHk-21 
c e l l s were infected with HSV-2 and labelled with 3 5S-methionine 
as before, but two hours p r i o r to l a b e l l i n g 2/ig/ml tunicamycin 
was added to the c e l l supernatant. This p reven t s the at tachment 
of ce r ta in carbohydrate res idues to newly synthes ized p r o t e i n s {Pizer e t a l , 1980 Takatsuki e t a l , 1 9 7 1 ) . The c e l l s were then 
l a b e l l e d and lysed , and immunoprecipi tat ion c a r r i e d o u t . The 
r e su l t s of t h i s experiment are shown in f i g . 7 . A polypept ide 
with a molecular weight of 49,000 D was prec ip i ta ted by both LP2 
and LP3. The control of normal mouse serum failed to p r e c i p i t a t e 
any prote ins from the ly sa t e . 
Antibodies directed against gC and gE. 
The a n t i b o d i e s LPS and LP6 were c h a r a c t e r i s e d by 
fluorescence, c r o s s - r e a c t i v i t y with HSV-1, n e u t r a l i s a t i o n and 
immunoprecipitation. 
Immunoprecipitations. 
Immunoprecipitation experiments with LP5 and LP6 were 
performed according to protocol B (materials and methods), using 14C-glucosamine and 3 5S-methionine l a b e l l e d i n f e c t e d c e l l 
e x t r a c t s . The r e su l t s of these experiments are shown in f i g . 8 . 
Antibody LP6 prec ip i ta ted two proteins with M.W. of 67K and 80K. 
These proteins were p r e c i p i t a t e d both from 35S-methionine and 14C-glucosamine labelled c e l l e x t r a c t s . As these c h a r a c t e r i s t i c s 
correspond to those of g lycopro te in E, a monoclonal ant ibody 
directed against gE (kind g i f t of S.Bacchett i ,Canada) was used 
as a r e f e r e n c e . A monoclonal antibody aga ins t gF, which has 
s imilar migration c h a r a c t e r i s t i c s as gE (Balachandran e t a l , 
1981), was also included. The proteins prec ip i ta ted by the a n t i -
gE monoclonal antibody and antibody LP6 co- ran exac t l y on SDS-
polyacrylamide g e l s , which i n d i c a t e s t h a t LP6 i s d i r e c t e d 
against gE. 
The two p r o t e i n s p r e c i p i t a t e d by ant ibody LP5 have a 
M.W. of 110K and 130K. These were detectable on gels using 14C-
glucosamine as well as 35S-methionine l a b e l l e d in fec ted c e l l 
e x t r a c t s . These c h a r a c t e r i s t i c s are those of g lycopro te in C. 
Another monoclonal ant ibody d i r e c t e d a g a i n s t gC ( g i f t from 
S.Bacchetti) was used in a p a r e l l e l p r e c i p i t a t i o n r e a c t i o n and 
bound to two p r o t e i n s with exac t ly the same e l e c t r o p h o r e t i c 
mob i l i t y as those p r e c i p i t a t e d by LP5. LP5 was t h e r e f o r e , 
t en ta t ive ly designated as being directed against gC. 
Using l a b e l l i n g in the presence of tun icamyc in , i t was 
proved t h a t b o t h LP5 and LP6 were d i r e c t e d a g a i n s t t h e 
polypeptide pa r t of gE and gC respect ively , ( r e su l t s not shown). 
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Cross-react ivi ty of LP5 and LP6 with HSV-1. 
The c r o s s - r e a c t i v i t y of LP5 and LP6 with HSV-1 was 
determined using a radioimmunoassay (RIA-l) .The r e s u l t s a re 
shown in table 3. LP5 and LP6 are both specif ic for HSV-2. 
Neutra l isa t ion. 
Neutral isat ion experiments were c a r r i e d out with a s c i t i c 
f lu ids derived from LP5 and LP6, as described in "mate r ia l s and 
methods". The r e s u l t s are presented in t a b l e 4. No s p e c i f i c 
r educ t ion of v i r u s i n f e c t l v i t y was observed u s i n g LP5, b u t 
neut ra l i sa t ion of HSV-1 and HSV-2 was de tec ted with LP6 a t a 
d i lu t ion of 10"1 . At higher d i lu t ions the effect disappeared. 
The same re su l t s were obtained using h e a t - i n a c t i v a t e d or non-
inactivated serum, which proves the neut ra l i s ing a c t i v i t y i s not 
dependent on the presence of complement. This demonstrated t h a t 
LP6 i s cross-react ive with HSV-1 by neu t ra l i sa t ion , even though 
no c ross - r eac t iv i ty was observed using a radioimmunoassay.. 
Fluorescence. 
Fluorescence t e s t s on fixed c e l l s using LP5 and LP6 were 
carr ied out as described in "materials and methods". The r e su l t s 
are shown in f ig . 5. Both antibodies showed f luorescence on the 
o u t s i d e of the c e l l and in the c y t o p l a s m . F l u o r e s c e n c e on 
unfixed c e l l s showed t h a t b o t h LP5 and Lp6 gave r i s e to 
membrane-fluorescence ( r e s u l t s not shown). Controls of normal 
mouse serum and uninfected BHK-cells were a l l negative. 
Antibodies LP7, LP8 and LP9. 
Antibodies LP7, LP8 and LP9 were a l l c h a r a c t e r i s e d by 
fluorescence, c r o s s - r e a c t i v i t y with HSV-1, n e u t r a l i s a t i o n and 
immunoprecipitation. The three antibodies are n o n - n e u t r a l i s i n g , 
even in combination, as can be seen from the r e s u l t s p resen ted 
in table 4. LP7 and LP8 are c ross - reac t ive with HSV-1, but LP9 
i s t y p e - s p e c i f i c ( s ee t a b l e 3) .LP9 g i v e s r i s e t o s u r f a c e 
fluorescence, whilst LP7 on fixed c e l l s stained the nucleus and 
cytoplasm, and LP8 was f l uo re scen t mainly in t h e c y t o p l a s m ( resu l t s not shown). 
Immunoprecipitation react ions with these ant ibodies did not 
r e s u l t in any detectable bands on a protein ge l . Both methods A 
and B were t r i e d . In e a c h c a s e a R a b b i t a n t i - m o u s e 
immunoglobulin serum was added to the react ion mixture, as these 
a n t i b o d i e s do not bind to p r o t e i n A. The p r e c i p i t a t i o n s were 
performed with 35S-methionine, 32P and '4C-glucosamine l a b e l l e d 
infected c e l l e x t r a c t s . The IgG f r a c t i o n of a s c i t i c f l u i d s of 
antibody LP8 was s u b s e q u e n t l y p u r i f i e d , coup led to CNBr-
a c t i v a t e d Sepharose beads , and these used in a p r e c i p i t a t i o n 



















































Table 3. Cross-reactivity of several antibodies 
with HSV-1 as measured by RIA-1 or RIA-3. 
imm=hyperimmune anti-HSV-2 serum; nms= 
























































Table 4.Neutralisation of HSV-1 and HSV-2 by 
different monoclonal antibodies. 
inun=hyperimmune anti-HSV-2 serum; 
nms=normal mouse serum. 
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DISCUSSION. 
Ant ibod ies t o gD. 
The r e s u l t s p r e s e n t e d i n t h i s c h a p t e r show t h a t t h e 
monoclonal a n t i b o d i e s LP2, LP3, AP7 and AP12 a r e d i r e c t e d a g a i n s t 
gD. The a n t i b o d i e s a l l r e c o g n i s e type-common d e t e r m i n a n t s on t h e 
gD-molecule, and on ly LP2 and AP12 a re d i r e c t e d a g a i n s t t h e same 
a n t i g e n i c s i t e , o r a t l e a s t a g a i n s t s i t e s which a r e s i t u a t e d so 
c l o s e t o each o t h e r t h a t t h e b i n d i n g of one a n t i b o d y p r e v e n t s 
t h e b i n d i n g of t h e o t h e r . T h i s means t h a t t h e r e a r e a t l e a s t 
t h r e e type-common a n t i g e n i c s i t e s on gD, one n e u t r a l i s i n g , one 
n o n - n e u t r a l i s i n g a n d o n e f o r c o m p l e m e n t - d e p e n d e n t 
n e u t r a l i s a t i o n . T h i s i s i n a g r e e m e n t w i t h t h e f i n d i n g s o f 
S h o w a l t e r e t a l ( 1 9 8 1 ) , who, u s i n g a p a n e l of 10 m o n o c l o n a l 
a n t i b o d i e s d i r e c t e d a g a i n s t gD of HSV-1, could d i s t i n g u i s h f i v e 
d i s t i n c t a n t i g e n i c s i t e s on t h i s m o l e c u l e , of which t h r e e a r e 
type-common. As no c o m p e t i t i o n b i n d i n g s t u d i e s were p e r f o r m e d 
w i t h i n each "group" of a n t i b o d i e s p r e s e n t e d by him, t h i s number 
i s n e c e s s a r i l y a minimum. U n t i l such s t u d i e s a r e c a r r i e d o u t , 
u s ing a l a r g e number of monoc lona l a n t i b o d i e s a g a i n s t gD, t h e 
a c c u r a t e number of a n t i g e n i c s i t e s on t h i s m o l e c u l e c a n n o t be 
known. 
The p r o c e s s i n g of gD of HSV-1 h a s b e e n s t u d i e d i n g r e a t 
d e t a i l . Cohen e t a l (1980) and Haa r r e t a l (1981) have shown 
t h a t pgD(52K) of HSV-1 i s p rocessed in 11 d i s c r e t e s t e p s t o gD 
(59K) . P o s i t i v e i d e n t i f i c a t i o n of s e v e r a l o f t h e o b s e r v e d 
i n t e r m e d i a t e s a s b e i n g r e l a t e d t o gD came from t h e u s e of a 
m o n o c l o n a l a n t i b o d y a g a i n s t gD ( D e r r i c k e t a l , 1 9 8 1 ) . The 
p r o c e s s i n g of gD of HSV-2, however, has not been s t u d i e d in such 
d e t a i l . E i senbe rg e t a l (1980) showed t h a t gD of HSV-2 has a 
M.W. of 56K, and a p r e c u r s o r of 51K. But no s t u d i e s s i m i l a r t o 
t h e ones fo r HSV-1, u s i n g t u n i c a m y c i n i n o r d e r t o i d e n t i f y an 
ung lycosy l a t ed p r e c u r s o r , have been r e p o r t e d . In t h i s c h a p t e r we 
p r e s e n t evidence for an ung lycosy la t ed p r e c u r s o r of HSV-2, w i t h 
a m o l e c u l a r w e i g h t o f 49K. T h i s i s s i m i l a r t o t h e 50K 
ung lycosy la t ed p r e c u r s o r r e p o r t e d for HSV-1 ( P i z e r e t a l , 1 9 8 0 ) , 
and i t seems r ea sonab l e t o suppose t h a t gD of HSV-2 i s p r o c e s s e d 
in a s i m i l a r way as gD of HSV-1. 
The s u r f a c e f l u o r e s c e n c e s t u d i e s and t h e r o s e t t i n g 
exper iments show t h a t t h e a n t i g e n i c s i t e s t o which LP2, LP3, AP7 
and AP12 a r e d i r e c t e d a r e p r e s e n t on t h e s u r f a c e of t h e i n f e c t e d 
c e l l , and a r e r e a d i l y a c c e s s i b l e t o a n t i b o d y . The l o w e r 
pe r cen t age of r o s e t t e s o b t a i n e d f o r L P 3 - c o a t e d r e d b l o o d c e l l s 
might mean t h a t t h i s a n t i g e n i c s i t e i s n o t a s a c c e s s i b l e a s t h e 
LP2-AP12 s i t e and t h e L P 7 - s i t e , b u t t h i s r e s u l t c a n a l s o b e 
exp la ined by the lower a f f i n i t y of LP3 fo r gD. 
The phenomenon of enhancement of t h e number of pfu when 
us ing HSV-2 and AP7 i s a t p r e s e n t under i n v e s t i g a t i o n . That t h i s 
i s a t r u e e f f e c t , and not j u s t an i n h i b i t i o n of t h e i n a c t i v a t i o n 
o f t h e v i r u s i n t i m e , h a s a l r e a d y b e e n d e m o n s t r a t e d 
(Ms.A.Buckmaster, p e r s o n a l communicat ion) . 
Antibody LP5. 
T h i s t y p e - s p e c i f i c , n o n - n e u t r a l i s i n g a n t i b o d y i s 
t e n t i t a v e l y i d e n t i f i e d as an an t i -gC a n t i b o d y . The d e t e c t i o n of 
s u r f a c e f l u o r e s c e n c e u s i n g t h i s a n t i b o d y s h o w s t h a t t h e 
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antigenic site to which it is directed is present on the surface 
of the infected cell. 
All the monoclonal an t ibod ie s aga in s t gC repor ted so f a r 
have been type-spec i f ic . Some are n e u t r a l i s i n g in the presence 
of complement (Showalter e t a l , 1 9 8 1 ) , some are n e u t r a l i s i n g 
without complement (Pereira e t a l ,1980) . This corresponds to the 
r e s u l t s obtained with conventional sera a g a i n s t gC, which were 
also completely type-specif ic but differed in t h e i r n e u t r a l i s i n g 
a b i l i t y . (Spear, 1976; Powell and Wat son ,1975 ; Powell and 
Courtney, 1975; Vestergaard and Norrlld,1978; Cohen e t a l ,1980) . 
At some stage a f t e r the i s o l a t i o n of LP5, seven more 
m o n o c l o n a l a n t i b o d i e s a g a i n s t gC were p r o d u c e d by Ms 
A.Buckmaster. All these antibodies were s p e c i f i c for HSV-2 and 
neutral ised infect ious virus in the presence of complement to a 
varying degree . LP5, as p resen ted in t h i s c h a p t e r , does not 
neu t ra l i se infect ious v i r u s . However, when compet i t ion binding 
experiment were c a r r i e d o u t be tween t h e e i g h t monoclonal 
antibodies against gC, using a radioimmunoassay, i t was found 
tha t a l l the antibodies competed with each o ther . Obviously they 
were a l l d i r e c t e d a g a i n s t t h e same o r c l o s e n e i g h b o u r i n g 
a n t i g e n i c s i t e s . This seems to suggest t h a t t h i s p a r t i c u l a r 
a n t i g e n i c s i t e i s ve ry dominant in p r o d u c i n g an a n t i b o d y 
response in the infected host . I t may be t h a t t h i s i s the only 
s i t e t h a t i s a c c e s s i b l e to a n t i b o d i e s . The r e a s o n fo r t h e 
inaccess ib i l i t y of any o ther a n t i g e n i c s i t e s might be the f ac t 
t h a t gC seems to e x i s t in m u l t i m e r i c forms ( E b e r l e and 
Courtney, 1982), so that cer ta in par ts of the gC-molecule might 
be shielded by each o ther . 
I t i s not known if the antibodies described by Showalter 
e t al (1981) or Pereira e t a l (1980) are a l l d i r e c t e d aga ins t 
the same antigenic s i t e . Until competition binding experiments 
with a l a r g e number of monoclonal a n t i b o d i e s a g a i n s t gC, 
resu l t ing from a number of di f ferent fus ions , a re c a r r i e d o u t , 
i t i s d i f f i c u l t t o say a n y t h i n g wi th c e r t a i n t y about t he 
dominance of one pa r t i cu la r antigenic s i t e on th i s molecule. 
Antibody LP6. 
Antibody LP6 i s t e n t a t i v e l y des igna ted as being d i r e c t e d 
against gE. This was indicated by the immunoprecipitation d a t a . 
This antigen i s present on the surface of the infected c e l l , as 
our f luorescence da ta show. This i s in agreement wi th t he 
r e s u l t s of Para e t a l (1982a and b ) , who used a polyclonal a n t i -
gE serum to d e t e c t gE on the s u r f a c e of i n f e c t e d c e l l s and 
v i r i o n s . They also described gE for HSV-2 in d e t a i l , sugges t ing 
a molecular weight of 90,000D for t h i s pro te in , as opposed to a 
M.W. of 8O,000D for gE of HSV-1. In our gel-system, gE of HSV-2 
has a M.W of 80,000D. This d i f f e rence i s probably due to the 
d i f f e r e n t v i ru s s t r a i n used, and to a d i f f e r e n t g e l sys t em. 
Varying M.W were found for gE in dif ferent s t r a i n s of HSV-1, and 
i t i s l i k e l y t h a t a s i m i l a r v a r i e t y e x i s t s be tween HSV-2 
i s o l a t e s . 
Antibody LP6 has some n e u t r a l i s i n g a b i l i t y for HSV-1 as 
well as for HSV-2, but t h i s could only be detected a t very high 
serum c o n c e n t r a t i o n s . The apparent d iscrepancy between t h e 
r e s u l t s of the c ross - r eac t iv i ty t e s t using a radioimmunoassay, 
where LP6 seems to be type-speci f ic , and the r e su l t s obtained by 
n e u t r a l i s a t i o n , can be explained in the following way. I t i s 
possible that the RIA demands a higher a f f in i ty antibody due to 
the s t r ingent washing procedures , than a n e u t r a l i s a t i o n a s say . 
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Antibody LP6 might therefore be capable of r e a c t i n g with HSV-1 
in a neu t ra l i s ing assay but f a i l to r e a c t with HSV-1 infec ted 
c e l l s in a radioimmunoassay. The finding of a type-common s i t e on 
gE i s , however, in contras t with the r e su l t s of Para e t a l , who, 
using a polyclonal anti-gE serum, suggest t h a t the type-common 
s i t e s on gE are not the t a r g e t of n e u t r a l i s i n g a n t i b o d i e s . The 
f a c t t h a t LP6 n e u t r a l i s e s o n l y a t v e r y h i g h a n t i b o d y 
concentrations (a d i lu t ion of 1/10, compared to a R I A - t i t r e of 
1/100,000) may be the reason for t h i s : i t i s unlikely t h a t t h i s 
pa r t i cu la r antibody would be present in such high concentrations 
in a conventional serum. 
The neutra l is ing a b i l i t y of LP6 i s not dependent on the 
presence of complement. The convent ional ant iserum mentioned 
above (Para e t a l , 1982) does only neut ra l i se when complement i s 
present . 
Antibodies LP7,LP8 and LP9. 
The f a i l u r e to p r e c i p i t a t e any p r o t e i n s with a n t i b o d i e s 
LP7, LP8 and LP9 may be due to several reasons. One p o s s i b i l i t y 
i s that the antigenic s i t e recognised by the a n t i b o d i e s on the 
f ixed radioimmunoassayplates i s destroyed by t h e d e t e r g e n t 
t rea tment necessary for the i m m u n o p r e c i p i t a t i o n r e a c t i o n s . 
Another reason might be tha t the ant ibodies bind to the an t igen 
with a r e l a t ive ly low af f in i ty and binding i s not possible under 
the cond i t ions of the immunoprecipi tat ion p rocedure . A t h i r d 
p o s s i b i l i t y i s that the t a r g e t an t igen i s p r e s e n t in such low 
concentrations that i t i s not detectable against the background 
p rec ip i t a t ion . Further experiments using di f ferent detergents or 
very large amounts of labelled infected c e l l antigen might solve 
the p rec ip i t a t ion problem. The use of a f f in i ty columns or western 
b lo t t ing are two other a l t e rna t ive approaches for the d e t e c t i o n 
of the ta rge t antigen of these a n t i b o d i e s , which have not yet 
been t r i e d out for a l of them. 
In a recent repor t , the use of monoclonal ant ibodies a g a i n s t 
HSV-1 and HSV-2 in s e r o l o g i c a l a n a l y s i s was d e m o n s t r a t e d (Pereira e t a l , 1982). The antibodies described in t h i s chapter, 
in pa r t i cu la r LP5 and LP6, might be useful in typing c l i n i c a l 
i s o l a t e s . In a d d i t i o n , the d i f f e r e n t monoclonal a n t i b o d i e s 
against gC, which compete with each other but do not have exactly 
the same c h a r a c t e r i s t i c s , might be useful in answering ques t ions 
about the occurrence of antibodies with d i f f e r e n t i d io types to 
the same antigenic domain on a pa r t i cu la r molecule. 
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CHAPTER 5: A N T I V I R A L ROLE OF LP2 AND L P 3 IN V I V O . 
INTRODUCTION 
The r e l a t i v e r o l e s of t h e c e l l u l a r and humora l immune 
r e s p o n s e i n r e c o v e r y f rom a p r i m a r y h e r p e s s i m p l e x v i r u s 
i n f e c t i o n a r e s t i l l p o o r l y u n d e r s t o o d . I n i t i a l r e p o r t s h a v e 
emphasized the importance of c e l l - m e d i a t e d immunity (Roger-Zisman 
and A l l i s o n , 1 9 7 6 ; Oakes,1975) and t h e r e seems to be l i t t l e doubt 
t h a t i n d e e d c e l l u l a r mechanisms p l a y an i m p o r t a n t r o l e i n 
med ia t ing recovery (Nash e t a l , 1980a and b ) . However, a number 
of r e c e n t r e p o r t s have shown t h a t a n t i b o d y c a n a l s o p l a y an 
i m p o r t a n t r o l e i n t h i s r e s p e c t ( O a k e s and La v i s h , 1 9 8 1 ; 
W o r t h i n g t o n , 1 9 8 0 ; McKendall e t a l , 1 9 7 9 ; Davis e t a l , 1 9 7 9 ) . I n 
normal a n i m a l s , p a s s i v e l y t r a n s f e r r e d serum hyperimmune to e i t h e r 
HSV-1 o r HSV-2 c a n e f f e c t i v e l y r e d u c e t h e s e v e r i t y o f 
n e u r o l o g i c a l d i s e a s e and i n h i b i t v i r a l s p r e a d ( O a k e s , 1 9 7 8 ; 
McKendall e t a l , 1 9 7 9 ; Dix e t a l , 1 9 8 1 ; Luye t e t a l , 1 9 7 5 ) . In 
immunosuppressed a n i m a l s , t h e s i t u a t i o n i s l e s s c l e a r , b u t i t 
seems t h a t n e u t r a l i s i n g an t ibody can have some p r o t e c t i v e e f f e c t 
on v i r u s i n f e c t i o n in some c a s e s (Worthington e t a l , 1 9 7 9 ) . 
The mechanisms by which a n t i b o d i e s e x e r t t h e i r p r o t e c t i v e 
a b i l i t y a r e known o n l y t o a l i m i t e d e x t e n t . A l t h o u g h 
n e u t r a l i s i n g a n t i b o d i e s may be impor tan t i n a r r e s t i n g the spread 
of v i r u s , n e u t r a l i s a t i o n can not be t h e on ly mechanism by which 
they work, as v i r u s s p r e a d s from c e l l t o c e l l , t h u s a v o i d i n g 
n e u t r a l i s a t i o n by a n t i b o d i e s (Lodmel l e t a l , 1 9 7 3 ) . In v i t r o 
s t u d i e s have shown t h a t s e v e r a l o t h e r m e c h a n i s m s , s u c h a s 
a n t i b o d y - d e p e n d e n t c e l l - m e d i a t e d c y t o t o x i c i t y (ADCC) and 
complement-dependent c y t o t o x i c i t y (AbC 1 ) , may be i m p o r t a n t i n 
t h e d e s t r u c t i o n of v i r u s - i n f e c t e d c e l l s . A n t i b o d i e s a g a i n s t 
s e v e r a l g l y c o p r o t e i n s , i n c l u d i n g gD, h a v e b e e n shown t o b e 
capab le of media t ing l y s i s of i n f e c t e d c e l l s i n e i t h e r ADCC o r 
AbC t e s t s (Glor ioso e t a l , 1 9 7 8 ; Nor r i l d e t a l , 1 9 7 9 ) . 
In a r e c e n t s t u d y , n e u t r a l i s i n g m o n o c l o n a l a n t i b o d i e s 
d i r e c t e d a g a i n s t gD and gC o f HSV-1 w e r e u s e d i n p a s s i v e 
t r a n s f e r s t u d i e s , i n o r d e r t o a s s e s s t h e i r p r o t e c t i v e a b i l i t y 
a g a i n s t a c u t e v i r u s - i n d u c e d n e u r o l o g i c a l d i s e a s e (Dix e t 
a l , 1 9 8 1 ) . Both a n t i s e r a were e f f e c t i v e i n r e d u c i n g v i r a l s p r e a d 
and d e c r e a s i n g t h e i nc idence of n e u r o l o g i c a l d i s e a s e i n m i c e . I t 
was , however, not p o s s i b l e from t h e s e s t u d i e s t o d e t e r m i n e t h e 
e x t e n t t o which t h e n e u t r a l i s i n g a b i l i t y o f t h e a n t i b o d i e s 
c o n t r i b u t e d t o t h e p r o t e c t i o n . We i n v e s t i g a t e i n t h i s c h a p t e r 
t h e e f f e c t of two m o n o c l o n a l a n t i b o d i e s a g a i n s t g D , o n e 
n e u t r a l i s i n g and one n o n - n e u t r a l i s i n g , on t h e c o u r s e of HSV-1 
i n f e c t i o n i n normal B a l b / c m i c e , and d e m o n s t r a t e a r o l e f o r 
n e u t r a l i s i n g a n t i b o d y i n r e d u c i n g v i r a l i n f e c t i v i t y and t h e 
inflammatory r e s p o n s e . The r o l e of n e u t r a l i s i n g a n t i b o d y , a s 
o p p o s e d t o n o n - n e u t r a l i s i n g a n t i b o d y , i n t h e e s t a b l i s h i n g o f 
l a t e n t i n f e c t i o n i s a l s o i n v e s t i g a t e d . 
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MATERIALS AND METHODS. 
Virus, cells. 
The virus strains used were: type 1 strain SC16, and type 2 
strain 25766, as described in chapter 3. BHK-21 cells were grown 
in ETC as described in chapter 2. 
M i c e . 
I n b r e d f e m a l e B a l b / c m i c e ( o b t a i n e d f r o m B a n t i n a n d 
Kingman, A l d b o r o u g h , UK) w e r e u s e d when 5-6 w e e k s o l d . 
I n o c u l a t i o n o f v i r u s and m e a s u r e m e n t o f e a r s w e l l i n g . 
1 0 4 p f u o f v i r u s i n 20 u l o f GMM w a s i n o c u l a t e d , 
s u b c u t a n e o u s l y i n t o t h e p i n n a o f t h e l e f t e a r o f a n e a s t h e t i z e d 
m i c e . The t h i c k n e s s o f t h e e a r was m e a s u r e d o n s u c c e s s i v e d a y s 
u s i n g a M i t u t o y o E n g i n e e r s s c r e w g a u g e m i c r o m e t e r . T h e r e s u l t s 
w e r e e x p r e s s e d a s t h e d i f f e r e n c e b e t w e e n i n f e c t e d and u n i n f e c t e d 
p i n n a e (Nash e t a l , 1 9 8 0 a ) . 
I n f e c t i v i t y a s s a y s . 
a . E a r s . T h e l e f t e a r p i n n a e w e r e r e m o v e d f r o m m i c e a t 
d i f f e r e n t t i m e s a f t e r i n f e c t i o n . E a r s w e r e h o m o g e n i z e d 
s e p a r a t e l y i n 1 ml o f ETC. T h e a m o u n t o f i n f e c t i o u s v i r u s w a s 
m e a s u r e d o n BHK-21 c e l l s ( R u s s e l l , 1 9 6 2 ) . 
b . G a n g l i a . C e r v i c a l d o r s a l r o o t g a n g l i a C 2 , C 3 a n d C4 w e r e 
removed s i x weeks a f t e r i n f e c t i o n and c u l t u r e d i n GMM-1% FCS f o r 
6 d a y s . The g a n g l i a w e r e t h e n h o m o g e n i z e d and a s s a y e d f o r v i r u s 
i n f e c t i v i t y o n BHK-21 c e l l s . 
S e r a and a s c i t i c f l u i d s . 
S e r a a n d a s c i t i c f l u i d s w e r e o b t a i n e d a s d e s c r i b e d i n 
c h a p t e r 2 . LP2, LP3 and LP4 s e r a had an a p p r o x i m a t e R I A - t i t r e o f 
1 / 1 0 6 . L P 2 - s e r u m had a n e u t r a l i s a t i o n t i t r e o f 1 / 1 0 4 . 
RESULTS. 
The c o u r s e o f t h e i n f e c t i o n o f B a l b / c m i c e w i t h HSV-1 , s t r a i n 
S C 1 6 , h a s b e e n w e l l c h a r a c t e r i z e d b o t h i n t e r m s o f t h e 
i n f l a m m a t o r y r e s p o n s e and v i r u s g r o w t h ( N a s h e t a l , 1 9 8 0 a a n d 
b ) . I n o u r s t u d i e s we p r e f e r r e d t h e r e f o r e t o work w i t h t h i s t y p e 
1 s t r a i n w h e r e p o s s i b l e . One o f t h e o b j e c t i v e s o f t h e e x p e r i m e n t s 
d e s c r i b e d b e l o w was t h e i n v e s t i g a t i o n o f t h e r e l a t i v e i m p o r t a n c e 
o f n e u t r a l i s i n g v e r s u s n o n - n e u t r a l i s i n g a n t i b o d i e s i n t h e i r 
e f f e c t on H S V - i n f e c t i o n . To t h i s e n d , two a n t i b o d i e s a g a i n s t t h e 
s a m e p r o t e i n ( g D ) , o n e n e u t r a l i s i n g ( L P 2 ) a n d o n e n o n -
n e u t r a l i s i n g ( L P 3 ) , w e r e c o m p a r e d f o r t h e i r e f f e c t o n a c u t e 
i n f e c t i o n o f m i c e w i t h HSV-1 ( s t r a i n S C 1 6 ) . B o t h a n t i b o d i e s a r e 
o f t h e s a m e s u b c l a s s ( 2 a ) . T h e c h o i c e o f SC16 w a s p o s s i b l e 
b e c a u s e b o t h LP2 and LP3 a r e f u l l y c r o s s - r e a c t i v e w i t h HSV-1 a s 
m e a s u r e d b y r a d i o i m m u n o a s s a y , n e u t r a l i s a t i o n a n d 
i m m u n o p r e c i p i t a t i o n ( s e e c h a p t e r 4 ) . 
54 









i V* \ 
I / • \ 
I y \ 
I / ° ° 
'• •' r, ° ^ „ 
,—B-
0 1 2 3 4 9 4 7 
days aftar infection 















^1 \ \ \ 
«A\ \\\ \\\ 
\\\ 
3 4 S 9 7" 
days after Infactlon 
D 13 L»S 
Antibody injected one day before Infection. 
Fiq.l Effect of injection of 50 ul antibody on the primary ear thickness 
response and ear virus titres in mice infected with 10 pfu HSV-1 
(SC16). Virus titres expressed as log. pfu. 
la: antibody LP2 and control (no antibody), 
lb: antibodies LP3 and LP4, and control. 
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Effect of LP2 and LP3 on infection with HSV-1. 
In the f i r s t experiment, the effect of LP2 and LP3 on the 
in f lammatory r e s p o n s e and v i r a l i n f e c t i v i t y t i t r e s when 
administered 24 hours before i n f e c t i o n was determined. To t h i s 
end mice were given an in t ravenous dose of 50 JJI a n t i b o d y ( a sc i t i c f l u i d ) , and 24 hours l a t e r were infected with 104 pfu 
SC16 in the l e f t ear pinna. Ear thickness was measured each day 
for 7 days . The growth of v i r u s in the ear was monitored by 
removing the l e f t ear of groups of mice on days 1 ,2 ,3 ,5 and 7 
and measuring the i n f e c t i v i t y . The r e s u l t s of t h i s experiment 
are shown in f i g . l a and l b . The normal course of i n f e c t i o n i s 
given by the control group (no a n t i b o d y ) , and corresponds with 
the data published by Nash e t al (1980a). The admin i s t e r ing of 
antibody LP2 24 hours before infection r e s u l t e d in the v i r t u a l 
e l i m i n a t i o n of v i r u s growth and a marked r e d u c t i o n in e a r 
swe l l i ng . Antibody LP3 had no e f f e c t on t h e c o u r s e of t h e 
infect ion, except for a s l i gh t l y enhanced inflammatory response 
in the l a t e r stages of the infect ion. An e x t r a c o n t r o l , namely 
antibody LP4, which does not react with HSV-1 (see chap te r 3 ) , 
was incorporated in t h i s experiment. This ant ibody a l so had no 
effect on e i the r virus in fec t iv i ty or ear swelling. 
The second e x p e r i m e n t was d e s i g n e d t o a s s e s s t h e 
effectiveness of monoclonal antibodies in a r r e s t i n g the growth 
of v i r u s in the ea r when a d m i n i s t e r e d a f t e r i n f e c t i o n was 
e s t a b l i s h e d . In t h i s experiment ant ibody was adminis terd 24 
hours a f te r i n f e c t i o n . The r e s u l t s in f i g . 2 show t h a t LP2 i s 
s t i l l effect ive in reducing v i r a l i n f e c t i v i t y in the e a r , while 
the inflammatory response is also diminished. LP3 again had no 
effect on the course of infect ion, although a s l i g h t l y enhanced 
inflammatory response was observed. 
Effect of LP2 and LP4 on infection with HSV-2. 
Although the course of i n f e c t i o n with type 2 v i r u s in 
Balb/c mice has not been f u l l y c h a r a c t e r i s e d , we t e s t e d 
antibodies LP2 and LP4 in HSV-2 infected mice. LP4 i s d i r e c t e d 
against the major DNA-binding p r o t e i n , i s n o n - n e u t r a l i s i n g and 
specif ic for HSV-2. The antibody was administered 24 hours before 
infect ion. Although the amount of virus i n f e c t i v i t y in the ear 
pinna a t these t imes was low, the r educ t ion in v i r u s t i t r e s 
caused by LP2 was s t i l l very marked, as was the reduction in ear 
swelling. Antibody LP4 had no effect (see f i g . 3 ) . 
In theory i t was possible that the effect of LP2 on virus 
i n f e c t i v i t y might be caused by n e u t r a l i s a t i o n of t h e v i r u s 
during the assay of the ear , ra ther than in the animal i t s e l f . 
The neutra l is ing t i t r e of serum in the mouse was s t i l l around 
1/200 s e v e r a l days a f t e r i n f e c t i o n . To e l i m i n a t e t h i s 
p o s s i b i l i t y , groups of mice were infected with 104 pfu SC16, and 
half of the mice t reated with 50pl LP2-antiserum 24 hours before 
infect ion. Five days af ter infection the ea r s of the mice were 
col lec ted . The ears were assayed in three d i f f e r e n t groups : in 
the f i r s t group ears of LP2-treated mice were homogenized and 
assayed separa te ly as b e f o r e . In the second group the c o n t r o l 
ears were treated in the same way. In the th i rd group, one ear of 
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- Effect of antibodies LP2 and LP4 on the primary ear thickness 
response and ear virus titres, when injected 24 hours before 
infection with 10 pfu HSV-2. 
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an LP2-treated and one ear of a non- trea ted mouse were 
homogenized together and assayed. This was done for three mice 
in each group ( s i x in group 3 ) . The r e s u l t s in t a b l e 1 
demonstrate clearly that the virus was not neutralised during the 
homogenisation procedure. 
Effect of LP2 and LP3 on the establishment of latency. 
The effect of antibodies LP2 and LP3 on the establishment 
of latency was invest igated by removing cerv i ca l dorsal root 
ganglia C2,C3 and C4 from HSV-1 infected mice four weeks a f ter 
infection and assaying them, after a period of culture, for the 
presence of infectious virus. The mice had been given 50ul LP2 
or LP3 antiserum 24 hours before i n f e c t i o n . The r e s u l t s are 
shown in table 2. Although LP2 did not prevent latency from 
being established, i t did reduce both the number of l a t e n t l y 
infected mice and the amount of virus recovered from the ganl ia 
following in vitro react ivat ion. It appeared that neutra l i s ing 
antibody reduced the spread of virus to the ganglia. Antibody LP3 






Virus titre in ear 
0.3, 0, 0.6 
3.0, 3.5, 4.2 
3.8, 3.4, 4.1 
(log10pfu) 
Table 1. Virus t i t re in ears of mice infected with 
104 pfu SC16, on day 5 after infection. 
LP2-treated:50ul LP2-serum 24 hours before 






















Table 2. Proportion of latent ganglia in mice infected 
with SC16. Mice were given LP2 or LP3 serum 
24 hours before infection. Ganglia were removed 
4 weeks after infection. 
DISCUSSION. 
The e f f e c t of monoclonal ant ibody LP2 in r e d u c i n g t h e 
sever i ty of HSV-infection in mice confirms t h a t gD a c t s as a 
t a rge t for immune responses in v ivo , confirming the r e p o r t by 
Dix e t a l (1981). The f ac t t h a t ant ibody LP3, which i s non-
neu t ra l i s ing , did nothing to a r r e s t v i r a l i n f ec t iv i t y , while LP2 
was effect ive in reducing v i r u s t i t r e s in the e a r , argues t h a t 
neu t ra l i sa t ion i s one of the mechanisms by which v i r a l spread i s 
reduced. When antibody was administered before infec t ion i t was 
more effect ive in reducing v i r u s t i t r e s than when given a f t e r 
infect ion. 
When considering the case of adminis ter ing ant ibody before 
the infect ion, these r e s u l t s a re in agreement with many o t h e r 
publ icat ions (Oakes and Lausch, 1981; Dix e t a l , 1981 ; McKendall 
e t a l ,1979; Baron e t a l , 1 9 7 5 ) . Although in s eve ra l r e p o r t s a 
p r o t e c t i v e e f f e c t could be found even i f a n t i b o d y was 
administered up to 48 hours a f t e r i n f e c t i o n , the mechanism by 
which antibodies work in t h i s case might well be ce l l -med ia t ed 
ra ther than by neu t ra l i sa t ion . This was suggested in a r e p o r t by 
Oakes and Lausch (1981), who used Fab (2) fragments of Rabbi t -
anti-HSV-IgG in order to invest igate the importance of the Fc-
piece of the antibody in conferring protect ion e i t he r before or 
a f te r infect ion. They found that the Fab(2)-fragments, which were 
s t i l l capable of neu t ra l i s ing i n f e c t i o u s v i r u s in v i t r o , were 
effect ive in promoting recovery of i n f e c t i o n if adminis tered 
before or s imultaneous with v i ru s i n o c u l a t i o n . However, i f 
t ransferred 8 hours a f te r i n f e c t i o n , no p r o t e c t i v e e f f e c t was 
o b s e r v e d . These f i n d i n g s a rgue t h a t , when i n f e c t i o n i s 
es tabl ished, cell-mediated mechanisms,such as ADCC or ant ibody 
dependent comlement mediated c e l l l y s i s , ope ra t e r a t h e r than 
antibody-dependent virus neu t ra l i sa t ion . In our model, however, 
n o n - n e u t r a l i s i n g ant ibody had no e f f e c t on r e d u c i n g v i r u s 
i n f e c t i v i t y , n e i t h e r before or a f t e r i n f e c t i o n , whereas t h e 
n e u t r a l i s i n g ant ibody reduced both v i ru s i n f e c t i v i t y and ear 
59 
swel l ing d r a m a t i c a l l y in bo th i n s t a n c e s . Wor th ing ton and 
coworkers (1980) found a p r o t e c t i v e r o l e fo r n e u t r a l i s i n g 
antibodies in immunosuppresssed animals when t r a n s f e r r e d as 
l a t e as 6 days af ter infect ion. They s t r e s sed the importance of 
the concentration of neutra l is ing antibody in the animal , which 
must be reasonably h igh . This might account for some of the 
d i s c r e p a n c i e s in p u b l i s h e d d a t a so f a r . In our c a s e t h e 
an t ibody- t i t r es remain 1/200 a t 14 days af te r i . v . in jec t ion . 
Support for the importance of ce l l -media ted mechanisms in 
e l i m i n a t i n g primary H S V - i n f e c t i o n , comes from a s e r i e s of 
experiments performed by Dr.A.Kapoor and coworkers (A.K.Kapoor 
e t a l , 1982a) in our laboratory. I t was found t h a t ant ibody LP2 
had l i t t l e or no effect on the course of i n f e c t i o n in the ear 
pinna of nu/nu mice, when adminis tered one to t h r e e days a f t e r 
infec t ion . However, productive i n f e c t i o n in t he p e r i p h e r a l and 
c e n t r a l ne rvous s y s t e m i s m a r k e d l y r e d u c e d . A l t h o u g h 
n e u t r a l i s a t i o n by a n t i b o d y of v i r u s i s no t e f f e c t i v e in 
eliminating virus from the ear pinna, i t i s considered that t h i s 
mechanism may well r e s t r i c t the spread of virus to sensory nerve 
endings in the skin and prohibi t virus movement to the c e n t r a l 
nervous system at synaptic j u n c t i o n s . Unt i l more experiments 
with larger numbers of neutra l is ing as well as non-neu t r a l i s ing 
monoclonal antibodies are performed, i t i s not p o s s i b l e to say 
anything with ce r ta in ty about the role of neut ra l i s ing antibodies 
in protect ion from v i r u s d i s ea se when adminis te red a f t e r the 
infection i s es tabl ished. 
The role of antibodies in preventing the e s t a b l i s h i n g of 
l a t en t infection has been the sub jec t of much d i s c u s s i o n . That 
l a t en t infection of ganlia wi l l occurr even in the presence of 
hyperimmune serum i s i n d i s p u t a b l e (Kle in ,1980; Openshaw,1979 ; 
Price,1975). Dr.A.Kapoor found t h a t l a t e n t i n f e c t i o n could be 
e s t a b l i s h e d in nu/nu mice which were g iven LP2 a n t i b o d y ( u n p u b l i s h e d d a t a ) . However, a n t i b o d y may r e s t r i c t t h e 
establishment of l a t en t infection to fewer ganglia (McKendall e t 
a l ,1979) . This i s in agreement with our r e s u l t s , where we showed 
a r o l e for n e u t r a l i s i n g ant i -gD ant ibody in r e s t r i c t i n g the 
number of l a t e n t l y i n f e c t e d s i t e s in t h e g a n g l i a t h a t a r e 
establ ished during the course of infect ion. This phenomenon was 
further investigated by Kapoor e t a l (1982b), who used B-ce l l 
suppressed mice to a s s e s s the impor tance of c e l l u l a r and 
humoral immune mechanisms in primary and l a t en t i n f ec t i on . Their 
f i n d i n g s i n d i c a t e d t h a t , when n e u t r a l i s i n g a n t i b o d y was 
suppressed, there was an increased incidence of l a t en t infection (and primary infection of the ganglia and spinal cord) . Together 
with the observations reported in t he i r paper on the nu/nu mouse 
sys tem (Kapoor e t a l , 1982a ) , t h e s e f i n d i n g s a r g u e t h a t 
neut ra l i s ing antibody is important in r e s t r i c t i n g the spread of 
virus to the nervous system. 
The r e s u l t s reported in t h i s chapter are only a s t a r t in the 
d i rec t ion of elucidating the r e l a t i v e importance of an t ibody-
mediated mechanisms in the recovery of mice from p r i m a r y 
i n f e c t i o n and the e s t a b l i s h m e n t of l a t e n c y . M o n o c l o n a l 
a n t i b o d i e s w i l l not o n l y p r o v i d e t h e o p p o r t u n i t y f o r more 
deta i led s tudies of the importance of neu t ra l i sa t ion versus other 
ant ibody-mediated immune mechanisms, b u t w i l l a l s o p r o v i d e 




In t h i s r epor t the product ion and c h a r a c t e r i s a t i o n of nine 
monoclonal an t ibod ies to herpes simplex v i r u s type 2 has been 
described. The implications of the experiments described in the 
various chapters have already been discussed. In t h i s s e c t i o n I 
w i l l therefore concentrate on some current and po ten t ia l uses of 
some of the antibodies described. 
One example of the use of these antibodies has a l ready been 
given in chap te r 5. The f ind ings of Kapoor e t a l (1982a) in 
nu/nu mice suggest tha t neutra l is ing antibodies are involved in 
reducing the spread of virus to the c e n t r a l nervous system. In 
combination with the r e s u l t s in B-cell suppressed mice (A.Kapoor 
e t al ,1982b), where an increased incidence of l a t e n t i n f e c t i o n 
was observed when n e u t r a l i s i n g a n t i b o d y was s u p p r e s s e d , an 
important r o l e for n e u t r a l i s i n g a n t i b o d y in r e d u c i n g t h e 
inc idence of l a t e n c y i s i n d i c a t e d . These e x p e r i m e n t s a r e 
current ly being extended to include other neu t ra l i s ing and non-
neut ra l i s ing ant ibodies , and HSV-2 infected nu/nu mice. They wi l l 
contr ibute to our understanding of the r o l e of humoral ve r sus 
c e l l u l a r immune responses fo l lowing i n f e c t i o n wi th h e r p e s 
simplex v i rus , and may indicate in what i n s t ances n e u t r a l i s i n g 
antibodies are important. 
In a r ecen t r e p o r t , the use of monoclonal a n t i b o d i e s in 
serological analysis of HSV-1 and HSV-2 i s o l a t e s was eva lua ted (Pereira e t a l , 1 9 8 2 ) . I t was shown by f l uo re scen t techniques 
tha t monoclonal antibodies could not only d i s t i n g u i s h HSV-1 and 
HSV-2, bu t provided t h e f i r s t d e m o n s t r a t i o n of i n t r a t y p i c 
a n t i g e n i c v a r i a t i o n . In a p a p e r by Cranage e t a l ( t o be 
published) we demonstrate the p o t e n t i a l use of ant ibody LP4, 
which i s s p e c i f i c fo r HSV-2, in c l i n i c a l s e r o t y p i n g . T h i s 
a n t i b o d y was l i n k e d t o red b lood c e l l s , and used i n an 
haemagglutination assay to d is t inguish HSV-1 and HSV-2 s t r a i n s . 
The usefulness of several type-specif ic monoclonal a n t i b o d i e s , 
inc lud ing LP4, as RPH-reagents fo r t h e t y p i n g of c l i n i c a l 
i s o l a t e s , i s current ly being evaluated. 
In the above mentioned r e p o r t by Cranage e t a l , another 
a p p l i c a t i o n of monoclonal a n t i b o d i e s , coupled t o r ed b lood 
c e l l s , was described. When ant ibody LP2 o r AP7 (both d i r e c t e d 
against gD) were coupled to sheep red blood c e l l s , they f a i l e d 
to a g g l u t i n a t e in the presence of s o n i c a t e d o r s o l u b i l i z e d 
antigen prepared from e i t h e r HSV-1 o r HSV-2 in fec ted i s o l a t e s . 
However, agglut inat ion was achieved upon the subsequent a d d i t i o n 
of a polyclonal r a b b i t anti-HSV-2 b r idg ing an t i se rum. In t h i s 
system agglut inat ion was only possible if the bridging serum or 
monoclonal ant ibody had a c t i v i t y a g a i n s t gD. Al though t h e 
a d d i t i o n of LP2 to L P 2 - s e n s i t i z e d c e l l s d id not r e s u l t in 
a g g l u t i n a t i o n , LP2-linked a n t i g e n - s e n s i t i z e d c e l l s cou ld be 
agglutinated with ant ibody AP7. The r e s u l t s suggest t h a t the 
a n t i b o d y coup led to t h e red c e l l s e l e c t i v e l y b i n d s t o 
monodispersed gD-molecules in the ant igen-preparat ion. 
The a b i l i t y of LP2-linked virus ant igen-sensi t ized c e l l s to 
measure anti-HSV ant ibody was used to t e s t a panel of human 
s e r a , which had p r e v i o u s l y been t e s t e d fo r HSV-1 p l a q u e 
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neutra l is ing a c t i v i t y . A very good corre la t ion was found between 
r e s u l t s obtained using LP2-linked c e l l s and the plaque reducion 
assay. The heamagglutination method is obviously much more rapid 
and simple than the n e u t r a l i s a t i o n assays which are used a t 
present . In addit ion, i t may be possible to use t h i s procedure 
to measure immune responses to d i f f e r e n t components of HSV, as 
apparen t ly only one an t igen s p e c i f i c i t y i s c ap tu red by the 
a n t i b o d y on t h e r e d c e l l . C u r r e n t p r o c e d u r e s s u c h as 
immunoprecipi tat ion followed by e l e c t r o p h o r e s i s ( E b e r l e and 
Courtney,1981) are technical ly much more demanding. 
In an experiment which involved the use of antibody LP4, i t 
was shown that mouse L-ce l l s , transformed with fragments of HSV-
2 DNA, expressed the major DNA binding p r o t e i n of HSV-2 upon 
superinfection with HSV-1. This was demonstrated using the c e l l 
l ine D21 (Minson e t a l ,1982) , which was infected with HSV-1 and 
stained with fluorescent label led antibody LP4. I t was found tha t 
HSV-2 s p e c i f i c major DNA-binding p r o t e i n was p re sen t in the 
nuclei of these c e l l s . The use of LP4 represents an easy way of 
demonstrat ing the a c t i v a t i o n of genes coding for the type 2 
major DNA-binding pro te in . 
An ant i - id io type serum against antibody LP2 has been prepared 
in r abb i t s , which i s s p e c i f i c for the LP2- ld io type , has been 
prepared. This serum did not react with any of the other anti-gD 
a n t i b o d i e s in ou r p o s s e s s i o n . F u r t h e r m o r e , t h e v i r u s 
neutra l is ing ac t i v i t y was completely inhibited by the an t i se rum. 
Again th i s was specif ic for LP2 on ly . The use of a n t i - i d i o t y p e 
serum raised aga ins t s p e c i f i c monoclonal a n t i b o d i e s could be 
useful in demonstrat ing the frequency of c e r t a i n i d i o t y p e s 
present during natural HSV-infection. In addi t ion, the po ten t ia l 
use of a n t i - i d i o t y p e s a g a i n s t monoclonal a n t i b o d i e s cou ld 
theore t i ca l ly be useful as p u t a t i v e vaccines or s t i m u l a t o r s of 
protect ive immune responses as considered by the Jerne Network 
Theory. 
A var ie ty of applicat ions of monoclonal antibodies to HSV in 
immunological, basic vi rological and c l i n i c a l r e sea rch has been 
o u t l i n e d above. At p r e s e n t , t he r e p e r t o i r e of monoclonal 
antibodies to HSV in our laboratory is much larger than the nine 
antibodies reported in t h i s t h e s i s . I t is of course p o s s i b l e to 
outine more po ten t ia l applicat ions of these a n t i b o d i e s , such as 
s t u d i e s regarding the s t r u c t u r e and funct ion of p a r t i c u l a r 
ant igens, and the i r po ten t i a l usefu lness in the produc t ion of 
vaccines, but I have concentrated upon the present uses made of 
the antibodies by workers in our department . I t i s c l e a r t h a t 
monoclonal an t ibod ies can be of g r e a t value in answering many 
questions of varying na ture . In t h i s c o n t e x t , the exchange of 
a n t i b o d i e s between d i f f e r e n t l a b o r a t o r i e s would be ve ry 
valuable. 
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S U M M A R Y . 
In t h i s t h e s i s t h e p r o d u c t i o n and c h a r a c t e r i s a t i o n of 
monoclonal a n t i b o d i e s to Herpes Simplex Vi rus Type 2 i s 
described. The developement of a su i t ab le radioimmunoassay for 
the detect ion of anti-HSV-2 ant ibodies , and the s e l e c t i o n of an 
opt imal immunisation schedu le , i s given in c h a p t e r 2 . Three 
fusion experiments were performed, r e s u l t i n g in n ine s t a b l e 
hybridoma l i n e s . The monoclonal a n t i b o d i e s s ec r e t ed by these 
l i n e s were s u b s e q u e n t l y c h a r a c t e r i s e d . A l i s t of t h e s e 
antibodies and the i r p roper t i e s , including t a r g e t a n t i g e n s , i s 
given a t the back of t h i s t h e s i s . Four of the a n t i b o d i e s were 
directed against glycoproteins of the v i r u s , two reac ted with 
non-glycosylated p r o t e i n s and for t h r ee a n t i b o d i e s no t a r g e t 
an t igen could be i d e n t i f i e d . All a n i t b o d i e s were of the IgG 
c l a s s . 
Two ant ibodies , LP2 and LP3, were d i r e c t e d aga ins t the same 
p r o t e i n , gD. Competition binding experiments i n v o l v i n g two 
addi t ional monoclonal a n t i b o d i e s a g a i n s t t h i s p r o t e i n showed 
tha t there are a t l eas t th ree d i f f e r e n t type-common a n t i g e n i c 
s i t e s on the gD molecule of HSV-2. LP2 and LP3 a r e d i r e c t e d 
against d i f ferent antigenic s i t e s . 
Using tunicamycin, an unglycosyla ted p recu r so r of gD was 
found with a molecular weight of 49,000D. 
The r e a c t i v i t y of a n t i b o d i e s LP1 and LP4 with a number of 
d i f ferent HSV-1 and HSV-2 s t r a i n s s t r a i n s was determined. LP4 
proved to be s p e c i f i c for HSV-2, while LP1 showed comparible 
r e a c t i v i t y with HSV-1 and HSV-2 s t r a i n s . 
The a b i l i t y of antibodies LP2, LP3 and LP4 to p ro t ec t Balb/c 
mice from infection with HSV-1 or HSV-2 was a s se s sed . Antibody 
LP2, which is strongly neu t ra l i s ing , markedly reduced both the 
inflammatory response and virus t i t r e s in the s i t e of i n f e c t i o n 
compared to non-treated mice. Antibody LP3, which i s d i r e c t e d 
against the same prote in and i s of the same s u b - c l a s s , had no 
effect except for a s l i g h t l y enhanced inflammatory response. Mice 
t rea ted with antibody LP4 were ident ica l to the control group. 
Treatment with antibody LP2 reduced the frequency with which 
l a t en t infection was established in infected animals, and reduced 
the v i r u s t i t r e s recovered from r e a c t i v a t e d g a n g l i a . Again 
antibody LP3 had no e f fec t . 
The implications of the findings described above are discussed 
a t the end of each of the c h a p t e r s . A review of some of the 
current and po ten t ia l applicat ions is given in the Discussion. 
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S A M E N V A T T I N G . 
In d i t proefschrif t worden de p roduk t ie en k a r a k t e r i s e r i n g 
van monoklonale antilicharaen tegen Herpes Simplex Virus Type 2 (HSV-2) beschreven. 
HSV-2 heeft een dubbelstrengs DNA-genoom met een molekula i r 
gewicht van ongeveer 96 miljoen, verpakt in een eiwitmantel. Rond 
de nucleocapside z i t een nog ongedefinieerde s t r u k t u u r , d ie het 
tegument genoemd word t , en h e t g e h e e l i s omgeven door een 
t r i l amina i re membraan. 
In de v i rusdeel t jes komen ongeveer 33 s t r u k t u r e l e e i w i t t e n 
voor. Daarnaast z i jn in virus-geinfecteerde c e l l e n een nog veel 
g r o t e r a a n t a l , in i ede r geval meer dan 50, v i r u s - s p e c i f i e k e 
eiwit ten geident i f iceerd. Onze kennis van de s t r u k t u r e l e en de 
n i e t - s t r u k t u r e l e v i r u s - s p e c i f i e k e e i w i t t e n i s nog u i t e r s t 
b e p e r k t . Het onderzoek h i e r o v e r wordt b e m o e i l i j k t door de 
ingewikkelde struktuur van het virus en de moeilijkheden b i j het 
ident i f iceren van eiwit ten in gelnfekteerde ce l l en , omdat tussen 
verschil lende eiwit ten precursor-produktrelat ies mogelijk z i jn . 
Monoklonale an t i l i chamen tegen v i r u s - s p e c i f i e k e e i w i t t e n 
kunnen van groot belang z i jn b i j het onderzoek naar p r e c u r s o r -
produktre la t ies tussen ve r sch i l l ende e i w i t t e n . Met monoklonale 
a n t i l i c h a m e n kunnen v e r d e r ook h e t a a n t a l a n t i g e n e 
bindingsplaatsen per eiwitmolekuul worden v a s t g e s t e l d . Dit kan 
van groot belang zi jn b i j het ident i f iceren van HSV-1 en HSV-2 en 
het onderscheiden van verschil lende subgroepen van deze virussen. 
Nadat een geschikte methode was ontwikkeld voor de d e t e k t i e 
van antilichamen tegen HSV-2 met behulp van een radioimmunoassay, 
en verscheidene immunisatleschema's geevalueerd waren, werden 
d r i e fus ie-exper imenten u i tgevoe rd . Deze r e s u l t e e r d e n in de 
i s o l a t i e van negen s t a b i e l e c e l l i j n e n , d i e an t i l i chamen tegen 
HSV-2 ui tscheidden. Deze ant i l ichamen werden g e k a r a k t e r i s e e r d 
door middel van i m m u n o f l u o r e s c e n t i e , n e u t r a l i s a t i e - en 
i m m u n o p r e c i p i t a t i e - e x p e r i m e n t e n . Ook werd nagegaan of de 
an t i l i chamen reageerden met HSV-1, en werd bepaald t o t welke 
immunoglobulineklasse ze behoren. 
Een samenvatting van de eigenschappen van de v e r s c h i l l e n d e 
monoklonale an t i l i chamen , alsmede een l i j s t van de e i w i t t e n 
waartegen ze g e r i c h t z i j n , wordt gegeven aan het eind van d i t 
p r o e f s c h r i f t . Vier an t i l ichamen bleken g e r i c h t t e z i j n tegen 
geglycosyleerde e i w i t t e n , twee t egen n i e t - g e g l y c o s y l e e r d e 
e iwi t ten , te rwi j l van dr ie an t i l ichamen het e i w i t waartegen ze 
ger icht zi jn n ie t kon worden geident i f iceerd. Twee an t i l i chamen , 
LP2 en LP3, bleken g e r i c h t t e z i j n tegen he t ze l fde e i w i t , gD, 
maar door compet i t ie -exper imenten kon worden bewezen d a t de 
antigene b ind ingsp laa t sen voor deze an t i l i chamen v e r s c h l l l e n d 
z i jn . Met behulp van nog twee andere monoklonale an t i l i chamen , 
g e r i c h t tegen gD, kon worden aangetoond da t gD minstens d r i e 
cross-reakt ieve bindingsplaatsen b e z i t . 
Met behulp vam tunicamycine , dat de glycosylering remt, kon 
worden aangetoond da t er in g e i n f e k t e e r d e c e l l e n een n i e t -
geglycosyleerde vorm van gD voorkomt met een molekula i r gewicht 
van 49,000 D. 
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Voor een aantal verschillende stammen van HSV-1 en HSV-2 werd 
getest of ze reageerden met de antilichamen LPl en LP4, met 
behulp van een radioimmunoassay. LPl reageerde met alle stammen, 
maar LP4 reageerde alleen met de stammen behorende tot de HSV-2 
groep. 
In een serie experimenten werd het vermogen van de 
antilichamen LP3 en LP2, die beiden gericht zijn tegen gD, om 
Balb/c muizen te beschermen tegen infektie met HSV-1 of HSV-2, 
geanalyseerd. Deze proeven toonden aan dat LP2 de ontsteking ten 
gevolge van de virusinfektie, en ook de virus titers op de plaats 
van de infektie, sterk reduceerde, terwijl LP3 geen effekt had, 
behalve een geringe vergroting van de ontsteking. Een derde 
antilichaam, LP4, dat reageert met het major DNA-binding protein, 
werd ook getoetst in het Balb/c muizen systeem. De resultaten van 
deze proeven wijzen erop dat neutraliserende antilichamen een rol 
spelen zowel bij de reduktie van de primaire infektie, als bij de 
reduktie van de verspreiding van het virus. Dit effekt op de 
verspreiding van het virus lijkt ook een reduktie in het aantal 
dieren, dat door de virusinfektie latent wordt, tot gevolg te 
hebben. Dit leek waarschijnlijk door de resultaten van een 
expriment waarbij het effekt van LP3 en LP2 op het voorkomen van 
latentie werd onderzocht. Het injekteren van LP2 reduceerde zowel 
het aantal latente muizen als de titers van het virus, dat uit de 
gereaktiveerde ganglionen kon worden verkregen. 
In de diskussie aan het eind van dit proefschrift wordt een 
kort overzicht gegeven van de verschillende manieren waarop deze 
antilichamen kunnen worden gebruikt in fundamenteel en klinisch-
gericht onderzoek van Herpes Simplex Virus. Een aantal van de 
antilichamen beschreven in dit proefschrift hebben inmiddels hun 





































































Table with proper t i e s of nine monoclonal a n t i b o d i e s . MDBP=Major 
DNA binding pro te in .nuc l .=nuc l ear ; cy t .=cytop lasmic . 
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A B B R E V I A T I O N S . 
AbC antibody-dependent complement mediated cytotoxicity. 
ADCC antibody-dependent cell-mediated cytotoxicity. 
BMV Bovine Mammalitis Virus. 
CDI carbodiimide. 
Ci curie 
cpm c o u n t s p e r minu te . 
CTL c y t o t o x i c T-lymphocyte. 
D d a l t o n . 
DMM Dulbecco's modified medium. 
EAV Equine Abortion Virus. 
EDTA ethylene diaminetetraacetate. 
ETC Glasgow's modified Eagles medium, supplemented with 
tryptose phosphate broth and calf serum. 
FCS foetal calf serum. 
GMM Glasgow's modified Eagles medium, 
hr hour 
HSV Herpes Simplex Virus. 
ICP infected cell polypeptide. 
ICSP infected cell specific polypeptide. 
IFCS heat-inactivated foetal calf serum 







M.W. molecular weight, 
nms normal mouse serum. 
PBS phosphate buffered saline, 
pfu plaque forming units. 
PMSF phenyl methyl sulphonyl fluoride. 
PRV pseudorabies virus. 
Pb rabbit. 
RIA radioimmunoassay. 
RPH reverse passive haemagglutination. 
RPHI reverse passive haemagglutination inhibition. 
SDS sodium dodecyl sulphate. 
Shrbc sheep red blood cells. 
Tr.Shrbc trypsinized sheep red blood cells. 
VP virion polypeptide. 
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